Search the web
Sign In
New User? Sign Up
StemCellInformation · Stem Cell Research Information + Impact
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Hear how Yahoo! Groups has changed the lives of others. Take me there.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Messages 6933 - 6962 of 6993   Newest  |  < Newer  |  Older >  |  Oldest
Messages: Show Message Summaries   (Group by Topic) Sort by Date v  
#6962 From: "Stephen Meyer" <Stephen276@...>
Date: Mon Apr 13, 2009 12:42 pm
Subject: NORTH DAKOTA, STEM CELLS, AND THE GREAT “PERSONHOOD” LIE by Don C. Reed
stephen_meye...
Offline Offline
Send Email Send Email
 

NORTH DAKOTA, STEM CELLS, AND THE GREAT "PERSONHOOD" LIE

 

by Don C. Reed

 

Filling sandbags against a raging river, North Dakota citizens inspired the world not long ago. Shoulder to shoulder the residents of Fargo, North Dakota worked, long nights in the pouring rain-- and they built that sandbag dam, protecting the lives and homes of their neighbors.

 

But now imagine a piece of foolishness:  suppose a new law has been enacted, criminalizing the making of sandbags. The legislation says each grain of sand has an existence of its own, and must be allowed freedom, independence, and a lawyer: full standing in a court of law.

 

The new legislation permits—no, requires!—that every sandbag be set free, yanked out of those North Dakota dams. And so the floods come roaring down, on the undefended homes…

 

Ridiculous? Don't laugh too soon.

 

On February 17th, 2009, North Dakota's House of Representatives passed an equally short-sighted bill with potentially devastating real-life consequences. That bill goes now to the state's Senate.

 

House Bill 1572 is a "personhood" law… establishing microscopic human cells as a person, a full-fledged human being.

 

It sounds harmless enough, at first.

 

But this new definition of personhood—giving legal status to tissue samples smaller than a grain of sand-- could blast the entire field of embryonic stem cell research.

 

Let's take a quick run through this bill, which would so casually criminalize one of humanity's best hopes.

 

Here are a few brief highlights; complete text follows at the end.

 

 

98312.0200  Sixty-first Legislative Assembly HOUSE BILL NO. 1572 of North Dakota, Introduced by Representative Ruby.

 

"Section 1. Equality and rights guaranteed to all human beings….

 

a.    "Human being" means any organism, (emphasis added) including the single-cell human embryo… (which) possesses a genome (for)… the human species."

 

Comment: According to the Human Genome Project, the genome is "found in every nucleus of a person's many trillions of cells…"

 (http://www.ornl.gov/sci/techresources/Human_Genome/publicat/primer/prim1.html)

 

There are approximately 100 trillion human cells in every human body—according to the new definition, how many are human beings? 

 

 

"2. The state shall naturalize all preborn persons and shall afford to them all the privileges and immunities of state citizenship, except that the state is not required to include preborn children in state and local censuses."

 

Comment:   The great commentator and comedian Will Rogers once said, "When Congress makes a joke, it's a law." HB 1572 does contain some unintended humor, like the above-named census exemption.

 

With trillions of newly-defined "preborn persons", a census would indeed be difficult— not to mention the income tax complications -- could we claim our own cells as dependents? 

 

But the proponents of this bill are deadly serious.

 

In a clear attempt to tar stem cells by association (like repeatedly naming a Congressman in an article on horsetheft) HB 1572 contains numerous references to:  incest, abortion, dismemberment, torture-- and the killing of children. 

 

 

"Section 3, part d:

 

"Because scientists have discovered a way of creating pluripotent cells using umbilical stem cells, there is no need to kill children to obtain their embryonic stem cells." 

 

There it is: the great personhood lie-- the pretense that there are children involved in embryonic stem cell research.

 

And what a shameful deception it is.

 

A blastocyst in a Petri dish is living tissue, not a life. 

 

To prove this, we need only ask ourselves one question:

 

Can a sperm and egg become a child—outside the womb? 

 

Common sense provides the answer. Without the nurturing shelter of a mother's womb, it is biologically impossible to make a child. 

 

No mother, no child: this is not rocket science.

 

Stem cell research, as the name implies, is cells, cells, nothing but cells—and the possibility of cure.

 

Why would such a ludicrous bill even be considered?

 

First, the opposition is running scared. They are losing, and they know it. When President Obama overturned the Bush restrictions on embryonic stem cell research, that put the Federal government  officially on our side.  The game is almost up. 

 

However:  if personhood laws can re-define life as having citizenship at the single-cell level, the U.S. Supreme Court (remember, the Roberts Court is very conservative) might actually find grounds to criminalize the entire field of embryonic stem cell research.

 

 Impossible?

 

The Dickey-Wicker Amendment already blocks federal funding for any new embryonic stem cell lines—and it does so with personhood language and concepts.

 

To be continued…

 

As promised, here is the full text of HB 1572.

 

"98312.0200  Sixty-first Legislative Assembly

HOUSE BILL NO. 1572 of North Dakota

Introduced by Representative Ruby

 

A BILL for an Act to provide for equality and rights to all human beings at every stage of

biological development; to create and enact two new sections to chapter 12.1-17, relating to the crimes of dismemberment and torture; to amend and reenact subsection 3 of section 12.1-20-03, section 12.1-20-11, subsection 2 of section 12.1-20-17, and section 12.1-27.2-04.1 of the North Dakota Century Code, relating to penalties for crimes against born alive children; to provide legislative intent; and to provide a penalty.

 

BE IT ENACTED BY THE LEGISLATIVE ASSEMBLY OF NORTH DAKOTA:

SECTION 1. Equality and rights guaranteed to all human beings.

 

1. For purposes of this Act:

a. "Born", "birth", "partially born", "born alive", and any derivation thereof, apply

to any child located inside a uterus, which is pulled out of the mother; or who

has ever had any part of its body, including the head, pulled out of the uterus,

such as during natural birth, artificial birth, or abortion.

 

b. "Human being" means any organism, including the single-cell human embryo,

irrespective of the method of reproduction, who possesses a genome specific

for and consistent with an individual member of the human species.

 

c. "Human embryo" means all human beings from the beginning of the

embryonic period of their biological development through eight weeks,

irrespective of age, health, function, physical dependency, or method of

reproduction, whether in vivo or in vitro.

 

d. "Human fetus" means all human beings from the beginning of the fetal period

of their biological development, which begins at nine weeks gestation through

birth, irrespective of age, health, function, physical dependency, or method of

reproduction, whether in vivo or in vitro.

 

e. "Human genome" means the total amount of nuclear and extra-nuclear DNA

genetic material that constitutes an organism as an individual member of the

human species, including the single-cell human embryo.

 

f. "Person" or "individual" means the legal recognition of a human being's full

status as a human person that applies to all human beings, irrespective of

age, health, function, physical dependency, or method of reproduction,

including their preborn offspring at every stage of their biological

development.

 

2. The state shall naturalize all preborn persons and shall afford to them all the

privileges and immunities of state citizenship guaranteed in section 21 of article I of

the Constitution of North Dakota, except that the state is not required to include

preborn children in state and local censuses.

 

3. The state shall afford the equality and inherent rights guaranteed to individuals in

section 1 of article I of the Constitution of North Dakota and the right to due

process guaranteed to persons in section 12 of article I of the Constitution of North

Dakota to all human beings, including the preborn, partially born, born alive, and

born alive who reenter the womb.

 

4. Personhood may not be denied:

a. If all the body parts are pulled out of the uterus except the legs or arms or

portions of legs or arms are still inside the uterus;

b. When the child is about to be born;

c. When the child's head is taken out and placed back inside the uterus;

d. If a child's head is pushed back inside the uterus;

e. To partially born or born alive babies; or

f. Once a uterus is placed back inside the mother.

 

SECTION 2. Legislative findings regarding certain effects of establishing

personhood.

 

1. With respect to preborn personhood, it is the intent of the legislative assembly to:

a. Immunize a woman from criminal prosecution for abortion.

b. Increase and decrease the penalties for crimes against persons.

 

2. It is the intent of the legislative assembly that every available means to assert

preborn personhood be used, which has been denied to even late term preborn

and partially born children.

 

3. It is the finding of the legislative assembly that:

 

a. The right to life is the paramount right of a person. The right to life is a more

fundamental right of a preborn child than the mother's right to liberty or pursuit

of happiness, which does not include the right to kill other people. In no way

does a child's right to life interfere with a mother's right to life.

 

b. The state does not need to prove that it has a prerogative or a compelling

interest before the courts allow this state to recognize that all children are

persons and human beings, which they are. The legislative assembly may

not attempt to immediately solve all the effects of preborn personhood until

after thorough study and more importantly until after actually establishing

preborn personhood and waiting for the courts to recognize it.

 

c. When the uterus with a child inside is placed back inside the mother,

personhood extends to all other preborn children due to equal protection of

the laws.

 

d. Because scientists have discovered a way of creating pluripotent cells using

umbilical stem cells, there is no need to kill children to obtain their embryonic

stem cells.

 

e. It is not yet possible to conclusively determine whether all chemical

contraception is abortifacient or not.

 

f. All abortions, whether surgically or chemically induced, terminate the life of a

whole, separate, unique, living human being. There is an existing relationship

between a pregnant woman and her preborn child during the entire period of

gestation.

 

g. Because all preborn children are persons, no abortion performed with specific

intent is legal. A direct abortion is always performed with the specific intent to

bring death to a preborn child; it is a deprivation of the right to life and the right

to the equal protection of the law and is the ultimate manifestation of the

involuntary servitude of one human being to another.

 

 h. A mother is not going to die by recognizing her child's right to life. When the

mother needs a life-saving medical operation, then an indirect abortion is not

legally or morally considered abortion because it is not performed with specific

intent to bring death to a preborn child. The death of the child may be

permitted as an indirect and unavoidable result of steps necessary to save the

mother's life. Physicians shall make, in all cases, every effort to preserve

both the life of the mother and the life of the preborn child. Physicians shall

provide equal care and equal consideration to the mother and child.

 

i. Medical treatment that has as its primary purpose to cure a disease of the

pregnant woman or of a twin preborn human being may not be considered

abortion. The pregnant woman must be given the choice of which treatment

to receive provided it is treatment intended to act upon or cure a disease.

This excludes the possibility of ever performing an abortion under the

pretense of a medical necessity since a preborn human being is not a

disease.

 

j. In the case of twins, all medical procedures designed to address specific

medical conditions that affect both twins are lawful provided as the physician's

actions are performed with the specific intent to save the life of the preborn

human being with highest chance of survival.

 

k. If a pregnant woman's health is in danger during a pregnancy, the physician

may not be held criminally responsible for unintentionally causing the death of

the preborn human being from legitimate treatment administered to the

pregnant woman. Chemotherapy, radiation treatment, and other medical

procedures that are not intended to cause the death of the preborn human

being but that are likely to do so, may not be prohibited if prescribed to cure

the pregnant woman. Under no circumstance may abortion be considered

legitimate treatment.

 

SECTION 3. Two new sections to chapter 12.1-17 of the North Dakota Century Code

are created and enacted as follows:

 

Dismemberment - Penalty.

 

1. A person is guilty of an offense if that person intentionally dismembers the body of

another human being, as defined in section 1 of this Act, without causing the death

of the other human being.

 

2. The offense is a class C felony, except if the victim is a born alive child, as defined

in section 1 of this Act, the offense is a class B felony.

 

Torture - Penalty.

1. A person is guilty of an offense if that person intentionally inflicts excruciating pain

on another human being, as defined in section 1 of this Act, without causing the

death of the other human being.

 

2. The offense is a class C felony, except if the victim is a born alive child, as defined

in section 1 of this Act, the offense is a class B felony.

 

SECTION 4. AMENDMENT. Subsection 3 of section 12.1-20-03 of the North Dakota

Century Code is amended and reenacted as follows:

 

3. a. An offense under this section is a class AA felony if in the course of the

offense the actor inflicts serious bodily injury upon the victim, if the victim is a

born alive child, as defined in section 1 of this Act, if the actor's conduct

violates subdivision a of subsection 1, or if the actor's conduct violates

subdivision d of subsection 1 and the actor was at least twenty-two years of

age at the time of the offense. For any conviction of a class AA felony under

subdivision a of subsection 1, the court shall impose a minimum sentence of

twenty years' imprisonment, with probation supervision to follow the

incarceration. The court may deviate from the mandatory sentence if the

court finds that the sentence would impose a manifest injustice as defined in

section 39-01-01 and the defendant has accepted responsibility for the crime

or cooperated with law enforcement. However, a defendant convicted of a

class AA felony under this section may not be sentenced to serve less than

five years of incarceration.

 

  1. Otherwise the offense is a class A felony.

 

SECTION 5. AMENDMENT. Section 12.1-20-11 of the North Dakota Century Code is

amended and reenacted as follows:

 

12.1-20-11. Incest. A person who intermarries, cohabits, or engages in a sexual act

with another person related to him within a degree of consanguinity within which marriages are declared incestuous and void by section 14-03-03, knowing such other person to be within said degree of relationship, is guilty of a class C felony. If the victim is a born alive child, as defined in section 1 of this Act, the person is guilty of a class B felony.

 

SECTION 6. AMENDMENT. Subsection 2 of section 12.1-20-17 of the North Dakota

Century Code is amended and reenacted as follows:

 

2. A person who, knowing that that person is or has been afflicted with acquired

immune deficiency syndrome, afflicted with acquired immune deficiency syndrome

related complexes, or infected with the human immunodeficiency virus, willfully

transfers any of that person's body fluid to another person is guilty of a class A

felony. The person is guilty of a class AA felony if the victim is under the age of

fifteen or the victim is a born alive child as defined in section 1 of this Act.

 

SECTION 7. AMENDMENT. Section 12.1-27.2-04.1 of the North Dakota Century Code

is amended and reenacted as follows:

 

12.1-27.2-04.1. Possession of certain materials prohibited. A person is guilty of a

class C felony if, knowing of its character and content, that person knowingly possesses any motion picture, photograph, or other visual representation that includes sexual conduct by a minor. A person is guilty of a class B felony if the minor is a born alive child as defined in section 1 of this Act.

 

SECTION 8. STATE TO DEFEND CHALLENGE. The legislative assembly, by joint

resolution, may appoint one or more of its members, as a matter of right and in the legislative member's official capacity, to intervene to defend this law in any case in which its constitutionality is challenged.


#6961 From: "Stephen Meyer" <Stephen276@...>
Date: Tue Mar 31, 2009 1:16 pm
Subject: ONE PHONE CALL—TO SAVE TEXAS STEM CELL RESEARCH RIGHTS!--by Don C. Reed
stephen_meye...
Offline Offline
Send Email Send Email
 

ONE PHONE CALL—TO SAVE TEXAS STEM CELL RESEARCH RIGHTS!

 

                                                                    by Don C. Reed

 

Dear Friends:

 

Anti-research forces in Texas are trying to pull a fast one, to kill all hopes for embryonic stem cell research in the state, permanently. They are doing it two ways.

 

First, Senator Steve Ogden (R-Bryan) "quietly" inserted a 24-word provision banning state funds for any form of embryonic stem cell research-- into the Texas budget (SB 1). If the budget passes (which it must) as is, the research is effectively banned.

 

According to the Dallas Morning News, "The Senate finance committee, which Ogden heads, took only two minutes to consider his rider. It says, "No funds appropriated under this act shall be used in conjunction with or to support research which involves the destruction of a human embryo."—R. T. Garrett, Dallas Morning News, March 30, 2009.

 

Senator Ogden did not allow research scientists or patient advocates to speak.

 

Afterwards, Ogden was asked if that provision would kill embryonic stem cell research in Texas. He reportedly responded, "If that one doesn't, my next one will."

 

Second, Senator Ogden's bill, SB 1695, would "…end all embryonic stem cell research…in any of the laboratories of our state. Even private institutions like Baylor College of Medicine would be affected because they receive state funding."—Texas research advocate Dr. Ralph Dittman, cited in Huffington Report.

 

Folks, the debate on the Texas budget begins Wednesday, which is TOMORROW.

 

Any chance you could make one phone call, to try and preserve Texas stem cell research? (Which, by the way, is very much worth fighting for; I will tell you later about some of the outstanding scientists in the Lone Star state.)

 

It doesn't matter where you live. Texas voters have the most importance of course, but right now, the main thing is to make some noise.  This is attack legislation-- in a state which has the possibility of genuinely vast amounts of research, as much as three billion dollars for cancer alone. We dare not lose the enormous contributions of this vital state.

 

As always, Texans for the Advancement of Medical Research, TAMR, is leading the charge against this insidious infringement on research rights.

 

Friend Judy Haley, immediate past President of TAMR, says:

 

"This is the worst situation we have ever had… an emerging disaster. They (the rider to the budget, SB 1, and the bill, SB 1695--dr) would ban ALL hESC in Texas in any research facility that receives any state funding—(including) all our public and private labs. This would be a disaster, not only in Texas, but as a model for how to do it (damaging legislation) for the rest of the nation."

 

Joe Brown, current President of TAMR suggests a message:

 

First, if you live in Texas:

 

Click on this link http://www.fyi.legis.state.tx.us/ and enter your home address under "who represents me" to find your senator and their phone number.

 

CALL OR FAX YOUR STATE SENATOR WITH THE MESSAGE:

 

"Stem cell research is important to me, to my family, and to millions of Texans; it is unacceptable for the Texas Legislature to pass any bill or rider which restricts embryonic stem cell research done under National Academy of Science ethical guidelines. I want Senator _____________ to actively work to make sure that neither SB 1's prohibitive  rider nor SB 1965 do not become part of Texas law."

 

Don't live in Texas?

 

Call anyway.

 

Three calls you could make:

 

  1. David Dewhurst, President of the Senate and Lt. Governor: (512) 463-0001
  2. Jim Pitts, Chairman of House Appropriations Committee:  (512) 463-0516
  3. Joe Straus, Speaker of the House: (512) 463-0516

 

Nothing fancy is required. Just tell whoever answers that you oppose the anti-embryonic stem cell research rider on the Texas budget this year, and  also you oppose SB 1695.

 

You might even tell them why, maybe mentioning a condition which affects you or a loved one.

 

The opposition calls itself "right to life" people. But the way I see it, my sister Barbara has both cancer and leukemia, and she has a right to life as well.

 

Please make that phone call; it will take you five minutes, and it could make the difference.

 

To help heal our loved ones—stand tall for Texas today!

 


#6960 From: "Stephen Meyer" <Stephen276@...>
Date: Thu Mar 26, 2009 12:43 pm
Subject: A YEAR IN THE LIFE OF CALIFORNIA’S STEM CELL RESEARCH PROGRAM By Don C. Reed
stephen_meye...
Offline Offline
Send Email Send Email
 

A YEAR IN THE LIFE OF CALIFORNIA'S STEM CELL RESEARCH PROGRAM
 
                                                By Don C. Reed
 
Imagine that you and I are involved in a terrible war, against a relentless enemy which fully intends to kill us and all our families. But we are fighting back hard, and despite tremendous odds against us, we are beginning to win.
 
Suddenly good news arrives: reinforcements are on the way!  
 
Should we respond by laying down our arms, to surrender?  
 
President Obama's reversal of the Bush stem cell restrictions is wonderful: a decision that will echo down the halls of history. But it is not victory.  
 
The Obama edict brings no guarantees of new stem cell funding. Those "extra" NIH funds you heard about? At best, they help make up for 5 years of flat-lined funding, when National Institutes of Health budgets remained stagnant, not even matching increases of inflation.
 
Now is the time to redouble our efforts, not relax them.

  
Let me show you why.
 
In the midst of all the economic gloom and doom, something shining has emerged in California: the beginning of a vastly better world.
 
Take a look at some highlights of what the California Institute for Regenerative Medicine (CIRM) did—with just twelve months of reliable funding, in 2008.
 
(You can verify the following amazements by going to http://www.cirm.ca.gov/  Scroll down the left side of the page, until you find a bright red picture of stem cells, click under that: 2008 report, download it for free.)
 
LABORATORIES: have you tried to find parking for your car at an overcrowded college campus lately? Imagine what a nightmare it is to find space for new stem cell laboratories, let alone equip them. Dedicated buildings are urgently needed.
 
But bricks and mortar costs a lot, and the last thing California wants is to spend precious research dollars on a bunch of unnecessary buildings. So, a limit was set: no more than 10% of the entire program's cost, $300 million, could be used for facilities. But, that's not much money. In today's market, it would pay for only about three or four hundred homes: nowhere near enough for serious labs.


How did the CIRM meet this challenge?
 
They authorized $271 million on facilities (buildings and equipment)—and, to make sure we got the most possible bang for its buck, a special requirement…. Any organization wanting a grant had to bring their own money as well.
 
This strategy brought in an additional $880 million dollars. Our $271 million in taxpayer money was leveraged (great word) into $1.15 billion dollars.
 
Twelve major facilities will be built—and soon. All these buildings are contractually obligated to be up and running by the end of 2010.

 

And of course, we must not forget the stem cells…
 
CIRM NEW CELL LINES AWARDS

After 8 years of being stuck with a tiny number of ancient stem cell lines, America desperately needs new ones--$25 million went to derive new cell lines.  Some were disease-specific: allowing us, for the first time in history, to watch the development of Alzheimer's disease in a Petri dish, instead of only seeing—too late—its devastating results on a person.
 
Other stem cell lines are needed to compare embryonic stem cells with the new kind of cells, induced Pluripotentiary Stem cells (iPS). As we struggle to find out if the new (iPS) method can be made safe for human use, or even as a research tool, we also need to know if it can really do the job.
 
And who will be allowed access to these new stem cell lines funded by CIRM?

 

These valuable biomaterials will be available to any responsible researcher working toward cures…

 

New buildings, new stem cell lines-- how about some new scientists?
 
TRAINING NEW SCIENTISTS: CIRM RESEARCH TRAINING PROGRAM II

 

For too long, only scientists in their mid to late forties, folks who had their PhD's for almost a decade, have been able to receive funding from the NIH.

 

But if we only fund scientists that far along in their career, how will the field grow? If young scientists cannot get grants, their options are limited. At best, they will  work for other scientists, doing research directed by them instead of blazing their own trail; or, financial need may drive them out of the field altogether.


The very first project CIRM funded was training grants, to help new scientists into our field, an oasis of funding in what had been barren desert. Training Program II continues providing funds for these young men and women and their labs: allocating $40 million for this vital effort.  

 

But even the greatest scientist cannot do his or her work alone.


TEAM ASSISTANCE:  Generals are nothing without soldiers; even so, scientists rely on the assistance of trained professionals; where will they come from?  

 

"An educated and properly trained workforce is essential if our state is to retain its premier position and fully realize the medical and economic benefits from this emerging industry."—joint statement, Senator Gloria Romero and Senate President Pro Tem Darrel Steinberg.
 
The "CIRM Bridges to Stem Cell Research Awards" program is designed to insure training exists for these incredibly valuable technicians: the workforce to make the miracles possible, perhaps becoming future superstars themselves– you never know where success in such a new enterprise may lead.

 

$17 million in these Bridges awards has been approved.

 

But what about the business side? The greatest stem cell idea in the world means nothing, if it is not translated into something real and usable: and that means biotech.
 
LOANS 

 

"Our new loan program for biotech companies is meant to provide… support for institutions testing the safety and efficacy of possible therapies."—Robert N. Klein, Chair, ICOC.
 
Developed by our new Vice-Chairman Duane Roth and Finance subcommittee Chairman Michael Goldberg, (and of course Chairman Klein, who is pretty much everywhere) the new loan program is for $500 million—and hopefully an additional $500 million in federal loan guarantees as part of the stimulus package.
 
Numbers that big numb my brain like novocaine at the dentist's.   

 

But wait, there's more! 
 
"That amount would be scaled up by recycling an additional $1 billion in repayment proceeds over the first decade of the program. In short, with $500 million in federal long-term guarantees and recycled principal repayments, interest and stock warrant revenue from borrowers, over $1.5 billion in additional resources could be added to the Proposition 71 portfolio."—BK.
 
As I understand it (always an element of doubt about that) this would be astonishing.

 

Leveraging five hundred million in state dollars to two billion, perhaps even two and half billion, so that California got five times the value of its initial investment?
 

And, these loans are targeted: designed to answer an unmet and colossal need.
 
CLINICAL TRIALS

Taking just one new product from idea to pharmacy costs hundreds of millions of dollars, due to safety testing.

 

The time between basic research and clinical trials completion is called the "Valley of death" because so many products and companies die during that period. What an agony it would be to have a great cure for paralysis, for example, and then watch it fail-- for lack of money to pay for those tests.
 
The new loan program is designed to help turn the ideas of cure into products everyone can use: promising new medicines or therapies through the grueling cycle of tests, so they can be submitted to the FDA for approval.

 

MODEL FOR THE COUNTRY

 

Look at the path that CIRM has laid down for cure: educating and supporting scientists, helping train their support staff, setting up loans for the companies that will risk so much to develop products for patients… this is something which should be shared, and imitated.
 
COMMUNICATION:
 
Next ICOC meeting you go to, look for a crew-cut, glasses-wearing individual with tremendous energy, listening to everything, hardly ever sitting still—this is Don Gibbons. Very often, he has the honor of being the voice of the CIRM. 

 

A tough job indeed. For starters, he has to understand enough of the science to be able to translate it into people talk, enough legalese to do the same for those complicated aspects.
 
In addition to sharing information through public outreach, some of Gibbons' projects include: updating the CIRM website, (major improvements just days away, btw) Town Hall Meetings (You MUST come to one of these—the first one was last week, and it was terrific—three outstanding scientists use people talk to share where their corner of the science is at—more info at bottom of page.

 

And what a message he has to share, as the CIRM's influence grows, even leaping beyond the artificial boundaries of lines drawn on a map.
 
COOPERATING WITH OTHER STATES AND NATIONS:

 

"…no one state or nation (can) do this alone," stated Governor Arnold Schwarzenegger,"…collaborations…which bring together leading medical researchers from around the globe have a great potential in improving the lives of not only Californians, but all the people around the world."

 

The CIRM has already made agreements for combined research with countries including Australia, Spain, Japan, the United Kingdom and Canada, bringing in additional funds to the effort. Those countries have already committed over $200 million dollars to collaborative efforts with CIRM.

 

For example, Canada will be teaming with California to fight cancer.


There is more to come. California money must always be spent inside the borders of our state (as required by Prop 71 statute), but knowledge can and should be shared.

 

State to state cooperation will, increase our strength. Consider the example set by Dr. Dennis Clegg of UC Santa Barbara. Working with colleagues in Massachusetts, he found a molecule that helps embryonic stem cells multiply faster, while still maintaining their stability, vital characteristics for the large quantities of pure cells we will need for cure.

 

CALIFORNIA GOLD

 

It is not enough just to labor endlessly—everybody wants results.  As President Alan Trounson puts it: "I tell my colleagues here at CIRM probably at least once a week: "We are in a hurry; we have a short time frame, and we need to get genuine cures to Californians."

 

The opening page of the 2008 report shows the official motto of the CIRM:

 

"turning stem cells into cures".—Roman Reed.

 

That is my son who wrote those words, in case you did not know—and that is our goal.

 

Success will come in careful reliable steps, and we are taking them right now.

 

We benefit from the leadership of chief science officer Marie Csete (pronounced chet-uh) an energetic little exclamation point of a person, and the indefatigable Director of Scientific Activities, Patricia Olson.

 

Do you know them? If you live in California, you should. Walk up and say hello to them at the next CIRM meeting.

 

Are they approachable? You bet. Here is an example.

 

There will soon be an autism workshop: for scientists only. This is fairly common, giving the scientists a chance to speak their own language, and interchange ideas—very important.  BUT— such knowledge should be shared. So, seeing Dr. Csete at another public meeting (there have been about 150 public meetings so far) I asked her if there was a way to make the autism meeting more open, because there were literally millions of people interested in this all-too-common condition. She thought about it for a minute, and then said, there should be a transcript, print and video, and that could be made available on the web. (Something I forgot to ask was: could parents of autistic children send in questions to be asked of the scientists?)

 

That is how this program works. The decisions are made in public, and anyone who wants to get involved is welcome.

 

Come to the meetings; California wants you! (to find out when and where the meetings are, go to http://www.cirm.ca.gov/  and click on Meetings; it is up near the top of the page.

 

Already, CIRM scientists have authored more than 70 scientific publications, adding to the world's understanding.

 

If you go to the meetings, you will get to hear Dr. Trounson talking about the latest breakthroughs in stem cell science. Such as:

 

Remember one huge difficulty with the new stem cell method,  iPS, induced Pluripotent Stem cells, mainly that the use of viruses might cause cancer? At Scripps Institute, a scientist named Sheng Ding may have found a way around that obstacle, using "small molecules rather than viruses to carry reprogramming genes into cells, moving the iPS cells closer to being safe for clinical use."

 

And speaking of genes, this miniscule marvels which turn body processes on and off, it is vital we know exactly which genes do what-- and  Dr. Jean Loring and her team "published a database of gene expression profiles", vital information for the sorting of cells.

 

(Both those scientists, by the way, received CIRM grants.)

 

Sometimes, a step in one area helps in another; look at the next two paragraphs.

 

First, If we can learn how healthy cells are turned into cancer cells, (as Dr. Wei Guo of UCLA did with blood cells), maybe we can learn how to do the reverse-- and turn cancerous cells back into healthiness.

 

Second, at Stanford, Dr. Emmanuelle Passegue showed that a "family of cancer-fighting proteins also helps blood-forming stem cells divide normally."

 

As CIRM President Dr. Alan Trounson observed, "These two push-and-pull findings hold great promise for uncovering novel ways of treating cancer and preventing its spread."

 

CIRM helped Dr. Catriona Jamieson of UCSD as she brought a new approach to fighting leukemia to human trials.

 

So much more: at Stanford, human embryonic stem cells were grown into "primitive cardiac tissue (which) repaired heart damage in mice".

 

At UCLA, scientists matured human embryonic stem cells into T cells and inserted a gene—why does that matter? "Their eventual goal is to insert a gene that makes the cells immune to HIV/AIDS, then replace a person's infected cells with the resistant ones…"
 
Yet there are still dark days ahead, much work to do, battles yet to fight—including financial ones.

 

WILL THERE BE MONEY TO PAY FOR EVERYTHING?

 

If the financial equivalent of Hurricane Katrina crashes down upon us, (and it did) we have only two choices: adjust, or let the program die. 

 

First, every new grant comes with a proviso that the money will be provided if and when it is available. Some extremely worthwhile projects may have to be delayed a year. This is just a fact of economic life.

 

Our program depended on selling bonds. 

 

If California cannot sell bonds, will we be able to keep the stem cell program alive?

 

Here is the official CIRM answer.

 

"CIRM's Financial Commitments Are Secure… CIRM currently has significant cash reserves of $160 million, which can fund all existing commitments through at least September. The agency's plans have always called for raising new capital on a cash-flow, as-needed basis. We expect the traditional bond market will open soon with resolution of California's budget situation. To supplement this public bond market, CIRM is working with the State Treasurer's office on a CIRM private placement of $200 million in general obligation bonds this year and $200 million again next year… The Agency intends to continue the planning and review needed to maintain its mission on schedule…"

 

The men and women of California's stem cell program have taken up the gauntlet, accepting this new challenge.

 

They deserve the support and thanks of a nation.

 

SO WHAT DO WE DO NOW?

 

In California we have funded a solid beginning. We must build on that, in "synergistic cooperation" (Gibbons' phrase) with the federal government, each side strengthening the other, and the same with other states across the land.

 

Ten thousand stem cell advocates developed Proposition 71; seven million Californians voted it into law; what we need now is more of the same.

 

Not every state wants or needs to be a California or New York, with major biomedical infrastructure employing hundreds of thousands of workers in excellent and good-paying jobs. But every state should at least have funding for regenerative research, and the freedom to do it. 
 
As patient advocates, you and I are involved in a war against chronic disease and disability. And it is a war, make no mistake about that. Millions of lives are at stake, as well as the economies of every nation.

 

Our motivation is continual; for those who themselves are suffering, the pain and distress is a constant reminder. For we who have the luck of health, our loved ones must be fought for.
 
But ours is a war like none that ever was before. It is a very civilized combat.

 

We have two sides essentially throwing words at each other. We pound the keyboards for a while—argue, argue, argue—then rest, do some other chores for a while, and then come back to the computer, fight some more.

 

These are epic confrontations, on which the future of the world depends; yet, nobody is killed. There are no ruined families, no widows made, nor orphans, no silent graveyards, no white crosses on a hill.

 

In this war, we are fighting to save lives, not take them. 

 

And when we win, there will be no reason for tears: save only those of joy.

 

 

 

 


#6959 From: "Stephen Meyer" <Stephen276@...>
Date: Wed Mar 11, 2009 1:38 pm
Subject: Stem Cell Action News-Issue Number 5-March 10, 2009
stephen_meye...
Offline Offline
Send Email Send Email
 
Stem Cell Action News
Powered by Genetics Policy Institute

March 10, 2009

Welcome to issue number 5 of Stem Cell Action News, dedicated to informing the stem cell community on the latest and most important developments impacting the Pro-Cures Movement.

Obama Lifts Stem Cell Restrictions
No Time for Complacency—Tough Stem Cell Policy Battles Ahead

Yesterday, President Barack Obama delivered a striking blow in favor of sound science by overturning the Bush Executive Order of August 9, 2001, which banned federal funding of embryonic stem cell research beyond the 21 presidential lines.  The Genetics Policy Institute applauds President Obama for signing a new executive order that expands federal funding for this life-saving research.  

However, at this pivotal moment the stem cell community can not become complacent. Our most difficult work lies ahead, as we expect research foes to unleash new legal roadblocks and delaying tactics by continuing to assert unsupported arguments playing upon ignorance and fear.  We urge all stem cell stakeholders to take action and support yesterday's executive order and future advocacy 2.0 efforts.  

In order to provide certainty, the next step is to protect embryonic stem cell research by legislation. Building on the momentum, it's time to repeal the Dickey-Wicker Amendment that serves as a blockade for funding research on work on embryos discarded from in vitro fertilization procedures to derive new cell lines or somatic cell nuclear transfer. We applaud Congresswoman Diana DeGette who has expressed her intention to seek reversal of this fundamental funding restriction.

 

Headlines & Advocacy

 
Obama overturns Bush policy on stem cells - BostonHerald.com  09/03-2009 13:22  (BostonHerald.com)
WASHINGTON — President Barack Obama signed an order today that allows federal taxpayer dollars to fund expanded embryonic stem cell research, reversing one of his predecessor's policies viewed by many as blocking development of potentially life-saving medical treatment.


Eight Reasons to Applaud Action on Stem Cells  09/03-2009 13:20  (Center for American Progress)
Report: A Life Science Crucible: Stem Cell Research and Innovation Done Responsibly and Ethically Interactive timeline: A Brief History of Stem Cell Research President Barack Obama takes a first step today toward bringing the United States back to the scientific cutting edge by issuing an executive order...


Obama Lifts Stem Cell Restrictions  09/03-2009 13:20  (Center for American Progress)
With the stroke of a pen, President Barack Obama today erased the Bush administration's eight-year-old restrictions on federal funding of research involving human embryonic stem cells, reaffirming his commitment to evidence and biomedical hope over his predecessor's ideological distortion of science.


Obama Addresses Decision to Lift Embryonic Stem Cell Limits  09/03-2009 13:01  (The Washington Post)
PRESIDENT OBAMA: Today, with the Executive Order I am about to sign, we will bring the change that so many scientists and researchers; doctors and innovators; patients and loved ones have hoped for, and fought for, these past eight years: we will lift the ban on federal funding for promising embryonic stem...


Obama to Let Health Institute Decide on Stem Cells - NYTimes.com  08/03-2009 20:22  (The New York Times)
Filed at 7:02 p.m. ET WASHINGTON (Reuters) - President Barack Obama will lift his predecessor's restriction on federal funding of human embryonic stem cell research on Monday and will give the National Institutes of Health four months to come up with new rules on the issue, officials said on Sunday.


Obama Expected to Reverse Limits on Stem Cells - NYTimes.com  06/03-2009 17:49  (The New York Times)
WASHINGTON President Obama is expected to announce on Monday that he is reversing Bush administration limits on federal financing for embryonic stem-cell research, White House officials said on Friday.


Stem Cell Funding Roadblock  01/03-2009 12:07  (Genetic Engineering & Biotechnology News)
When President Bush assumed office in 2000, the human embryonic stem cell revolution was primed to launch. The outgoing Clinton administration directed the NIH to prepare comprehensive rules to govern the nascent field of discovery, with funding to follow.


piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells  01/03-2009 03:58  (Nature.com refers DOI)
Knut Woltjen1, Iacovos P. Michael1,2, Paria Mohseni1,2, Ridham Desai1,2, Maria Mileikovsky1, Riikka Hämäläinen1, Rebecca Cowling1, Wei Wang3, Pentao Liu3, Marina Gertsenstein1, Keisuke Kaji4, Hoon-Ki Sung1 & Andras Nagy1,2 Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5,...

Stem cells give hope to ailing pets, rich owners - BostonHerald.com
BostonHerald.com - 02/22/2009 00:44
CHICAGO - Meet Zoey Walsh, a teenage stem-cell recipient who is pushing the frontier of medical science. He's a dog. Unable to alleviate his pain with drugs and unwilling to risk another hip surgery on a dog so old, Zoey's owners turned to a treatment that involved injecting stem cells, which had been...

Stem Cell Treatment For Crohn's Disease
redtram (ENG) - 02/21/2009 22:14
Hospital Clínic, Barcelona is one of the few hospitals in the world to apply this new therapeutic option for patients with Crohn's disease, and it does so with the guarantee of success experienced in the US and Italy, where the » Full text » 2009-02-22 03:14:46 Stem Cell Treatment For Crohn's Disease...

WiCell, California firm agree to distribute stem cell lines derived with new technique
Bio-Medicine - 02/20/2009 22:16


Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient
PLOS Journal - 02/18/2009 00:07
Ninette Amariglio1,2, Abraham Hirshberg3, Bernd W. Scheithauer4, Yoram Cohen1, Ron Loewenthal5, Luba Trakhtenbrot2, Nurit Paz1, Maya Koren-Michowitz2, Dalia Waldman6, Leonor Leider-Trejo7, Amos Toren6, Shlomi Constantini8, Gideon Rechavi1,6* 1 Cancer Research Center, Sheba Medical Center and Sackler School...
 
New kind of stem cells can turn into heart cells, University of Wisconsin-Madison researchers show
Wisconsin State Journal - 02/12/2009 22:51
A new kind of stem cells developed by UW-Madison researcher James Thomson performs like his old kind in a lively way. The new cells can be turned into heart cells that beat in a lab dish, other scientists on campus have shown.
 
Stem cells to cure HIV?
Channel 7 abc - 02/11/2009 16:49
NEW YORK (WABC) -- There is an amazing report in the New England Journal of Medicine, in which doctors say a stem cell transplant may have cured a man of HIV.
 
Stem cell treatment heals police dog
Channel 7 abc - 02/09/2009 14:12
FREMONT, CA (KGO) -- The first human trials involving stem cell therapy were approved just weeks ago, but a growing number of other patients are already benefitting from stem cell treatments.
 
Hadassah urges action on stem cells
JTA - 02/08/2009 09:31
WASHINGTON -- A pro-stem cell research coalition which includes Hadassah urged President Obama to act quickly on the issue. In a letter to the president, the Coalition for the Advancement of Medical Research said it was encouraged by a media report that Obama told a member of Congress it was a "guarantee" he...
 
Stem cell, cloning expert Jerry Yang dies
Capital Press - 02/07/2009 00:34
HARTFORD, Connecticut (AP) - Xiangzhong "Jerry" Yang, a Chinese-born stem cell scientist who successfully cloned the first farm animal in the United States, has died after a long battle with cancer.
 
U of MN researchers use human embryonic stem cells to kill cancer cells
Bio-Medicine - 02/04/2009 07:36
For the first time stem cell researchers at the University of Minneso... Researchers generated natural killer cells from the human embryo... This is the first published research to show the ability to make .
 
Stanford Scientists Awarded $10.7 Million in Latest State Stem Cell Grants
Stem Cell Arabia - 02/04/2009 01:53
December 12, 2007 - Stanford, California- Stanford University School of Medicine researchers today received $10.7 million from the California Institute for Regenerative Medicine in awards designed to help jump-start the careers of young scientists in the field of stem cell research.
 
Adverse events among 2408 unrelated donors of peripheral blood stem cells: Results of a prospective trial from the National Marrow Donor Program
Blood - 02/02/2009 18:42
CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this? Michael A. Pulsipher*, Pintip Chitphakdithai, John Miller, Brent R. Logan, Roberta J.
 
UCSB gets $1.2 million stem cell grant
Santa Barbara News - 02/01/2009 04:57
The California Institute for Regenerative Medicine awarded a $1.2 million training grant to UCSB to fund Stem Cell research. BILL McMORRIS, NEWS-PRESS STAFF WRITER 2009-02-01 09:57:48 UCSB gets $1.


Policy

 
Management fails at stem cell centre  03/03-2009 09:12  (The Australian)
AUSTRALIA'S $115 million taxpayer-funded flagship for financing stem cell research was sliding towards insolvency as early as 2009-10, hit by high corporate costs and poor management, a review into the Australian Stem Cell Centre reveals.


$1 Billion for Stem Cell Labs: Troubles and Status  02/03-2009 00:20  (California Stem Cell Report)
California's $1 billion stem cell lab construction program will be under scrutiny on March 9 as the state's stem cell agency weighs a request for changes in one approved grant while other recipients report difficulty in raising the required matching money to build their labs.

Embryonic Stem Cell Bill Defeated
D County - 02/24/2009 09:35

The South Dakota legislature had been considering a repeal of the state ban on embryonic stem cell research. However, the state senate voted yesterday voted to reject SB 195 by a vote of 20-14.

Funding for stem cell body drained
Congoo - 02/17/2009 14:09
THE Australian Stem Cell Centre will be scaled down and shed its role as a research funding body under a new business plan being finalised by the interim board.

Vietnam opens 1st stem cell bank for medical purposes
Scottrade - 02/15/2009 22:58
Vietnam's first stem cell bank MekoStem opened in southern Ho Chi Minh City on Sunday, offering services of cell collection, analysis and separation for medical treatment purposes, the local newspaper Young People reported Monday.

Missouri stem cell ballot measure prompts two lawsuits
Missourian - 02/10/2009 16:40
JEFFERSON CITY — A proposed constitutional amendment barring the use of public funds for abortion and human cloning has prompted dueling lawsuits contending the ballot summary is insufficient and unfair.

Doyle authorizes $5 million to woo stem cell companies
Bio-Medicine - 02/09/2009 01:50

Mount Sinai Hospital researcher develops Canada's first embryonic stem cell lines
Bio-Medicine - 02/08/2009 20:22
A senior scientist at Mount Sinai Hospital has developed Canada's firs... My hope and the hope of my world-class laboratory team is that our ... Our research remains in an early phase but the ability of these cells.

Doyle urges passage of federal stem cell bill
Bio-Medicine - 02/06/2009 06:52
In the House, the Wisconsin delegation voted along party lines, with Democrats Dave Obey, Ron Kind, Tammy Baldwin, and 2009-02-06 11:52:14 Doyle urges passage of federal stem cell bill...

State puts up $1 million for James Thomson's new stem cell startup
Bio-Medicine - 02/06/2009 02:01

Oklahoma stem cell funding plan approved
NewsOK.com - 02/04/2009 20:11
State lawmakers have given preliminary approval to legislation that could provide nearly $2 million for adult stem cell research in Oklahoma. House Joint Resolution 1035 by Rep.

Stem cell expert: Proposal 2 will bring new opportunities to the University of Michigan
Concentrate - 02/04/2009 07:11
Stem cells are a hot topic of conversation in southeast Michigan, but this time its all about what kind of economic development opportunities they will create.

Stanford Scientists Awarded $10.7 Million in Latest State Stem Cell Grants
Stem Cell Arabia - 02/04/2009 01:53
December 12, 2007 - Stanford, California- Stanford University School of Medicine researchers today received $10.7 million from the California Institute for Regenerative Medicine in awards designed to help jump-start the careers of young scientists in the field of stem cell research.

New Jerseys Stem Cell Referendum defeat and lessons learned - by Jersey Girl - Helium
Helium - 02/04/2009 01:14
The people have spoken - enough Is enough! In last Tuesday's election, 53% of New Jersey voters rejected a ballot measure that will allow the state to borrow $450 million for stem cell research.

Doyle urges Senate to loosen stem cell restrictions
Bio-Medicine - 02/03/2009 21:22


Science
 

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells  
01/03-2009 03:58  (Nature.com refers DOI)

Knut Woltjen1, Iacovos P. Michael1,2, Paria Mohseni1,2, Ridham Desai1,2, Maria Mileikovsky1, Riikka Hämäläinen1, Rebecca Cowling1, Wei Wang3, Pentao Liu3, Marina Gertsenstein1, Keisuke Kaji4, Hoon-Ki Sung1 & Andras Nagy1,2 Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5,...

Human Stem Cells Provide A New Model For Lou Gehrig's Disease, University of California, Los Angeles (UCLA) Study
Biospace - 02/24/2009 10:59
ScienceDaily (Feb. 24, 2009) — Motor neurons derived from embryonic stem cells mimic the progress of familial ALS. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a devastating condition in which motor neuron degeneration causes progressive loss of movement and muscle tone,...

Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state
Bio-Medicine - 02/20/2009 05:57
...For more than 25 years stem cells have been defined based on what the...Now a team of Canadian scientists has identified 1155 genes under th..."You could call this a `theory-of-everything' for stem cells" said se.

Reprograming of Stem Cells by a single gene: Oct4
Scientist Solutions - 02/11/2009 22:36
If you follow the stem cell literature, this latest finding is of special interest. A group from Germany was able to reprogram cells into stem cells by expressing a single gene: Oct4.

Mount Sinai Hospital researcher develops Canada's first embryonic stem cell lines
Bio-Medicine - 02/08/2009 20:22
A senior scientist at Mount Sinai Hospital has developed Canada's firs... My hope and the hope of my world-class laboratory team is that our ... Our research remains in an early phase but the ability of these cells.

Researchers use single gene to return mature stem cells to embryonic state
JS Online - 02/05/2009 16:45
German scientists have sent mouse stem cells back to their embryonic origin by introducing just a single gene, a finding that could eventually lead to simpler, safer ways of generating cells for human medicine.

Scientists discover source of cancer stem cells' resistance to radiation
PhysOrg.com - 02/04/2009 14:01
Much to the dismay of patients and physicians, cancer stem cells — tiny powerhouses that generate and maintain tumor growth in many types of cancers — are relatively resistant to the ionizing radiation often used as therapy for these conditions.

U of MN researchers use human embryonic stem cells to kill cancer cells
Bio-Medicine - 02/04/2009 07:36
For the first time stem cell researchers at the University of Minneso... Researchers generated natural killer cells from the human embryo... This is the first published research to show the ability to make .

UCLA researchers develop T-cells from human embryonic stem cells
Bio-Medicine - 02/03/2009 17:29
Researchers from the UCLA AIDS Institute and the Institute for Stem Ce...The study to be published the week of July 3 in the online edition of...The results mark the first time that scientists have been able to deri.

Cold Spring Harbor Protocols features stem cell differentiation, plant RNAi methods
Science Codex - 02/02/2009 21:36
COLD SPRING HARBOR, N.Y. (Mon., Feb. 2, 2009) -- By using OP9-DL1 cells as a support system, researchers can study the differentiation of embryonic stem cells into mature components of the immune system.

Stem Cell Breakthrough for Diabetes Treatments
Invest Victoria - 02/01/2009 17:43
Stem cell researchers backed by a joint Victorian and NSW Government grant have created Australia's first human induced pluripotent stem (iPS) cell line. The ability to produce human iPS cell lines locally will greatly assist researchers to progress their research into the causes of serious diseases and to d...

Business

 
StemCells Inc. (STEM) to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc  02/03-2009 10:30  (Biospace)
PALO ALTO, Calif. & LONDON--(BUSINESS WIRE)--StemCells, Inc. (NASDAQ:STEM - News) and Stem Cell Sciences plc (AIM:STEM) (ASX:STC - News) announced today that they have entered into a definitive agreement pursuant to which StemCells will acquire the operating subsidiaries and certain related assets of Stem...

Pluristem Therapeutics Receives FDA Clearance to Begin â First-In-Humanâ Placenta-Derived Stem Cell Clinical Trial  
02/03-2009 03:36  (PR-Inside.com)
Pluristem Therapeutics Inc. (NasdaqCM:PSTI)(DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that the US Food & Drug Administration (FDA) has cleared the Company's Investigational...

NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
Cai Hua Net - 02/23/2009 22:26
æ—¥ 08:01 æ¥æºï¼šæ–°åŽç¾Žé€šã€å­—ä½":大 中 å°ã€` License Enhances NeoStem's Presence in Anti-Aging Arena NEW YORK, Feb. 23 /PRNewswire-Asia/ -- NeoStem, Inc. (NYSE Alternext US: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed a license agreement to obtain the exclusive worldwide rights to innovative stem cell technology and applications for cosmetic facial and body procedures and skin rejuvenation...
 
Neuralstem's ALS Trial with Stem Cell Therapy Delayed
Genetic Engineering & Biotechnology News - 02/20/2009 11:14
GEN News Highlights Neuralstem reports that its spinal cord stem cell trial to treat ALS is on clinical hold. FDA has provided the company with specific comments, questions, and recommendations for modifications to its protocol.
 
Stanford University Uses Fluidigm Integrated Fluidic Circuits To Help Identify The Source Of Cancer Stem Cell's Resistance To Radiation
MediLexicon - 02/19/2009 12:37
Fluidigm Corporation announced that Stanford University has used the unique single-cell gene expression capabilities of the company's integrated fluidic circuits (IFCs) to help identify the source of cancer stem cells' resistance to radiation.
 
Alnylam Looks to Spinoffs To Unleash RNAi Technologies for Stem Cells, Vaccines
Congoo - 02/19/2009 08:11
Biotech, RNA Interference, Life Sciences Luke Timmerman 2/18/09 Alnylam Pharmaceuticals is one of the fortunate few in biotech with more than $500 million in the bank, so money is the least of its worries.
 
MaxCyte, Inc. Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
Biospace - 02/19/2009 00:12
"The MaxCyte GT(TM) Flow Transfection System addresses two of the primary challenges hindering acceleration of effective stem cell therapies. It enables design and development of stem cell products modified to allow for improved regenerative responses and permits robust, automated, cost-effective, cGMP and...
 
Singapore teams up to discover drugs using brain tumor stem cells
BioSpectrum - 02/18/2009 01:24
Lilly Singapore Center for Drug Discovery (LSCDD), the National Neuroscience Institute (NNI) and the Singapore Institute for Clinical Sciences (SICS) have teamed up to advance drug discovery using adult brain tumor stem cells.
 
San Diego's Stem Cell Startup Reports Hair-Regrowth Results
Xconomy - 02/17/2009 14:24
San Diego-based Histogen CEO Gail Naughton is presenting encouraging preliminary results today at a stem cell conference from the startup's first human trial of its hair regrowth treatment, ReGenica.
 
Astrazeneca and Cellartis extend their collaboration to develop new way to test drug safety using stem cells
Bio-Dundee - 02/16/2009 06:38
AstraZeneca and Cellartis AB announced today that they have signed an extension to their ongoing scientific collaboration to develop improved safety screening systems based on human embryonic stem cell (hESC) derived hepatocytes (liver cells) and cardiomyocytes (heart muscle cells) for target and lead...
 
Mesoblast Limited (ASX:MSB) To Provide Cutting Edge Treatment Using Proprietary Adult Stem Cell Products - Yahoo!7 Finance
Yahoo!7 Finance - 02/15/2009 21:35
- (ABN Newswire) - Mesoblast Limited (ASX: MSB.AX)(PINK:MBLTY) One of Singapore's leading private healthcare providers, Parkway Group Healthcare Pte Ltd, a subsidiary of Parkway Holdings Limited, and Australian regenerative medicine company, Mesoblast Limited, today announced a collaborative program to...
 
Ficano venture aims to lure stem cell work to Wayne County
Detroit Free Press - 02/13/2009 04:27
Wayne County Executive Robert Ficano said Thursday that county government will partner with Tech Town at Wayne State University to try to bring embryonic stem cell business to southeast Michigan.
 
Osiris touts stem cell trial results
Fierce Biotech - 02/12/2009 12:01
Osiris shares soar on $1.38B Genzyme pact ALSO NOTED: Osiris files IPO; Amgen initiates kidney disease study; and much more... Osiris Therapeutics blueprints $80M IPO SPOTLIGHT: Osiris granted orphan status Osiris gains $50M Osiris Therapeutics says its final set of two-year results from a trial for...
 
Stemgent Licenses TET's Stem Cell Reprogramming Reagents
Genetic Engineering & Biotechnology News - 02/11/2009 14:48
GEN News Highlights Stemgent entered into an agreement to market reagents based on TET Systems' technology for creating inducible stem cells. Stemgent will apply Tet Technology to its portfolio of viral vector systems for induced pluripotent stem (iPS) cells.
 
ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
Atlanta Business Chronicle - 02/11/2009 01:46
ATHENS, Ga., Jan. 30 /PRNewswire/ -- ArunA Biomedical, Inc., announced today that it will make its hN2(TM) cells commercially available to the research community in early 2009.
 
Edinburgh: Producing neural tumour stem cells
Congoo - 02/10/2009 20:56
unityResearchers at the have developed a new method of producing neural tumour stem cell lines. A patent covering all available territories has been filed and the university is seeking commercial partners to license the technology.
 
Stem Cell Therapeutics Corp. Provides Corporate Update
Sys.Con Canada - 02/09/2009 11:21
CALGARY, ALBERTA -- (Marketwire) -- 02/09/09 -- Stem Cell Therapeutics Corp. (the "Company" or "SCT") (TSX VENTURE: SSS) announces today an update on key corporate developments and strategies.
 
AstraZeneca and Cellartis extend stem cell collaboration - Pharmaceutical Executive Europe
Pharmaceutical Executive Europe - 02/08/2009 17:04
AstraZeneca and Cellartis have signed an extension in their collaboration to develop better safety screening systems based on human embryonic stem cell-derived (hESC) liver and heart muscle cells.
 
ITI Life Sciences achieves major milestone with first license deal with Cellartis for Stem Cell...
Newstin - 02/06/2009 17:39
Signing of 7th licence for ITI Life Sciences sees Dundee-based biotech company Cellartis AB commercialise pioneering stem cell technology Dundee, Scotland, ITI Life Sciences today announced it has signed a licensing agreement with world leading Stem Cell company Cellartis AB, granting them a worldwide...
 
World First For Glasgow University As Stem Cell Therapy Trials Are Approved
redtram (ENG) - 02/04/2009 04:33
ReNeuron announced today (19 January 2009) that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to commence a first-in-man clinical trial for the treatment of patients who have been left disabled by an ischaemic » Full text » 2009-02-04 09:33:58 World First For...
 
Aastrom Heart Stem Cell Trial on Hold After Adverse Event
Pharmacy Choice - 02/03/2009 22:50
Aastrom Biosciences Inc., a company that is developing stem cell products, said Monday that a patient enrolled in the company's U.S. Phase II heart failure trial developed a serious adverse event associated with anesthesia management during treatment at one of the study sites.
 
Neuralstem gets US patent for new stem cell immortalization tech
Pharmabiz - 02/02/2009 07:37
Neuralstem, Inc has received Official Notice of Allowance for its patent application, number 10/047,352, for Stable Neural Stem Cell Lines from the US Patent and Trade Office (USPTO).
 

Contact GPI
Robert E. Margolin
Associate Director
908-605-4203
rob@...

To unsubscribe click here


#6958 From: "Stephen Meyer" <Stephen276@...>
Date: Tue Mar 10, 2009 12:45 pm
Subject: YESTERDAY AT THE WHITE HOUSE by Don Reed
stephen_meye...
Offline Offline
Send Email Send Email
 
YESTERDAY AT THE WHITE HOUSE
 
by Don C. Reed
 
 
Dear Stem Cell Research Advocate:
 
Yesterday, being in the room when President Obama signed an executive order reversing ideological restrictions on embryonic stem cell research was an honor and a delight.
 
But for my paralyzed son Roman Reed and all the other patient advocates in the room, it meant so much more than that: the White House is now squarely on the side of cure.
 
The East Room was jammed with dignitaries as we waited for the President to come in. Just a few feet away were Senators Orrin Hatch, Dianne Feinstein, Jim Langevin, many more.  Scientists like Renee Reijo-Peira, Harold Varmus, and Irv Weissman. Patient advocates, champions all, Bob Klein, Zach Hall, Dan Perry, Kris Gulden, Alta Charo, literally hundreds more, each one deserving of his or her own book, champions all.
 
And then the voice said, "Ladies and gentlemen, the President of the United States." LAn emotion like an electric current surged through us, and I found myself on my feet without knowing how I got there.
 
You have to look up his speech, it was too great to miss. It is only ten minutes, but just packed with value.
 
Not only did he speak out strongly on behalf of stem cell research,but he also announced a new White House-directed effort to be sure that scientific policy was based on science, not ideology.
 
He spoke clearly, and calmly, and with the accuracy too often dismissed as mere eloquence. He spoke the truth, and it registered strongly because it was the truth.
 
All too soon it was over, and he was heading out the door, but he stopped to shake a few hands, and to take a picture or two, including one with my son, Roman. My wife Gloria tried to get him to allow another one with me personally, but he said "Hey, guys, I really have to go," talking to us like we were neighbors, and he had to go answer the phone.
 
Like John F. Kennedy who pointed toward the moon, the President has challenged a nation: we are all part of this tremendous adventure, as we work to cure diseases and disabilities that are not only ruining lives, but also devastating our economy.
 
Last year America spent $2.3 trillion on medical costs, more than all federal income taxes put together.
 
Only cure can substantially lower these mountainous costs.
 
That was what yesterday meant: that we have set cure as a goal for our nation, and the world.
 
P.S.
 
The Reed family got home at 11:30 last night, and will be on the road again at 4:30 this morning, one hour from now, to go down to the Roman Reed Spinal Cord Injury Research Act "Meet the Scientist" Days at UC Irvine and another day of meetings on California's stem cell program.
 
I will write more later, but I had to speak now or burst with happiness.
 

#6957 From: "Stephen Meyer" <Stephen276@...>
Date: Tue Feb 10, 2009 2:55 am
Subject: President Obama made some positive statements regarding for stem cell research
stephen_meye...
Offline Offline
Send Email Send Email
 
Advocacy in Action
JDRF Action Alert

Fwd to a Friend

 

At a recent meeting of legislators, President Obama made some positive statements regarding his Executive Order expanding the federal government's support for stem cell research. Please take a moment to send him a 'thank you' note for his promise to expand stem cell research by clicking here or on the link below.

Thank the President for His Stem Cell Research Support!

You can read what the President had to say about stem cell research by clicking here. Please send your message TODAY and encourage others to join you in thanking the President!

Thank you.


JDRF Government Relations


#6956 From: "Stephen Meyer" <Stephen276@...>
Date: Sun Feb 8, 2009 12:22 am
Subject: Latest Stem Cell Research Information
stephen_meye...
Offline Offline
Send Email Send Email
 

If you are really interested in the latest news in Stem Cell Research, check out the Genetics Policy Institute's web site at

http://www.genpol.org/

 

After you look at the site, join the Stem Cell Action Network.

http://www.genpol.org/newsletter.html

 

Steve

 


#6955 From: "Stephen Meyer" <Stephen276@...>
Date: Sun Feb 8, 2009 12:01 am
Subject: Excerpts are from Jan 29 article, available online in Hartford Courant
stephen_meye...
Offline Offline
Send Email Send Email
 

From the Hartford Courant, January 29, 2009

 

"State leaders praised the development of the new stem cell lines as validation of the state's 2005 decision to invest $100 million in stem cell research over 10 years. Because former President George W. Bush restricted the use of federal funds for human embryonic stem cell research, the state money allowed Connecticut researchers to work in a cutting-edge area of science that their counterparts in all but a handful of other states could not.

Now, at a time when the state's economic prospects look bleak and policymakers worry about the exodus of young, educated workers from Connecticut, stem cell research is offering a bit of hope. The state stem cell money has allowed Connecticut to lure top scientists — including Xu, Ge Lin, the postdoctoral fellow who created the stem cell lines, and Haifan Lin, director of the Yale Stem Cell Center — and has spurred research and biotech business efforts.

"Instead of having a brain drain where all of our best and brightest in Connecticut were going out of the country or to other states, we started to receive some of the best and the brightest in Connecticut," said Warren Wollschlager, who administers the state stem cell research program as the chief of the office of research and development at the state Department of Public Health.

That could soon pay off in even bigger ways.

President Barack Obama is expected to lift the restriction on federal funding for human embryonic stem cell research, and officials and researchers say Connecticut's head start will give it a major advantage in competing for federal research money.

"We have a track record now, which I think will be looked upon very favorably in Washington," Pescatello said.

So far, the $29.6 million in state stem cell money has been used to build the infrastructure for research facilities, recruit faculty and fund research by scientists from UConn, Wesleyan and Yale. Wollschlager said the state program has begun receiving more private sector applications and that they are improving in quality.

Already, businesses related to stem cells are developing in the state, Pescatello said. One company getting started in the New Haven area is planning to use stem cells to create a uniform supply of cells to test new drugs on, Pescatello said.

UConn's new stem cell lines, named CT1 and CT2, were derived from embryos from a fertility clinic, donated with the consent of the patients, according to UConn


#6954 From: "Stephen Meyer" <Stephen276@...>
Date: Thu Jan 29, 2009 1:33 pm
Subject: THE RETURN OF JOHN REED ...by Don Reed
stephen_meye...
Offline Offline
Send Email Send Email
 
 

THE RETURN OF JOHN REED

 

By Don C. Reed

 

 

On the 29th and 30th of this month, there will be a meeting of the Independent Citizens Oversight Committee, (ICOC), governing body of the California stem cell program. This one will be in San Francisco.

 

As always, you are invited. 

 

When you come in, you will first see rows and rows of folding chairs, for interested citizens like you and I. And at the front? Great tables decked in white cloth, each place with its own microphone, water glass, and folded cardboard name tag. Here is where the ICOC sits: our 29 members, every one a champion of their field.

 

One nametag you will see that has been missing for more than a year: Dr. John Reed, M.D., Ph.D., chief executive officer of the Burnham Institute for Medical Research. (He is no relation, though I would be proud to call him kin.)

 

His scientific field is somewhat grimly-titled: apoptosis, cell death. Understanding how and why cells die is crucial in the battle for cure. If cells die too soon, you can have a stroke; not soon enough-- cancer.

 

The Institute for Scientific Information identified Dr. Reed as the most frequently cited scientist in the decade 1995-2005. He has authored over 800 research publications, written more than 50 book chapters, and is the named inventor for more than 70 patents.

 

Why has he been gone for a year? That is the subject of this column.

 

Dr. Reed voluntarily absented himself from ICOC deliberations--  while California's Fair Political Practices Commission (FPPC) investigated something he did.

 

First, background: ICOC members like Dr. Reed are forbidden to participate in decisions affecting their home organizations.  Preventing such conflicts of interest is crucial to the program: or board members could just use their vote to send the money to themselves.

 

A scientist who works with Dr. Reed's organization, David Smotrich, applied for a grant through our California program. The proposal went through the usual process, was reviewed by a committee of scientists from out of state, then voted on by the ICOC— and, as is required by law, Dr. Reed took no part in that decision: so far, so good.

 

The project was judged excellent, receiving one of the highest scores given.

 

But-- when the CIRM staff and legal department did their "due diligence", making sure the grant fit every requirement, they found what they thought was a fatal flaw.

 

One of the requirements of this particular grant was that the recipient had to be a full-time employee of the institution making the request.

 

Burnham Institute was asking for the money, therefore Dr. Smotrich had to be a full-time employee.

 

Was he?

 

Maybe yes, maybe no—it depended on how you defined fulltime.

 

Smotrich had a "full faculty position and privileges at the Burnham… a small institution…(which) does not have a hospital, so it does not have full-time clinicians."—Terri Somers, "Top Burnham Official accused of conflict of interest", San Diego Union-Tribune, November 22, 2007.

 

He did not get a salary there, which would seem to disqualify him; but, on the other hand, with funding hard to get, many scientists at institutions have to pay their own way, bringing a grant with them, while they use the space and equipment of the Institute.

 

Suddenly, the whole project was dead—on a technicality-- which might be a mistake.

 

What would you have done? Stayed silent and accepted it, watch an outstanding project go down, through a possible misunderstanding?

 

Remember, there was at this time no official review process for complaints.

 

Also, the decision had already been made… so was Dr. Reed allowed to voice his concerns now? It was clear he could not use his power of voting or discussion to influence the project's chances when it was before the ICOC. But afterwards, when the decision was made, could he speak up then, like at a football game, where coaches do not interfere during the action, but may argue with the referee, after the play has been called?

 

Did the rulebook say anything about the timing of complaints? I visited the CIRM website, and could find nothing to clarify that.

 

Was this a new situation, which had not been considered, and therefore was not covered by the laws?

 

Also, there was something else:

 

"…executive officers of research institutions…who, as part of their responsibilities, oversee and advise researchers in their institution…shall not be deemed to have a conflict of interest under this provision. Recusal, however, is required…"

—"Conflict of Interest Policy for Members of the Independent Citizen's Oversight Committee", (footnote at the bottom of page 1-dr)

 

This is official policy, and it seems to me (admittedly a non-lawyer) to contain some wiggle room. On the one hand, the "recusal" part (not voting on money decisions affecting your outfit) had definitely been followed.

 

But did Dr. Reed's legal right to "oversee and advise" allow him to explain his institution's definition of a full-time employee? 

 

That was a gray area.

 

With a brand-new organization like the California stem cell program, the rules are not always crystal clear. The process of making the laws began with the writing and passage of Proposition 71. After the voters said yes, there was an immediate major conference with the National Academy of Sciences to figure out best practices, and the ICOC (with the continual input of Sacramento) has been working hard on the rules ever since.

 

But despite the best planning, going first is not simple.

 

Dr. Reed felt a mistake was being made, so, he contacted ICOC Chairman Bob Klein, asking him what he should do.

 

Bob Klein said he "didn't have the ability to evaluate the information in the administrative review, so if Dr. Reed thought there were errors, he should make them public by writing a letter to the scientific staff." (ibid)

 

This was done. Dr. Reed wrote a six and a half page letter, detailing the problem, and sent it to Dr. Arlene Chiu, head of the science department.

 

It was a mistake.

 

The CIRM legal department caught the error immediately, stopped it cold.  General Counsel Tamara Pachter pointed out there was no appeals process, and the matter would not be considered.

 

The grant did not receive funding.

 

But that was not the end of the matter.

 

Enter John Simpson of Consumer Watchdog, a frequent critic of our program.  He filed a complaint with California's Fair Political Practices Committee (FPPC), alleging a conflict of interest, and called for the resignations of both Dr. Reed and Chairman Klein.

 

To my mind, such a penalty is vastly out of proportion, like suggesting the electric chair for a parking violation, but Simpson feels otherwise.   

 

As he puts it: "This is not trivial…When you hand out millions of dollars in public money, you have to play by the rules. He (Smotrich) didn't meet the eligibility rules advertised for this grant and waiving them would have been unfair to everyone else." –California Stem Cell Report, November 21, 2007

 

How did CIRM feel about it?

 

In an interview with David Jensen of the California Stem Cell Report, CIRM Acting President Dr. Rich Murphy said:

 

"It is important to remember that Dr. Reed sent his letter after the ICOC had approved the grant…At the time, Dr. Reed mistakenly believed that conflict rules would not prevent him from providing technical information regarding the status of a faculty member to CIRM staff. As soon as CIRM staff received the letter, counsel advised Dr. Reed that he must refrain from contacting the staff and board members regarding a grant to the Burnham and advised staff to disregard Dr. Reed's letter. It therefore had no effect on CIRM's process, and Dr. Reed now fully understands the conflict rules."

 

The FPPC studied the accusation and background issues for more than a year.

 

Meanwhile, the rules were clarified, and a complaint process was established, whereby scientists denied grants could speak up, and be heard.

 

And Dr. Reed voluntarily took himself off the board, until the matter was resolved. 

 

For me, as a patient advocate, the loss was painful, like a favorite football team being forced to play all year with one of our best athletes sidelined: In addition to being incredibly intelligent, Dr. Reed is passionate, clear, dedicated, and caring.

 

So, we all waited.

 

At last, the answer came.

 

A few days ago, the FPPC answer was delivered, in a public letter.   

 

"In our view, by submitting a "letter of appeal" to CIRM staff, Dr. Reed intended to influence a decision that had the potential to affect his economic interests. However…it appears that Dr. Reed attempted to influence a prior-made governmental decision that could not be appealed… Thus, although this matter raises ethical concerns, we are closing this matter with a warning letter….Dr. Reed is advised that failure to comply with the provisions of the Act can result in an enforcement action against him, including monetary penalties of up to $5,000 for each violation…"

--Kourtney C. Vaccaro, Division Chief, Enforcement Division, Fair Political Practices Commission, January 7, 2009

 

That is harsh language, especially when you consider it took the FPPC itself, experts in the field, over a year to figure it out.

 

There was no penalty, because there was no violation of the law. Because Dr. Reed had objected to a decision which could not be undone, no crime had been committed.

 

But that does not mean Simpson was wrong in filing his complaint. Democracy depends on critics; like antibodies, their reactions are often painful to the body politic; yet they perform a vital function. Simpson's fuss and furor made everybody really stop and think about the issue.

 

Above all, our system worked. California's blend of public and private oversight found a problem, and dealt with it. Our legal department spotted the error, and immediately blocked it; while the transparent nature of our program (allowing and encouraging citizen involvement) made the blunder clear, accessible, and fixable.

 

The incident is done. As its letter states, "…the Fair Political Practices Commission… has closed its file…"

 

And Dr. John Reed?  One of America's greatest scientists is returning to the ICOC. His life goes forward, benefiting all: this molehill of controversy outweighed by his mountain of accomplishment.

 

Welcome home, Doctor Reed.

 

 

 


#6953 From: "Stephen Meyer" <Stephen276@...>
Date: Sun Jan 18, 2009 11:46 pm
Subject: A GLOBAL STEM CELL RESEARCH ACTION PLAN ....By Don C. Reed
stephen_meye...
Offline Offline
Send Email Send Email
 
A GLOBAL STEM CELL RESEARCH ACTION PLAN

                                               By Don C. Reed

Like a war more deadly than any in history, chronic disease is ravaging Earth.

The incurably ill suffer and die no less than if bullets had struck them; hospitals and sickrooms overflow, inadequate to the task.    

Our problem is simple. With expensive modern medicines, we can keep our loved ones alive despite almost any illness or injury—but we cannot make them well.  

Two staggering statistics: first, in America alone, medical costs exceed $2.3 trillion in 2007, more than all federal income tax receipts ($1.8 trillion) combined—and three-fourths of all medical costs are directly due to chronic (incurable) disease.

First, we need international recognition of the scope of the problem. 

The United Nations must urge the world to work together on research for cure: stem cell research, gene therapy, biomedicine-- within each nation's ideological belief system.

Some nations (the Vatican, for example) oppose embryonic stem cell research; but there is no reason they could not fund adult stem cell research: the Pope's recently urged the Earth's Catholic community to support non-embryonic stem cell research, including the new induced Pluripotentiary (iPS) stem cells, an important piece of the puzzle. 

In countries that already do support full stem cell research, advocates must build upon that hard-won foundation in the UK, China, Singapore, Spain, Japan, Sweden, and many others, including (very soon) the United States.

We need international scholarship programs, so even the poorest countries can lend their brightest young men and women to Earth's emergency. If a country cannot afford a medical research college, loan programs should be developed for this global benefit.

In the business community, every country can and should encourage the research, from basic theory in the laboratories, to translation into actual use: therapies and cures.

As was done in San Diego , where four great institutes joined their strength for the good of all, companies and colleges can form consortiums, sharing their scientists, their knowledge, and their equipment.

Cities, states, and provinces can make life easier for struggling startups: establishing "incubators" for biomedical Mom-and-Pop companies as Silicon Valley did for the fledgling computer industry.

New ways of thinking can foster cooperation among scientists, like the disease team approach of the California stem cell program, and beyond.

What if the best scientists in the country were locked in a room, and not let out until they found a cure for __________ disease? Ridiculous, perhaps, or maybe not: if disease came with explosions, and germs were big enough to wear uniforms, we would take it much more seriously.

 At every step, government must help.

Asia understands. In China , the government is offering tax incentives, as well as funding at national and local levels; in Singapore , an entire community, Biopolis, provides jobs and housing for biomedical scientists and their families. This is wisdom, and should be emulated here at home, unless we want the biomedical revolution to be outsourced, giving blessings only to other countries.

In America , the emerging life science industry must think of itself as a new Defense Department-- and quit being so bashful! What business is more vital, urgent, and irreplaceable than one which could save lives and ease the suffering of millions?

We dare not flinch from political involvement. On the contrary, Biomed must lobby aggressively, make campaign contributions to legislators who support our goals, and vigorously oppose ideologues who would block the industry of healing.

Talk about a justifiable tax exemption! To my mind, the entire biomedical industry should be tax free for at least a decade, give it time to grow.

In Washington , there is much to be done. President-elect Obama must follow through with his promise: to remove ideological restrictions on regenerative medicine. This goes deeper than the ill-conceived Bush restrictions.  The Dickey Amendment, for example, should no longer be automatically renewed, attached every year to some "must-pass" legislation. That miserable law defines cells in a Petri dish as the equivalent of a human being; it is even rewritten year after year to block new forms of research, like nuclear transfer research, which involves neither sperm nor womb. It is time we stopped allowing opponents of science to be the "deciders" on science policy—in a country based on liberty.

But freedom to research, while crucial as the air we breathe, is not enough. We cannot live on air alone, and neither can the families of scientists. These men and women are trying to do the impossible with the invisible, and we must look out for them.

Imagine if President John F. Kennedy had pointed to the sky, and said: we are going to the moon—but we're not actually going to pay for it? Research without funding is like a moonshot with no rocket.

The Castle/Degette Stem Cell Research Enhancement Act (twice vetoed by President Bush) must be rewritten to include major money for the research. 

The National Institutes of Health must no longer be ignored. The NIH was once the crown jewel of Earth's research, and it must be so again. Its funding levels have been "flat-lined" for the past five years; costs have risen, but its funding has not even kept pace with inflation. When a patient's vital signs flat-line, they need life support; so does the NIH.

We need help from every state.

At present, only a "Magnificent Seven" states provide funds for full stem cell research: California , New York , New Jersey , Massachusetts , Connecticut , Illinois , and Maryland .  Even here, there is no room to relax, as advocates must fight to protect what has been won.

Not even the magnificent California Institute for Regenerative Medicine is safe. There is money for grant programs until July of this year, and enough to run the Institute itself (on a skeleton crew) for a year after that. But our funding comes from bonds which are sold, and that sale must be approved by the Secretary of the Treasury. If the financial conditions in the Golden State do not improve, and new bond sales are not allowed, California may be forced to do again what ICOC chair Bob Klein did to protect us before.  When our funding was blocked by lawsuits, he and a dedicated few board members brought in loan/gifts from the public: a tremendously difficult job even then, and it will be immeasurably more difficult now. 

And what about the states which still handcuff their scientists? Places like Arizona , Arkansas , Iowa , Kentucky , Louisiana , Maine , Minnesota , Nebraska , New Hampshire , New Mexico , North Dakota , Pennsylvania ,  Rhode Island , South Dakota , Utah , and Virginia still put ideological hurdles in front of researchers, sometimes calling them criminals, and threatening them with prosecution for their life-giving work.

Advocates in such states do have options: they can directly challenge the negative laws; or work around them, pushing for funding bills which support only adult stem cell research; or, they may prepare the state for tomorrow, giving educational talks to community organizations: such speeches are hugely influential, planting seeds for future growth and beneft.  

One useful tool is a miniature research bill, like California 's Roman Reed Spinal Cord Injury Research Act. It is tiny, just $1.5 million a year. But from that small beginning, a way to cure paralysis may spring. If you saw the paralyzed rats that walked again, scampering around a purple plastic swimming pool on TV, you saw "our" work. One influential scientist,  Dr. Hans Keirstead, succeeded first with a Roman Reed grant, then used that success as leverage for larger grants from the NIH; That experiment (now funded by ground-breaking Geron) is under consideration by the FDA for human trials, the first in the world.

"Roman's Law" has funded about $12 million in research over the few years of its existence—and quintupled that investment for the Golden State, bringing in an additional $50 million in matching funds from the feds, new money for our state—funding more than 50 scientists and their staffs, good jobs for our state and nation

Why not a regenerative research funding law in every state?

One immediate benefit would be funding for new scientists, the young ones all too often locked out of grants from the NIH. Because there is so little money in the National Institutes of Health budget, a scientist often won't get help from this prime source until he or she reaches an average age of 43. A scientist who earns a doctor's degree (a huge accomplishment) may not be able to make a living for the first twenty years in the field!

In these and other ways, small and large, our states and nations can work together. Every contribution helps: like little cloth squares, meaningless by themselves, but when combined into a patchwork quilt, bring warmth and comfort on a freezing Winter's night.

Imagine how beautiful international research cooperation could be: like an Iranian/Israeli stem cell research institute.  Why not? Both countries are strong supporters of stem cell research, everybody loves their children, and every family deserves access to the best medicine science can provide.

Already, the State of California is working with countries like Canada, Japan and the UK, finding ways to multiply our efforts, getting far more bang to the buck, while still spending the money inside the Golden State, as mandated by Proposition 71.

We must support the research where it grows; plant seeds where it is not—with a global stem cell research action plan.

Don C. Reed is Vice-President for Public Policy, Americans for Cures Foundation; his opinions may or may not reflect the views of the Foundation.

Don C. Reed
Sponsor, Roman Reed Spinal Cord Injury Research Act
Founder and Co-Chair, Californians for Cures
 
Don Reed is also Vice President of Public Policy for Americans for Cures Foundation; opinions voiced here as an individual may or may not reflect those of the Foundation.
 
 
 

#6952 From: "Stephen Meyer" <Stephen276@...>
Date: Sun Jan 18, 2009 11:45 pm
Subject: Stem Cell Action News ,,,,,,January 16, 2009
stephen_meye...
Offline Offline
Send Email Send Email
 

Forward this newsletter to a Colleague by visiting this link








January 16, 2009


Welcome to issue number 4 of Stem Cell Action News, dedicated to informing the stem cell community
on the latest and most important developments impacting the Pro-Cures Movement.


Special Announcement

This week's special announcement is not about a landmark scientific breakthrough, a company acquisition,
or a major policy change, it's a about a student and friend of the Genetics Policy Institute that's fighting
for his life. Gideon Sofer, a hero of the Student Society for Stem Cell Research is on a mission to help
reform FDA clinical trial policies that could potentially save lives and alleviate unnecessary human
suffering. GPI encourages all stakeholders to read Gideon's op-ed piece in the December 30th edition
of the Wall Street Journal, which discusses his bought with Crohn's Disease and his clinical trial experience.



Read this Article



Business

 
CELLARTIS, WARF SIGN LICENSE AGREEMENT FOR HUMAN EMBRYONIC STEM CELLS
Media Newswire - 01/16/2009 11:32
MADISON - Cellartis AB, a premier provider of human embryonic stem cell (hES) derived products and technologies, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced today (Jan.
Sunrise's Bioheart struggles with capital woes
The Miami Herald - 01/16/2009 07:54
Bioheart, a Sunrise-based company that has developed stem cell therapies to treat heart attack patients, has run out of cash and is seeking new backers.
BioE Receives FDA 510(k) Clearance For Cord Blood Processing System
Medical News Today - 01/16/2009 03:33
BioE®, Inc., a biomedical company that provides enabling cord blood stem cell tools and technologies, announced it received 510(k) clearance from the U.
VistaGen and Capsant Sign Strategic Stem Cell Technology Commercialization Agreement
Pharmacy Choice - 01/15/2009 10:22
Business Editors/Health/Medical Writers SOUTH SAN FRANCISCO, Calif. & SOUTHAMPTON, U.K.--(BUSINESS WIRE)--January 15, 2009--VistaGen and Capsant have signed a strategic commercialization agreement under which the companies will combine their leading-edge stem cell biology and 3D cell culture platforms,...
Joint Venture Between CHA Biotech and Advanced Cell Technology to be called ?Stem Cell & Regenerative Medicine International?
PR-Inside.com - 01/08/2009 22:32
The joint venture between Advanced Cell Technology, Inc. (OTC:ACTC) and leading Korean-based biotechnology company CHA Biotech Co, Ltd. (CHA), announced today that the company would be named "Stem Cell & Regenerative Medicine International.
Stem Cell Sciences signs further licence agreement for stem cell technology with major pharmaceutical company
Stem Cell Sciences - 01/05/2009 15:49
Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce the signing of a further licence to its IRES technology. The undisclosed licensee is a major research-based international pharmaceutical company in the top 20 by market capitalisation and annual sales and it will use the technology in its own research and development activities. Financial terms are not disclosed for this fully paid-up licence, which was signed during the Christmas holiday period. This follows the recent signing of an IRES licence in November 2008 with a European company that provides genetically modified rat and mouse models for medical and pharmaceutical research for $750,000 over the next six years.
Functional Vasculature Generated From Advanced Cell Technologys Human Embryonic Stem Cells
Biz Yahoo! Finance US : News Providers - 01/05/2009 08:00
Hemangioblasts form multilayered blood vessels with functional smooth muscle could provide an inexhaustible source of cells to treat vascular...
NanoInk Launches NanoStem Cell Division-New Division Aims to Revolutionize the Utility of Adult Stem Cells Through Nanotechnology
Small Times - 01/05/2009 05:39
) SKOKIE, IL, Jan 05, 2009 (MARKET WIRE via COMTEX) -- NanoInk, Inc., a global leader in nanotechnology, began the new year by announcing the launch of its NanoStem Cell division.
Bayer filed for stem cell patent before Kyoto Univ. team
The Black Ship - 01/04/2009 07:24
TOKYO - German chemical giant Bayer AG applied for a patent in Japan on June 15, 2007, for a technique to generate induced pluripotent stem cells, or iPS cells, from human cells, according to Patent Office data released by Sunday.
International Stem Cell Corporation Closes Financing
Fierce Biotech - 12/31/2008 02:31
Posted December 31, 2008 International Stem Cell Corporation Closes Financing OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) announced today that it had received the first $1 million tranche of an anticipated private equity financing of up to $5 million to be funded over...
Technique for creating authentic rat embryonic stem cells published in `Cell'
Stem Cell Sciences - 12/29/2008 00:00
Technology licensed exclusively by Stem Cell Sciences ("Stem Cell Sciences", "SCS", "the Company") Stem Cell Sciences plc (AIM:STEM, ASX:STC) is pleased to announce that pioneering research describing a technique for creating authentic embryonic stem (ES) cells from rats has been published in the prestigious peer-reviewed journal, Cell (Ref. 1). This publication is believed to be the first in which germ-line transmission from rat ES cells has been definitively demonstrated. It uses technology licensed exclusively to SCS from the University of Edinburgh and developed by Professor Austin Smith and his team, now at Cambridge University. The technique is expected to allow the generation of consistently pure and stable rat ES cells, from which drug discovery assays as well as genetically modified animals can be created for academ! ic, medical and pharmaceutical research.
Madison stem cell firm nabs $50K state grant
WTN Media - 12/23/2008 14:12
Madison, Wis. - Shiloh Laboratories, a Madison-based biotechnology company, has received a $50,000 state grant to further develop a supplement used to grow stem cells in culture, according to a report in the Milwaukee Journal Sentinel.
VistaGen Receives Significant Stem Cell Tools And Technologies Grant From California Institute For Regenerative Medicine
Medical News Today - 12/23/2008 05:00
VistaGen Therapeutics announced that the California Institute for Regenerative Medicine (CIRM), the State's stem cell agency, has awarded a major grant to the Company to expand ongoing development and commercialization of its leading-edge stem cell-based technologies designed to predict clinical safety and...
Life Technologies To Develop Human Stem Cell Models Of Neurodegenerative Diseases To Advance Drug Development
Medical News Today - 12/23/2008 05:00
Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, announced it will use human embryonic stem cells to develop new models of Lou Gehrig's Disease and other neurodegenerative diseases with a grant it received this week from the California Institute for Regenerative...
Human Embryonic Stem Cell Technology: VistaGen, WARF Sign License Agreement
Medical News Today - 12/23/2008 04:00
VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools.
Neuralstem files FDA application for ALS stem cell trial
Pharmaceutical Business Review Online - 12/23/2008 01:51
Neuralstem has filed an investigational new drug application with the FDA to begin a clinical trial to treat amyotrophic lateral sclerosis.
Acquisition of stem cell company Axordia Limited
Intercytex Group - 12/22/2008 00:00
Intercytex Group plc (LSE: ICX) ("Intercytex"), the regenerative medicine company developing innovative products to restore skin and hair, announces today that it has acquired Axordia Limited ("Axordia"), a privately-held UK company focused on the development of stem cell therapies. Under the terms of the acquisition, Intercytex will issue 7,000,000 new ordinary shares of 1 pence each as consideration for the purchase of the entire issued share capital of Axordia, formerly a Fusion IP portfolio company. Based on Intercytex' closing share price of 24p on 19th December 2008, this values Axordia at £1.68m.
Novocell Announces Non-Exclusive Drug Discovery Collaboration with Pfizer Research to utilize Novocell's stem cell-derived pancreatic progenitor cells
Novocell - 12/19/2008 00:00
San Diego, CA (December 19, 2008) – Novocell, Inc., a stem cell engineering company, today announced it has entered into a non-exclusive drug discovery collaboration with Pfizer giving Pfizer access to Novocell's proprietary pancreatic progenitor cells derived from human embryonic stem (hES) cells.
Fluidigm to develop microfluidic chip for stem cell institute
Small Times - 12/17/2008 12:49
: California's Institute for Regenerative Medicine (CIRM), the state stem cell agency, has awarded Fluidigm Corp. and Stemgent Inc. a grant to develop a microfluidic cell culture chip (C2C) and support system that will help researchers accelerate stem cell research in California, the companies announced in a...
Fluidigm and Stemgent Awarded One of CIRM'S First Grants to the Biotech Industry
Fluidigm Corporation - 12/16/2008 00:00
California's Stem Cell Agency Invests in Cell Culture Integrated Fluidic Circuit System Tuesday, December 16, 2008; South San Francisco –California's Institute for Regenerative Medicine (CIRM), the state stem cell agency, has awarded Fluidigm Corporation and Stemgent, Inc. a grant to develop a cell culture chip (C2C) and support system that will help researchers accelerate stem cell research in California.
BD Biosciences Launches BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit
BD - Worldwide - 12/15/2008 00:00
News & Events Print [spacer image] BD Biosciences Launches BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit First in a series of ready-to-use kits offers a "total solution" approach for stem cell sorting and analysis Contact: Jeff Ezell BD Public Relations (201) 847-5533 Email: jeff_ezell@... San Jose, CA -- Monday, December 15, 2008 -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the launch of the BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit – a comprehensive research system for the reliable characterization and cell sorting of human pluripotent stem cells using flow cytometry. This marks the first in a series of flow cytometry-based kits that BD Biosciences plans to release in the coming year.
Product Provides Enhanced Mobilization of Stem Cells for Autologous Transplantation in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
Genzyme Corporation - 12/15/2008 00:00
Genzyme Corporation (Nasdaq: GENZ) announced today that the U.S. Food and Drug Administration has granted marketing approval for Mozobil™ (plerixafor injection), a drug intended to be used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM). The product has also been granted orphan drug designation.
Athersys Receives IND Authorization for Multistem in Treatment of Ischemic Stroke ( Third IND for Company's Proprietary Stem Cell Product in Less Than a Year )
RBC Dain Rauscher Inc. (fka Dain Rausche) - 12/11/2008 15:25
CLEVELAND, Dec 11, 2008 (GlobeNewswire via COMTEX) -- Athersys, Inc. (NASDAQ:ATHX) announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial evaluating the safety of administration of its "off-the-shelf" adult stem cell product,...

Headlines & Advocacy

 
Hebrew University scientists succeed through stem cell therapy in reversing brain birth defects
The Hebrew University of Jerusalem - 01/14/2009 15:42
Scientists at the Hebrew University of Jerusalem have succeeded in reversing brain birth defects in animal models, using stem cells to replace defective brain cells. The work of Prof. Joseph Yanai and his associates at the Hebrew University-Hadassah Medical School was presented at the Tel Aviv Stem Cells Conference last spring and is expected to be presented and published nest year at the seventh annual meeting of the International Society for Stem Cell Research in Barcelona, Spain.
Text size: increase text sizedecrease text size Research on embryonic stem cells at a crossroads
Chicago Tribune - 01/11/2009 15:36
Geron Corp. seeking federal approval to begin 1st human clinical trials NEW YORK—The future of controversial research on embryonic stem cells may be riding on the shoulders of Dr. Thomas Okarma, whose company is poised to begin the nation's first human clinical trials.
Stem Cells: A Life Sciences Crucible
Science Progress - 01/08/2009 19:16
Next week is bookended by science policy events at CAP: innovation and patent reform on Monday and stem cells on Friday: A Life Sciences Crucible Stem Cell Science and Innovation Done Responsibly and Ethically Featured Panelists: Amy Comstock Rick, President, Coalition for the Advancement of Medical Research...
CONVERTING ADULT SOMATIC CELLS TO PLURIPOTENT STEM CELLS USING A SINGLE VIRUS
Boston University - 01/08/2009 07:08
(Boston)-A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process.
Recipe For Capturing Authentic Embryonic Stem Cells May Apply To Any Mammal, Study Suggests
Science Daily - 12/24/2008 08:25
) Researchers have what they think may be a basic recipe for capturing and maintaining indefinitely the most fundamental of embryonic stem cells from essentially any mammal, including cows, pigs and even humans.
New stem cell debate DeGette urges Obama to take action, remove federal barriers
Denver Daily - 12/23/2008 00:00
U.S. Reps. Diana DeGette, D-Colo., and Michael Castle, R-Delaware, chief architects of legislation expanding stem cell research, led a bipartisan group of lawmakers yesterday in sending a letter to President-elect Barack Obama, urging him to immediately remove existing federal barriers to embryonic stem cell research by executive order upon taking office. DeGette and Castle recently introduced new stem cell legislation overturning President Bush's executive order, updating previous legislation to ensure that it is current with the field of stem cell research and bringing the National Institutes of Health to the forefront.
Eli Broad to donate $25M for stem cell lab
Daily Breeze - 12/18/2008 22:31
Los Angeles philanthropists Eli and Edythe Broad say they will donate $25 million to UC San Francisco for a state-of-the-art laboratory that will bring together some of the world's leading scientists in the field of stem cell research.
Stem cell pioneer goes to UM
The Daily Record - 12/17/2008 12:03
Dr. Curt I. Civin, a long-time faculty member of the Johns Hopkins University School of Medicine and a pioneer in cancer research who developed a way to isolate stem cells from other blood cells, has joined the University of Maryland School of Medicine.
Tracking down bowel cancer stem cells
Cancer Research UK - 12/17/2008 00:00
Stem cells are a hot topic in cancer. In recent years we've seen the rise of the "cancer stem cell" concept – the idea that many cancers are caused by a small group of immortal stem cells. These produce `bulk tumour cells', which can be killed off by treatments such as chemotherapy, but the stem cells themselves are resistant to treatment.
Vatican Issues Instruction on Bioethics
The New York Times - 12/12/2008 00:00
The Vatican issued its most authoritative and sweeping document on bioethical issues in more than 20 years on Friday, taking into account recent developments in biomedical technology and reinforcing the church's opposition to in vitro fertilization, human cloning, genetic testing on embryos before implantation and embryonic stem cell research.
Scientists Identify Exciting New Compounds for Stem Cell Production from Adult Cells
Scripps Research Institute - 11/10/2008 00:00
Scientists from The Scripps Research Institute have identified a combination of small molecules that significantly improve the reprogramming of general adult cells into pluripotent stem cells, which can then develop into all cell types.

Policy

 
Missouri judge rejects lawsuit over stem cell research
Missourian - 01/15/2009 23:08
JEFFERSON CITY — For the second time, a Missouri trial judge ruled against critics of embryonic stem cell research who want to block state funds from going to life science grants.
Coalition for the Advancement of Medical Research Releases New White Paper, 'Catalyst for Cures: Embryonic Stem Cell Research'
News Blaze - 01/15/2009 10:42
- National Poll Reveals Three-Quarters of Americans Want President-Elect Obama to Deliver on Campaign Commitment to Lift Restrictions on Embryonic Stem Cell Research - WASHINGTON, Jan.
National Academy of Sciences Weighs in on Stem Cell Research
JNCI - 01/15/2009 07:49
A comprehensive stem cell report from the nation s top scientific body recommends far more publicly funded research than is allowed by the policy President Bush announced in August.
Funding halted for Britain's stem cell research
Belfast Telegraph - 01/13/2009 08:49
Britain's effort to lead the world in stem cell research with the creation of human-animal "hybrid" clones has ground to a halt through lack of funding less than a year after the controversial technique was legalised.
Millipore Corporation Supports President-Elect Obama's Plans to Review Stem Cell Research Policy
DMN Newswire - 01/12/2009 20:09
By BusinessWire BILLERICA, Mass., BUSINESS WIRE -- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it would support President-elect Barack Obama's plans to review and possibly reverse an executive order that...
All NIH human embryonic stem cell registry lines now deposited at NSCB
University of Wisconsin-Madison - 01/12/2009 17:00
The U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden.
UCSF Snags $25 Million Stem Cell Donation
California Stem Cell Report - 12/18/2008 02:56
Despite the nation's financial woes, some philanthropists continue to pump out money with the latest coming from the Eli and Edythe Broad Foundation for the benefit of UC San Francisco's stem cell laboratory.

Science

 
Scientists can now differentiate between healthy cells and cancer cells
McMaster University - 01/14/2009 15:40
One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. But a new study by McMaster University researchers has provided insight into how scientists might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells
SINGAPORE SCIENTISTS UNCOVER NEW METHOD TO CREATE INDUCED PLURIPOTENT STEM CELLS
A*STAR - 01/12/2009 15:34
Protein transcription factor Esrrb found to have new role in cell reprogramming 1. Scientists at the Genome Institute of Singapore (GIS), a research institute under the Agency for Science, Technology and Research (A*STAR), and the National University of Singapore have discovered for the first time, that a protein – Esrrb – played an essential role in changing differentiated murine cells back to a pluripotent(1) stem cell state. Led by Dr Ng Huck Hui, in collaboration with two other GIS groups headed by Dr Thomas Lufkin and Dr Lim Bing, their discovery of this alternative method in creating induced pluripotent stem (iPS) cells was published in Nature Cell Biology on January 11, 2009. This is also the first paper highlighting novel R&D work done in Singapore in the field of cell reprogramming.
Penn Researchers Unlock Molecular Origin of Blood Stem Cells
Penn Medicine News - 01/09/2009 15:37
Implications for new blood disorder therapies PHILADELPHIA – A research team led by Nancy Speck, PhD, Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine, has identified the location and developmental timeline in which a majority of bone marrow stem cells form in the mouse embryo. The findings, appearing online this week in the journal Nature, highlight critical steps in the origin of hematopoietic (or blood) stem cells (HSCs), says senior author Speck, who is also an Investigator with the Abramson Family Cancer Research Institute at Penn.
Drosophila Stem Cells Share a Common Requirement for the Histone H2B Ubiquitin Protease Scrawny
Science Magazine - 01/09/2009 07:35
Michael Buszczak,* Shelley Paterno, Allan C. Spradling Stem cells within diverse tissues share the need for a chromatin configuration that promotes self-renewal, yet few chromatin proteins are known to regulate multiple types of stem cells.
Scientists identify new kind of stem cell found in testes
Stanford News Service - 01/07/2009 15:41
Scientists at the School of Medicine and at UCSF have succeeded in isolating stem cells from human testes. The cells bear a striking resemblance to embryonic stem cells—they can differentiate into each of the three main types of body tissue—but the researchers caution against viewing them as one and the same. According to the study, testes stem cells have different patterns of gene expression and regulation and don't proliferate and differentiate as aggressively as embryonic stem cells.
"Scrawny" Gene Keeps Stem Cells Healthy
Carnegie Institution for Science - 01/07/2009 15:39
Baltimore, MD—Stem cells are the body's primal cells, retaining the youthful ability to develop into more specialized types of cells over many cycles of cell division. How do they do it? Scientists at the Carnegie Institution have identified a gene, named scrawny, that appears to be a key factor in keeping a variety of stem cells in their undifferentiated state. Understanding how stem cells maintain their potency has implications both for our knowledge of basic biology and also for medical applications. The results will be published in the January 9, 2009 print edition of Science.
Researchers create first functional stem cell niche
Standford News Service - 01/07/2009 06:35
Like it or not, your living room says a lot about you. Given a few moments to poke around, a stranger could get a good idea of your likes and dislikes, and maybe even your future plans.
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Nature.com refers DOI - 01/01/2009 07:43
Andrea Viale1,5, Francesca De Franco1,2,5, Annette Orleth1,2,5, Valeria Cambiaghi1, Virginia Giuliani1, Daniela Bossi1, Chiara Ronchini1, Simona Ronzoni1, Ivan Muradore1, Silvia Monestiroli1, Alberto Gobbi1, Myriam Alcalay1,4, Saverio Minucci1,3 & Pier Giuseppe Pelicci1,4 Department of Experimental Oncology...
Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2–dependent regulatory dendritic cell population
Blood - 01/01/2009 04:17
1 Center of Excellence in Tissue Engineering, Department of Cell Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China; and 2 Institute for Biomedical Engineering, Department of Cell Biology, Rheinisch...
Single virus used to convert adult cells to embryonic stem cell-like cells
NewsRx - 01/01/2009 00:56
(NewsRx.com) -- Whitehead Institute researchers have greatly simplified the creation of so-called induced pluripotent stem (iPS) cells, cutting the number of viruses used in the reprogramming process from four to one.
Patient-derived induced stem cells retain disease traits
University of Wisconsin-Madison - 12/22/2008 00:00
When neurons started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased. The dying cells — the same type lost in patients with the devastating neurological disease spinal muscular atrophy — confirmed that the UW-Madison stem cell biologist had recreated the hallmarks of a genetic disorder in the lab, using stem cells derived from a patient. By allowing scientists the unparalleled opportunity to watch the course of a disease unfold in a lab dish, the work marks an enormous step forward in being able to study and develop new therapies for genetic diseases.
Stem cell funds may go to UNM
Daily Lobo - 12/21/2008 04:26
by Jeremy Hunt Daily Lobo Gov. Bill Richardson announced support for legislation Friday that will give $10 million for embryonic and adult stem cell research at UNM's Health Sciences Center.
Clinical trial tests treatment for heart failure with adult stem cells
University of California - 12/18/2008 22:20
The University of California, San Diego Medical Center is the first hospital in California to enroll patients in a multicenter clinical trial, sponsored by Angioblast Systems Inc.
Crypt stem cells as the cells-of-origin of intestinal cancer
Nature.com refers DOI - 12/17/2008 17:58
Nick Barker1,4, Rachel A. Ridgway2,4, Johan H. van Es1, Marc van de Wetering1, Harry Begthel1, Maaike van den Born1, Esther Danenberg1, Alan R. Clarke3, Owen J.
Researchers Show that a Single Adult Stem Cell Can Self Renew
Genetic Engineering & Biotechnology News - 12/15/2008 17:21
GEN News Highlights Stanford University scientists report that they have demonstrated for the first time that a single adult stem cell can repair tissue damage in a live mammal.
Mesenchymal stem cell-mediated ectopic hematopoiesis alleviates aging-related phenotype in immunocompromised mice
Blood - 12/12/2008 18:44
Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, United States Graduate School of Medicine, Kyoto University, Kyoto, Japan National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States Mesenchymal Stem Cell...

Contact GPI
Robert E. Margolin
Associate Director
908-605-4203
rob@...


#6951 From: "Stephen Meyer" <Stephen276@...>
Date: Fri Jan 16, 2009 2:09 pm
Subject: A GLOBAL STEM CELL RESEARCH ACTION PLAN By Don Reed
stephen_meye...
Offline Offline
Send Email Send Email
 
 

               A GLOBAL STEM CELL RESEARCH ACTION PLAN

 

                                               By Don C. Reed

 

 

Like a war more deadly than any in history, chronic disease is ravaging Earth.

 

The incurably ill suffer and die no less than if bullets had struck them; hospitals and sickrooms overflow, inadequate to the task.    

 

Our problem is simple. With expensive modern medicines, we can keep our loved ones alive despite almost any illness or injury—but we cannot make them well.  

 

Two staggering statistics: first, in America alone, medical costs exceed $2.3 trillion in 2007, more than all federal income tax receipts ($1.8 trillion) combined—and three-fourths of all medical costs are directly due to chronic (incurable) disease.

 

First, we need international recognition of the scope of the problem. 

 

The United Nations must urge the world to work together on research for cure: stem cell research, gene therapy, biomedicine-- within each nation's ideological belief system.

 

Some nations (the Vatican, for example) oppose embryonic stem cell research; but there is no reason they could not fund adult stem cell research: the Pope's recently urged the Earth's Catholic community to support non-embryonic stem cell research, including the new induced Pluripotentiary (iPS) stem cells, an important piece of the puzzle. 

 

In countries that already do support full stem cell research, advocates must build upon that hard-won foundation in the UK, China, Singapore, Spain, Japan, Sweden, and many others, including (very soon) the United States.

 

We need international scholarship programs, so even the poorest countries can lend their brightest young men and women to Earth's emergency. If a country cannot afford a medical research college, loan programs should be developed for this global benefit.

 

In the business community, every country can and should encourage the research, from basic theory in the laboratories, to translation into actual use: therapies and cures.

 

As was done in San Diego, where four great institutes joined their strength for the good of all, companies and colleges can form consortiums, sharing their scientists, their knowledge, and their equipment.

 

Cities, states, and provinces can make life easier for struggling startups: establishing "incubators" for biomedical Mom-and-Pop companies as Silicon Valley did for the fledgling computer industry.

 

New ways of thinking can foster cooperation among scientists, like the disease team approach of the California stem cell program, and beyond.

 

What if the best scientists in the country were locked in a room, and not let out until they found a cure for __________ disease? Ridiculous, perhaps, or maybe not: if disease came with explosions, and germs were big enough to wear uniforms, we would take it much more seriously.

 

 At every step, government must help.

 

Asia understands. In China, the government is offering tax incentives, as well as funding at national and local levels; in Singapore, an entire community, Biopolis, provides jobs and housing for biomedical scientists and their families. This is wisdom, and should be emulated here at home, unless we want the biomedical revolution to be outsourced, giving blessings only to other countries.

 

In America, the emerging life science industry must think of itself as a new Defense Department-- and quit being so bashful! What business is more vital, urgent, and irreplaceable than one which could save lives and ease the suffering of millions?

 

We dare not flinch from political involvement. On the contrary, Biomed must lobby aggressively, make campaign contributions to legislators who support our goals, and vigorously oppose ideologues who would block the industry of healing.

 

Talk about a justifiable tax exemption! To my mind, the entire biomedical industry should be tax free for at least a decade, give it time to grow.

 

In Washington, there is much to be done. President-elect Obama must follow through with his promise: to remove ideological restrictions on regenerative medicine. This goes deeper than the ill-conceived Bush restrictions.  The Dickey Amendment, for example, should no longer be automatically renewed, attached every year to some "must-pass" legislation. That miserable law defines cells in a Petri dish as the equivalent of a human being; it is even rewritten year after year to block new forms of research, like nuclear transfer research, which involves neither sperm nor womb. It is time we stopped allowing opponents of science to be the "deciders" on science policy—in a country based on liberty.

 

But freedom to research, while crucial as the air we breathe, is not enough. We cannot live on air alone, and neither can the families of scientists. These men and women are trying to do the impossible with the invisible, and we must look out for them.

 

Imagine if President John F. Kennedy had pointed to the sky, and said: we are going to the moon—but we're not actually going to pay for it? Research without funding is like a moonshot with no rocket.

 

The Castle/Degette Stem Cell Research Enhancement Act (twice vetoed by President Bush) must be rewritten to include major money for the research. 

 

The National Institutes of Health must no longer be ignored. The NIH was once the crown jewel of Earth's research, and it must be so again. Its funding levels have been "flat-lined" for the past five years; costs have risen, but its funding has not even kept pace with inflation. When a patient's vital signs flat-line, they need life support; so does the NIH.

 

We need help from every state.

 

At present, only a "Magnificent Seven" states provide funds for full stem cell research: California, New York, New Jersey, Massachusetts, Connecticut, Illinois, and Maryland.  Even here, there is no room to relax, as advocates must fight to protect what has been won.

 

Not even the magnificent California Institute for Regenerative Medicine is safe. There is money for grant programs until July of this year, and enough to run the Institute itself (on a skeleton crew) for a year after that. But our funding comes from bonds which are sold, and that sale must be approved by the Secretary of the Treasury. If the financial conditions in the Golden State do not improve, and new bond sales are not allowed, California may be forced to do again what ICOC chair Bob Klein did to protect us before.  When our funding was blocked by lawsuits, he and a dedicated few board members brought in loan/gifts from the public: a tremendously difficult job even then, and it will be immeasurably more difficult now. 

 

And what about the states which still handcuff their scientists? Places like Arizona, Arkansas, Iowa, Kentucky, Louisiana, Maine, Minnesota, Nebraska, New Hampshire, New Mexico, North Dakota, Pennsylvania,  Rhode Island, South Dakota, Utah, and Virginia still put ideological hurdles in front of researchers, sometimes calling them criminals, and threatening them with prosecution for their life-giving work.

 

Advocates in such states do have options: they can directly challenge the negative laws; or work around them, pushing for funding bills which support only adult stem cell research; or, they may prepare the state for tomorrow, giving educational talks to community organizations: such speeches are hugely influential, planting seeds for future growth and beneft.  

 

One useful tool is a miniature research bill, like California's Roman Reed Spinal Cord Injury Research Act. It is tiny, just $1.5 million a year. But from that small beginning, a way to cure paralysis may spring. If you saw the paralyzed rats that walked again, scampering around a purple plastic swimming pool on TV, you saw "our" work. One influential scientist,  Dr. Hans Keirstead, succeeded first with a Roman Reed grant, then used that success as leverage for larger grants from the NIH; That experiment (now funded by ground-breaking Geron) is under consideration by the FDA for human trials, the first in the world.

 

 

"Roman's Law" has funded about $12 million in research over the few years of its existence—and quintupled that investment for the Golden State, bringing in an additional $50 million in matching funds from the feds, new money for our state—funding more than 50 scientists and their staffs, good jobs for our state and nation

 

Why not a regenerative research funding law in every state?

 

One immediate benefit would be funding for new scientists, the young ones all too often locked out of grants from the NIH. Because there is so little money in the National Institutes of Health budget, a scientist often won't get help from this prime source until he or she reaches an average age of 43. A scientist who earns a doctor's degree (a huge accomplishment) may not be able to make a living for the first twenty years in the field!

 

In these and other ways, small and large, our states and nations can work together. Every contribution helps: like little cloth squares, meaningless by themselves, but when combined into a patchwork quilt, bring warmth and comfort on a freezing Winter's night.

 

Imagine how beautiful international research cooperation could be: like an Iranian/Israeli stem cell research institute.  Why not? Both countries are strong supporters of stem cell research, everybody loves their children, and every family deserves access to the best medicine science can provide.

 

Already, the State of California is working with countries like Canada, Japan and the UK, finding ways to multiply our efforts, getting far more bang to the buck, while still spending the money inside the Golden State, as mandated by Proposition 71.

 

We must support the research where it grows; plant seeds where it is not—with a global stem cell research action plan.

 

 

Don C. Reed is Vice-President for Public Policy, Americans for Cures Foundation; his opinions may or may not reflect the views of the Foundation.

 


#6950 From: "Stephen Meyer" <Stephen276@...>
Date: Fri Jan 9, 2009 1:35 pm
Subject: TIME TO TAX? OR-- THE YANT ALTERNATIVE..By Don Reed
stephen_meye...
Offline Offline
Send Email Send Email
 

TIME TO TAX? OR-- THE YANT ALTERNATIVE

 

by Don C. Reed

 

First, here is an argument FOR increased taxation of the very rich, the sort of folks for whom the first great Depression was a happy time: when prices were low, and servants worked cheap. For those who ignore the sufferings of millions, there may be no answer, except to tax.

 

But for the far-sighted, there is another way, which I will get to in a minute. 

 

 

Part One: Time to Tax

 

"Let the rich alone," said William F. Buckley, in a famous essay of 1968, and for forty years our country has taken that advice all too literally, as cornerstone financial policy. 

 

Until very recently, the worst thing that could be said about a politician was to be labeled a "tax and spend" Democrat. Instead, we were told, the "unseen hand of the market" was cited as the answers to all ills.

 

In California, that attitude is enshrined in law. A virtually unattainable 2/3 majority is required to pass any new tax. The result? We once provided the best public school education country have fallen to 46th in per-pupil spending—and the Golden State is reportedly just weeks away from bankruptcy. 

 

Nor is California alone in its difficulties. America is going broke: mired in debt, increasingly unable to pay our bills.  One huge expense alone, ($2.3 trillion in medical costs), outstrips all federal income tax receipts (1.8 trillion) combined. 

 

Real unemployment is close to 13%. The usual figure of 6.7% is misleading; if a person is out of work for more than a few weeks, they are considered to have given up seeking employment, and are not counted any more. But they have not gone away. They are still there, and are growing increasingly hungry.

 

The gap between rich and poor has widened, until the income of the top three hundred fifty thousand Americans is more than the bottom one hundred fifty million.

 

Is it not time to reconsider the dreaded "T word"? 

 

Or have we forgotten what took us out of the first Great Depression?

 

Massive governmental spending taxed-and-spent us out of depression-- and into the greatest lasting prosperity the world has ever known.

 

Soon, a new Administration will begin: a new President, a new Democratic majority in Congress and the Senate. We all wish them courage and wisdom for what lies ahead.

 

They must do what every politician dreads: inflicting new taxes on the very rich:  requiring them to give back to the country which made their wealth possible.

 

To do otherwise is to break faith with a woman named Andrea, a 30-year-old injured military veteran, whose unemployment benefits just ran out.

 

As she walked away from the volunteer soup kitchen, not long before Christmas Day, Andrea carried a small frozen turkey, some canned vegetables, and a tub of sour cream, which was all that charity had left to give her.

 

The little bit of food would have to last. Andrea is also a mother, a single mom, raising a little girl on her own. 

 

"I gave up on eating every day," Andrea said, "I want to make sure what we have lasts for my daughter."*

 

Voluntary charity is not enough for all the Andreas and their children in our country, the ten per cent of our population which goes to bed hungry every night.

 

America must not let her down.

 

It is time to tax.

 

  • "Food stamp recipients have quadrupled in the past year, study shows",

Karen de Sa, Fremont Argus, Bay Area News Group, 12/23/08

 

 

PART TWO: 

 

OR—there is Bob Yant's Way

 

Bob Yant is a gentle-voiced friend of scientific research-- and of anybody in a wheelchair who wants to get out.

 

A mainstay of the research movement, Bob has been fighting for science many years, always with a smile, and the attitude that "wouldn't it be great if it were possible to—", so the ideas linger in the mind.

 

He can handle giant ideas, and "talk science" with the best of them.

 

And—he is a businessman. His product?

 

Excuse me, but I must get personal for a moment.

 

Anybody in a wheelchair knows that bathroom needs cannot be taken for granted.

 

Once paralyzed, never again is it enough to just say, "Hey, where is the restroom?", and that is all it takes.

 

Assistance is required: like catheterization tubes that go inside the body.

 

A trustworthy product is needed. So, Bob designed his own catheterization gear, based not only on the most up-to-date science, but also backed by the irreplaceable knowledge of many years living in a chair.

 

I am no urologist to understand the medical side of such things.

 

But I know Bob Yant, and I trust him. In my opinion, any product he develops will be outstanding.

 

In a minute I will point you to his website.

 

But first, the reason for this editorial.

 

Because Bob also came up with an ALTERNATIVE TO TAXATION: his own personal

way to advance scientific research without being forced.

 

Instead of waiting to be taxed, the Yant approach was to voluntarily donate ten per cent of what he makes from the product, and give it to research.

 

I am no economist, but I cannot help wondering about the impact his example could bring. We already have a certain level of taxation, which has to be maintained, and loopholes closed: even the most tight-fisted of conservatives agree the national debt must be paid down, and there is no other way.

 

But what would happen if every company and wealthy individual followed the Yant example, and genuinely donated ten per cent of gross income to support a social goal? 

 

There might be no need to increase taxation at all.

 

For a look at Bob Yant's product, and his policy, go to http://www.curemedical.com.

 

 


#6949 From: "Stephen Meyer" <Stephen276@...>
Date: Sat Jan 3, 2009 8:49 pm
Subject: THE LONE STAR VOLUNTEERS, AND THE FAMILY OF CURE
stephen_meye...
Offline Offline
Send Email Send Email
 

THE LONE STAR VOLUNTEERS, AND THE FAMILY OF CURE

 

                                    By Don C. Reed

 

 

As friends of this column know, the past four years have been great fun for me. Not only have I been able to work with amazing people, doing exactly the kind of work I most enjoyed, but I received a part-time stipend from Americans for Cures Foundation for my out-of-state efforts. It was like being paid for vigorous fun.

 

Today, in the deepening winter of recession, it is much harder for non-profit organizations to gather donations for even part-time staff.

 

Chances are, I will be working volunteer again for a while.

 

I have applied to renew my teacher's credential, and will substitute (ask any teacher what that small hell is like) 2-3 days a week. Subbing exhausts you. Every period is like the first day of school, when a teacher must prove himself, and fight. That is no problem, when the kids are going to be yours all year, because on the first day of school they are a little off-balance, and you just have to take charge immediately. After a few days they realize they can live with you, and teaching becomes a great job, although of course grossly underpaid.

 

But as a substitute, it is you who are off-balance. The kids are comfortable, and the sub is the outsider. The students mostly come to play, because they know you are not staying. If you intend to actually teach (and I don't know any other way) it is a war. By the time they realize you intend to be taken seriously, it is the end of the period—and then the next class comes in, and the nightmare begins again—every period, all day, and it drains you, all that emotional fighting.

 

Unless I can find a grant, I will be doing advocacy work only in my spare time: twenty to thirty hours a week instead of sixty-to-eighty.

 

This will of course diminish my efficiency—but I have been there before. Part-time volunteer work was what I did in the first decade of the advocacy adventure.

 

So, what can a part-time volunteer do?

 

Practically anything.

 

 It is easier with a budget, no question: but the vast majority of stem cell research advocates everywhere are zero-budget folks.

 

Right now, I can think of ten chores that can be done by people without money.

 

  1. develop a state stem cell research funding bill;
  2. establish a state  "permissions" bill, for scientific freedom;
  3. develop and deliver informational presentations to advance awareness;
  4. help elect Congressional and Senatorial candidates who back research;
  5. support ongoing legislative efforts already begun by other advocates;
  6. oppose anti-research laws by speaking/writing/organizing;
  7. use Google alerts to keep in touch with regenerative medical progress;
  8. support efforts to at least double NIH funding;
  9. work to block the annual renewal of the Dickey-Wicker Amendment;
  10. respond to articles in the press, either positive or negative.

These are "doable"; I have done them, (with the help of hundreds of hard-working friends) and am trying to do them again, all on a volunteer basis. 

 

Most advocates never receive a salary at all. The most important work of their lives is done "for free".

 

Look at the amazing efforts of CAMR, the Coalition for the Advancement of Medical Research, our voice in Washington—I think they have one and a half paid staff—all the rest volunteer their services.

 

Look at the Texas folks: like Joe and Nina Brown, Judy Haley, Beckie McCleery and other Lone Star volunteers: people like Val, Kathy, Laura, Susan, Chris, Larry, Dianne, Wendy, Bill, Jennifer, Ellen, Cheryl, Gerald, Ralph, Clarence, Michael, Harry and Kent, to name a few.

 

If any of those endlessly-working people receives a salary, I would be delighted—(talk about justified!)—and, unfortunately, surprised.

 

These are folks who are willing to drive to the state Capitol in the middle of the night, when hearings may be suddenly called about stem cell issues. In addition to trying to follow and understand the science, and to communicate it to others, including the press, they spend countless hours arguing with legislators all too often under the thumb of the religious right.

 

Texas is controlled by a party which lets its science policy be determined by an ultra-conservative religious minority: remember, the current Republican party platform calls for the complete elimination of embryonic stem cell research. 

 

It must feel like trying to dig water wells in the Sahara desert.

 

And yet, the Texan stem cell research community continues to fight.

 

I remember an old boxer saying, "sometimes you win by just hanging on, waiting for an opportunity." They do a lot of that in Texas, fighting to defeat rotten bills that would deny the hope of cure to millions, while at the same time trying to pass good bills they know do not have a prayer of passing.

 

Why do they do it, month after month, year after year? Same reason as always, because their loved ones are at risk. They are fighting for their families, and yours and mine.

 

For one thing, they understand that cure research is a way to stabilize the economy. They know that of America's $2.3 trillion medical costs last year, 75% was spent on the care of folks who have incurable (chronic) disease or disability. That mountainous medical bill is a key reason our economy is starting to fail. Cure diabetes? That would save roughly a fifth of a trillion dollars.

 

They know that every step to advance regenerative medicine not only brings our families closer to safety from disease and disability, but also is a direct help to America's faltering economic system.

 

These are far-seeing folks: like the people who built the library in my hometown of Fremont.

 

If you visit our library sometime, you will find it jam-packed with happy people—probably none of whom ever stop and think, hmmm, how many council meetings had to be sat through, how many government officials had to be approached by unpaid volunteers, (a group called "Friends of the Library"), how many booksales, how many campaigns to try and get funding for this building and its books.

 

And, one suspects, this is how it has always been:  behind every victory are the efforts of many people, uncredited, unpaid; and who may not even get to see their horse come in.   

 

But we know. And when America finally grabs hold of the biomedical revolution, and cure begins to happen, it will be because of people like the Lone Star volunteers.

 

If you don't mind working free, (which by definition means part-time, because you have to do something else to pay the rent) there are endless jobs that need doing in your state's collegiate, legislative, charitable, or business arena.

 

For me, the first priority is putting pressure on government to fund  basic research for cure, laying the ground work for private enterprise, so they can get involved when financially sensible. It may cost as much as a billion dollars to develop a single drug, bringing it from the scientist's lab to people's medicine cabinet; it is unreasonable to expect the companies to pay for everyone else's research as well. Funding basic research is what the public sector does best, from the smallest state funding bill, to the National Institutes of Health, the NIH.

 

Eventually, the giant corporations will be "forced" to invest in regenerative medicine. Businesspeople cannot overlook a burgeoning opportunity.

 

 But first, states and national government agencies must to do their share.

 

And who will exert this pressure on our elected government, in a country which not only allows citizen involvement, but encourages it, depends on it?

 

That would be us.

 

We may never meet in person, you and I, never have the chance to shake hands and laugh, hug and have dinner, babble over coffee, share advocate war stories and pictures of our kids.

 

But we are brothers and sisters in struggle just the same.

 

We are the family of cure.

 

Happy New Year!

 

 

 

 

 

 

 

 

 

 


#6948 From: "Stephen Meyer" <Stephen276@...>
Date: Fri Dec 19, 2008 5:54 pm
Subject: CHRISTMAS, UNDER DURESS......... By Don Reed
stephen_meye...
Offline Offline
Send Email Send Email
 

CHRISTMAS, UNDER DURESS

 

 by Don C. Reed

 

I went to my Grandson's Christmas program last night.

 

Gloria, beloved wife of almost 40 years, goes to church at least once a week, without fail.

 

I go when forced by societal pressures, i.e. Gloria. Roman Junior goes to a Catholic school, so I go if it is something to do with him, plus the Mrs. always muscles me into a Christmas religious service of some kind or other.

 

Technically, I felt, I had already done my Christmas obligation.

 

Last week, Gloria put on a small dinner for the homeless. Our local church provides a place to sleep for about four families down on their luck. Gloria purchased multiple pizzas, sent her husband to purloin oranges off our neighbor's tree, arranged cupcakes from a friend, made homemade guacamole dip and cut up bread strips to dip with, as well as providing bottled drinks and items of the vegetable persuasion.

 

I thought there would be a lot of people involved in the providing part of the dinner, but there wasn't. It was just us.

 

When we came in the door, a woman looked up and said: "Did you bring the dinner?"

 

I thought: what if we had forgot? Would they have eaten?

 

There were about eight children.

 

One man, well-dressed, studied his shoes. Beside him were two little girls. Their hair was tied up in bows. I said hello, shook hands, he introduced his children proudly. I did not see a mom. What if I was a single parent, with two little girls to care for?

 

Gloria took command as usual, lining everyone up like she was in the military.

 

"No, just one piece of pizza till everybody gets served!"

 

"What, pizza again?" I heard somebody say.

 

The women hustled the children over, to make sure they were fed before the food was gone. They ate everything we brought and I wished there was more. Just one piece of pizza, for the main dish?

 

But it was something, and the Catholic Church had made it possible, encouraging parishioners like Gloria to help with food, while the Church provided shelter and also some real-life helps like job hunting assistance.

 

On the one hand Gloria's church is the epitome of charity; on the other, the Pope's narrow-minded and anti-scientific views (if listened to) would condemn millions to lives of needless suffering.

 

A former member of the Hitler Youth, Pope Benedict (formerly Joseph Ratzinger) may be over-reacting to his Nazi past. Probably all German-Americans are at least somewhat embarrassed about the horrible cruelties inflicted by the nation from which their ancestors sprang (I am half German on my mother's side, her Schneider family name changed to Snyder) and the Pope makes stem cell research sound like the Nazi science of eugenics, trying for the "master race", which is total nonsense. Trying to cure people's misery is a whole lot different than trying to create a bunch of Hitler mini-monsters.

 

Have you read the Pope's latest statement on bioethics? It is 32 pages long, and was created by a Church council which he led before becoming Pope. 

 

If you want to read the statement, a condensed version follows. it says: 

The document … expressly approved by the Holy Father, Pope Benedict XVI…is to be received by Catholics "with the religious assent of their spirit" (Dignitas personae, n. 37).

 

In other words, you cannot even disagree in your own mind, let alone argue about it

 

Stem cell research is life and death important to me.

 

And under the current Pope, almost every form of advanced stem cell research is forbidden.

 

Sure, there was a little disclaimer:  "The Church, by expressing an ethical judgment on some developments of recent medical research concerning man and his beginnings, does not intervene in the area proper to medical science itself…"    (emphasis added)

 

The truth is the Church will intervene and control exactly as much as it can get away with. In Italy, the Pope's word is pretty much law. In the United Nations, robed priests went with Bush Administration officials to put pressure on small countries to ban Somatic Cell Nuclear Transfer (SCNT, sometimes called therapeutic cloning), trying to criminalize it throughout the world. They failed, but not through lack of trying.

 

From Michigan to Missouri, the Catholic Church has mounted full-force political efforts to block embryonic stem cell research.

 

But there was one line in the Pope's statement, which gave me hope for the day when the Church will inevitably reconsider its stance, as it has done in the matter of x-rays, small-pox vaccine, anesthesia, and many other medical advances, initially opposed.

 

"…danger to the health of children could permit parents to use a vaccine which was developed using cell lines of illicit origin…"

 

That was a loophole, perhaps, which might one day be used to alter a mistaken policy.

 

Because what parent would not consider cure for a child, dying?

 

I remembered where my grandson got his middle name.

 

When Rome was four years old, he had a friend named Jacob, who was eight. Roman and he used to throw a football around, and Jacob was always patient and kind.

 

But he contracted leukemia, and there was no cure. His parents did the best they could for him, but the pain grew worse and worse.  I visited him one time, and brought my old Marine World slide show along, and told him about the sharks and dolphins, and for a little while the lines of pain eased on his face. But then the stories ended, and the pain sank in again.

 

Roman told him, when he grew up, if he ever had a son, he would name him after Jacob.

 

After many months of struggle, Jacob told his mother, he did not want to go on any more. And she held him in her arms as he let go, and died.

 

Our son remembered the promise, which was how Roman Jacob Reed got his name.

 

I thought about a rally I attended, a march against cancer, put on by Assemblymember John Dutra, original sponsor of the Roman Reed Spinal Cord Injury Research Act, and a devout Catholic. He had let me speak at the event, and of course I spoke strongly about stem cell research, therapeutic cloning, embryonic stem cell research, how it had nothing to do with making babies and everything to do with making cures-- the whole nine yards.

 

Afterwards, two little nuns came over to speak with me. I got a little frightened--

oh, no, I am in for it now—because how can you argue with a nun?

 

But the older nun said, quite firmly:

 

"We wanted you to know, we support the research."

 

The second nun nodded, and smiled.

 

Like the 72% of American Catholics who support embryonic stem cell research, she had made up her own mind.

 

My knee was hurting, so I had to stand up for a while. We there almost an hour early, sigh… I went out in the lobby, and there were many pamphlets and brochures. I did not thumb through them, knowing if I found anything about stem cell research, I would not like it. I remembered the 32 page document, which talked about opposing research because it lessens the "dignity" of humankind—where is the dignity in loss of bowel and bladder control? Where is the dignity in losing one's mind to Alzheimer's?

 

Gloria always tells me, the Pope is a man, and people make mistakes.

 

But this is such a powerful man, and the mistake is so enormous!

 

I went and sat down again, my stomach in knots.

 

Then the children filed in.

 

And began to sing.

 

As a lover of music, some of it was legitimately painful to my ears. These were just regular kids, everybody in the school, and some did not quite grasp the concept of following notes. At one point I suppressed a groan and muttered something to Gloria, in what I thought was the softest of whispers. She elbowed me sharply, indicating with a jerk of her head that one of the children's fathers was the enthusiastic cameraman directly to our left.

 

But then it was our grandson's turn to walk up on stage. Roman Jacob Reed Part Two,  son of our son. Roman senior was beaming in the back. Mom Terri and Jason were home taking care of our new puppy.

 

All the children sang. Most of the pieces (mercifully) were short.

 

But the music director harbored ambitions.

 

As I glanced at the program, I felt my eyes widen.

 

The last number was-- the Hallelujah Chorus, from Handel's Messiah?

 

Handel's Messiah has been called the greatest piece of music in the world. It is also genuinely difficult to sing right, even for trained professionals.  

 

I knew from experience, having massacred the piece myself, decades ago, in the choir of the church I attended before marrying Gloria. It took months of preparation and rehearsal, every one of us had a musical background-- and even then we barely survived.

 

And these little kids—regular normal kids off the street-- were going to attempt the Hallelujah Chorus?

 

Now. The most important two notes in that song are the first one, and the last. You have to start off STRONG-- The "Haaa" in Haleluja has to be a full-throated bellow, a shout-- and finish with a cutoff note that is clean and sharp, abdominal power, and control.

 

The conductor raised her baton—the audience held its breath—

 

And then it came.

 

"HAAA-lay-loo-ya!  HAAA-lay-loo-ya!"

 

As if by Christmas magic, power descended on those children's voices. It was like a second choir, and every child was caught up in the joy, faces bright as Christmas candles.

 

They sang the complicated parts, Halleluja, hallelujah, hall-lay-ay-loo-ya!",

when one group sings one thing, and another group does something else, And He shall reign forever, and ev--" while a third group sings another Halleluja altogether-- and every word has to be heard, and every note singularly appreciated.

 

They nailed it. It was plainly impossible, but they were kids and did not know it was impossible, and so they did it anyway, good and loud, going for it on every single note.

 

"…Hall-ayyyy—loooo-yaaaaa--!"— they cut off the last note clean and sharp, and it echoed in the hushed church.

 

An instant of silence—and then the roar of applause began.

 

For these, our voices of the future.

 

May they build a church more open, to the hope of a healthier world.

 

Merry Christmas, everyone.

 

 

ZE08121202 - 2008-12-12
Permalink: http://zenit.org/article-24541?l=english

Synthesis of Instruction "Dignitas Personae"

 

VATICAN CITY, DEC. 12, 2008 (Zenit.org).- Here is the synthesis of the instruction "Dignitas Personae" that was released today by the Congregation for the Doctrine of the Faith on certain bioethical questions. It was published in English, French, German, Italian, Spanish, Portuguese and Polish.

* * *

Regarding the Instruction Dignitas Personae

Aim

In recent years, biomedical research has made great strides, opening new possibilities for the treatment of disease, but also giving rise to serious questions which had not been directly treated in the Instruction Donum vitae (22 February 1987). A new Instruction, which is dated 8 September 2008, the Feast of the Nativity of the Blessed Virgin Mary, seeks to provide some responses to these new bioethical questions, as these have been the focus of expectations and concerns in large sectors of society. In this way, the Congregation for the Doctrine of the Faith seeks both to contribute "to the formation of conscience" (n. 10) and to encourage biomedical research respectful of the dignity of every human being and of procreation.

Title

The Instruction opens with the words Dignitas personae - the dignity of a person, which must be recognized in every human being from conception to natural death. This fundamental principle expresses "a great `yes' to human life and must be at the center of ethical reflection on biomedical research" (n. 1).

Value

The document is an Instruction of a doctrinal nature, published by the Congregation for the Doctrine of the Faith and expressly approved by the Holy Father, Pope Benedict XVI. The Instruction therefore falls within the category of documents that "participate in the ordinary Magisterium of the successor of Peter" (Instruction Donum veritatis, n.18), and is to be received by Catholics "with the religious assent of their spirit" (Dignitas personae, n. 37).

Preparation

For several years, the Congregation for the Doctrine of the Faith has been studying new biomedical questions with a view to updating the Instruction Donum vitae. In undertaking the examination of such new questions, the Congregation for the Doctrine of the Faith "has benefited from the analysis of the Pontifical Academy for Life and has consulted numerous experts with regard to the scientific aspects of these questions, in order to address them with the principles of Christian anthropology. The Encyclicals Veritatis splendor and Evangelium vitae of John Paul II, as well as other interventions of the Magisterium, offer clear indications with regard to both the method and the content of the examination of the problems under consideration" (n. 2).

Intended recipients of the document

The Instruction is meant for "all who seek the truth" (n. 3). Indeed, in presenting principles and moral evaluations regarding biomedical research on human life, the Catholic Church "draws upon the light both of reason and of faith and seeks to set forth an integral vision of man and his vocation, capable of incorporating everything that is good in human activity, as well as in various cultural and religious traditions which not infrequently demonstrate a great reverence for life" (n. 3).

Structure

The Instruction has three parts: "the first recalls some anthropological, theological and ethical elements of fundamental importance; the second addresses new problems regarding procreation; the third examines new procedures involving the manipulation of embryos and the human genetic patrimony" (n. 3).

First Part:

Anthropological, Theological and Ethical Aspects of Human Life and Procreation

The two fundamental principles

"The human being is to be respected and treated as a person from the moment of conception; and therefore from that same moment his rights as a person must be recognized, among which in the first place is the inviolable right of every innocent human being to life" (n. 4). "The origin of human life has its authentic context in marriage and in the family, where it is generated through an act which expresses the reciprocal love between a man and a woman. Procreation which is truly responsible vis-à-vis the child to be born must be the fruit of marriage" (n. 6).

Faith and human dignity

"It is the Church's conviction that what is human is not only received and respected by faith, but is also purified, elevated and perfected" (n. 7). God has created every human being in his own image, and his Son has made it possible for us to become children of God. "By taking the interrelationship of these two dimensions, the human and the divine, as the starting point, one understands better why it is that man has unassailable value: he possesses an eternal vocation and is called to share in the trinitarian love of the living God" (n. 8.).

Faith and married life

"These two dimensions of life, the natural and the supernatural, allow us to understand better the sense in which the acts that permit a new human being to come into existence, in which a man and a woman give themselves to each other, are a reflection of trinitarian love. God, who is love and life, has inscribed in man and woman the vocation to share in a special way in his mystery of personal communion and in his work as Creator and Father... The Holy Spirit who is poured out in the sacramental celebration offers Christian couples the gift of a new communion of love that is the living and real image of that unique unity which makes of the Church the indivisible Mystical Body of the Lord Jesus" (n. 9).

The Church's Magisterium and the legitimate autonomy of science

"The Church, by expressing an ethical judgment on some developments of recent medical research concerning man and his beginnings, does not intervene in the area proper to medical science itself, but rather calls everyone to ethical and social responsibility for their actions. She reminds them that the ethical value of biomedical science is gauged in reference to both the unconditional respect owed to every human being at every moment of his or her existence, and the defense of the specific character of the personal act which transmits life" (n. 10).

Second Part:

New Problems Concerning Procreation

Techniques for assisting fertility

Among the procedures which respond to problems of fertility are the following:

"techniques of heterologous artificial fertilization" (n. 12): that is, "techniques used to obtain a human conception artificially by the use of gametes coming from at least one donor other than the spouses who are joined in marriage" (footnote 22). "techniques of homologous artificial fertilization" (n. 12): that is, "the technique used to obtain a human conception using the gametes of the two spouses joined in marriage" (footnote 23). "techniques which act as an aid to the conjugal act and its fertility" (n. 12). "techniques aimed at removing obstacles to natural fertilization" (n. 13). "adoption" (n. 13).

Techniques are morally permissible if they respect: "the right to life and to physical integrity of every human being", "the unity of marriage, which means reciprocal respect for the right within marriage to become a father or mother only together with the other spouse" and "the specifically human values of sexuality" (n. 12), which require that the procreation of a new human person come about as a result of the conjugal act specific to the love between a husband and wife.

Therefore, "techniques which act as an aid to the conjugal act and its fertility are permitted" (n. 12). In such procedures, the "medical intervention respects the dignity of persons when it seeks to assist the conjugal act either in order to facilitate its performance or in order to enable it to achieve its objective once it has been normally performed" (n. 12). "Certainly, techniques aimed at removing obstacles to natural fertilization... are licit" (n. 13). "Adoption should be encouraged, promoted and facilitated so that the many children who lack parents may receive a home... In addition, research and investment directed at the prevention of sterility deserve encouragement (n. 13).

In vitro fertilization and the deliberate destruction of embryos

The experience of recent years has shown that in all techniques of in vitro fertilization "the number of embryos sacrificed is extremely high" (n. 14). Even in the most technically advanced centers of artificial fertilization, the number is above 80% (cf. footnote 27). "Embryos produced in vitro which have defects are directly discarded"; a increasing number of couples "are using artificial means of procreation in order to engage in genetic selection of their offspring"; of the embryos which are produced in vitro "some are transferred into the woman's uterus, while the others are frozen"; the technique of multiple transfer in which "the number of embryos transferred is greater than the single child desired, in the expectation that some embryos will be lost... implies a purely utilitarian treatment of embryos" (n. 15).

"The blithe acceptance of the enormous number of abortions involved in the process of in vitro fertilization vividly illustrates how the replacement of the conjugal act by a technical procedure...leads to a weakening of the respect owed to every human being. Recognition of such respect is, on the other hand, promoted by the intimacy of husband and wife nourished by married love... In the face of this manipulation of the human being in his or her embryonic state, it needs to be repeated that God's love does not differentiate between the newly conceived infant still in his or her mother's womb and the child or young person, or the adult and the elderly person. God does not distinguish between them because he sees an impression of his own image and likeness.. Therefore, the Magisterium of the Church has constantly proclaimed the sacred and inviolable character of every human life from its conception until its natural end" (n. 16).

Intracytoplasmic sperm injection (ICSI)

Intracytoplasmic sperm injection is a variety of in vitro procreation in which fertilization in the test tube does not simply "take place on its own, but rather by means of the injection into the oocyte of a single sperm, selected earlier, or by the injection of immature germ cells taken from the man" (footnote 32).

This technique, which is morally illicit, causes a complete separation between procreation and the conjugal act" (n. 17). It takes place "outside the bodies of the couple through actions of third parties whose competence and technical activity determine the success of the procedure. Such fertilization entrusts the life and identity of the embryo into the power of doctors and biologists and establishes the domination of technology over the origin and destiny of the human person" (n. 17).

Freezing embryos

"In order to avoid repeatedly taking oocytes from the woman's body, the process involves a single intervention in which multiple oocytes are taken, followed by cryopreservation of a considerable number of the embryos conceived in vitro. In this way, should the initial attempt at achieving pregnancy not succeed, the procedure can be repeated or additional pregnancies attempted at a later date" (n. 18). The freezing or cryopreservation of embryos "refers to freezing them at extremely low temperatures, allowing long term storage" (cf. footnote 35).

"Cryopreservation is incompatible with the respect owed to human embryos; it presupposes their production in vitro; it exposes them to the serious risk of death or physical harm, since a high percentage does not survive the process of freezing and thawing; it deprives them at least temporarily of maternal reception and gestation; it places them in a situation in which they are susceptible to further offense and manipulation" (n. 18).

With regard to the large number of frozen embryos already in existence the question becomes: what to do with them? All the answers that have been proposed (use the embryos for research or for the treatment of disease; thaw them without reactivating them and use them for research, as if they were normal cadavers; put them at the disposal of infertile couples as a "treatment for infertility"; allow a form of "prenatal adoption") present real problems of various kinds. It needs to be recognized "that the thousands of abandoned embryos represent a situation of injustice which in fact cannot be resolved. Therefore, John Paul II made an "appeal to the conscience of the world's scientific authorities and in particular to doctors, that the production of human embryos be halted, taking into account that there seems to be no morally licit solution regarding the human destiny of the thousands and thousands of `frozen' embryos which are and remain the subjects of essential rights and should therefore be protected by law as human persons" (n. 19).

The freezing of oocytes

"In order avoid the serious ethical problems posed by the freezing of embryos, the freezing of oocytes has also been advanced in the area of techniques of in vitro fertilization" (n. 20).

In this regard it needs to be stated that while the cryopreservation of oocytes is not in itself immoral, and is employed in other medical contexts which are not the subject of this document, when it takes place "for the purpose of being used in artificial procreation" it is "to be considered morally unacceptable" (n. 20).

The reduction of embryos

"Some techniques used in artificial procreation, above all the transfer of multiple embryos into the mother's womb, have caused a significant increase in the frequency of multiple pregnancy. This situation gives rise in turn to the practice of so-called embryo reduction, a procedure in which embryos or fetuses in the womb are directly exterminated" (n. 21).

"From the ethical point of view, embryo reduction is an intentional selective abortion. It is in fact the deliberate and direct elimination of one or more innocent human beings in the initial phase of their existence and as such it always constitutes a grave moral disorder" (n. 21).

Preimplantation diagnosis

"Preimplantation diagnosis is a form of prenatal diagnosis connected with techniques of artificial fertilization in which embryos formed in vitro undergo genetic diagnosis before being transferred into a woman's womb. Such diagnosis is done in order to ensure that only embryos free from defects or having the desired sex or other particular qualities are transferred" (n. 22).

"Unlike other forms of prenatal diagnosis..., diagnosis before implantation is immediately followed by the elimination of an embryo suspected of having genetic or chromosomal defects, or not having the sex desired, or having other qualities that are not wanted. Preimplantation diagnosis...is directed toward the qualitative selection and consequent destruction of embryos, which constitutes an act of abortion... By treating the human embryo as mere `laboratory material', the concept itself of human dignity is also subjected to alteration and discrimination...Such discrimination is immoral and must therefore be considered legally unacceptable..." (n. 22).

New forms of interception and contragestation

There are methods of preventing pregnancy which act after fertilization, when the embryo is already constituted.

"Such methods are interceptive if they interfere with the embryo before implantation" (n. 23); for example, the IUD (intrauterine device) and the so-called `morning-after pills' (footnote 42). They are "contragestative if they cause the elimination of the embryo once implanted" (n. 23); for example, the pharmaceutical known commercially as RU-486 (footnote 43).

Even if such interceptives may not cause an abortion every time they are used, also because conception does not occur after every act of sexual intercourse, it must be noted, however, that "anyone who seeks to prevent the implantation of an embryo which may possibly have been conceived and who therefore either requests or prescribes such a pharmaceutical, generally intends abortion". In the case of contragestatives "what takes place in reality is the abortion of an embryo which has just implanted... the use of means of interception and contragestation fall within the sin of abortion and are gravely immoral" (n. 23).

Third Part:

New Treatments which Involve the Manipulation of
the Embryo or the Human Genetic Patrimony

Gene therapy

Gene therapy commonly refers to "techniques of genetic engineering applied to human beings for therapeutic purposes, that is to say, with the aim of curing genetically based diseases" (n. 25).

Somatic cell gene therapy "seeks to eliminate or reduce genetic defects on the level of somatic cells" (n. 25). Germ line cell therapy aims "at correcting genetic defects present in germ line cells with the purpose of transmitting the therapeutic effects to the offspring of the individual" (n. 25).

From the ethical point of view:

Procedures used on somatic cells for strictly therapeutic purposes "are in principle morally licit...Given that gene therapy can involve significant risks for the patient, the ethical principle must be observed according to which, in order to proceed to a therapeutic intervention, it is necessary to establish beforehand that the person being treated will not be exposed to risks to his health or physical integrity which are excessive or disproportionate to the gravity of the pathology for which a cure is sought. The informed consent of the patient or his legitimate representative is also required" (n. 26). With regard to germ line cell therapy, "the risks connected to any genetic manipulation are considerable and as yet not fully controllable" and therefore "in the present state of research, it is not morally permissible to act in a way that may cause possible harm to the resulting progeny" (n. 26). ith regard to the possibility of using techniques of genetic engineering to introduce alterations with the presumed aim of improving and strengthening the gene pool, it must be observed that such interventions would promote a "eugenic mentality" and would introduce an "indirect social stigma with regard to people who lack certain qualities, while privileging qualities that happen to be appreciated by a certain culture or society; such qualities do not constitute what is specifically human. This would be in contrast with the fundamental truth of the equality of all human beings which is expressed in the principle of justice, the violation of which, in the long run, would harm peaceful coexistence among individuals... Finally it must also be noted that in the attempt to create a new type of human being one can recognize an ideological element in which man tries to take the place of his Creator" (n. 27).

Human cloning

Human cloning refers to "the asexual or agametic reproduction of the entire human organism in order to produce one or more `copies' which, from a genetic perspective, are substantially identical to the single original" (n. 28). The techniques which have been proposed for accomplishing human cloning are artificial embryo twinning, which "consists in the artificial separation of individual cells or groups of cells from the embryo in the earliest stage of development... which are then transferred into the uterus in order to obtain identical embryos in an artificial manner" (footnote 47) and cell nuclear transfer, which "consists in introducing a nucleus taken from an embryonic or somatic cell into an denucleated oocyte. This is followed by stimulation of the oocyte so that it begins to develop as an embryo" (footnote 47). Cloning is proposed for two basic purposes: reproduction, that is, in order to obtain the birth of a baby, and medical therapy or research.

Human cloning is "intrinsically illicit in that...it seeks to give rise to a new human being without a connection to the act of reciprocal self-giving between the spouses and, more radically, without any link to sexuality. This leads to manipulation and abuses gravely injurious to human dignity" (n. 28).

With regard to reproductive cloning, "this would impose on the resulting individual a predetermined genetic identity, subjecting him - as has been stated - to a form of biological slavery, from which it would be difficult to free himself. The fact that someone would arrogate to himself the right to determine arbitrarily the genetic characteristics of another person represents a grave offence to the dignity of that person as well as to the fundamental equality of all people... In the encounter with another person, we meet a human being who owes his existence and his proper characteristics to the love of God, and only the love of husband and wife constitutes a mediation of that love in conformity with the plan of the Creator and heavenly Father" (n. 29). With regard to cloning for medical therapy or research, it must be said that to "create embryos with the intention of destroying them, even with the intention of helping the sick, is completely incompatible with human dignity, because it makes the existence of a human being at the embryonic stage nothing more than a means to be used and destroyed. It is gravely immoral to sacrifice a human life for therapeutic ends" (n. 30). As an alternative to therapeutic cloning some researchers have proposed new techniques which are presented as capable of producing stem cells of an embryonic type without implying the destruction of true human embryos, for example, by altered nuclear transfer (ANT) or oocyte assisted reprogramming (OAR). Doubts still remain, however, "regarding the ontological status of the `product' obtained in this way" (n. 30).

The therapeutic use of stem cells

"Stem cells are undifferentiated cells with two basic characteristics: a) the prolonged capability of multiplying themselves while maintaining the undifferentiated state; b) the capability of producing transitory progenitor cells from which fully differentiated cells descend, for example, nerve cells, muscle cells and blood cells. Once it was experimentally verified that when stem cells are transplanted into damaged tissue they tend to promote cell growth and the regeneration of the tissue, new prospects opened for regenerative medicine, which have been the subject of great interest among researchers throughout the world" (n. 31).

For the ethical evaluation, it is necessary above all to consider the methods of obtaining stem cells.

"Methods which do not cause serious harm to the subject from whom the stem cells are taken are to be considered licit. This is generally the case when tissues are taken from: a) an adult organism; b) the blood of the umbilical cord at the time of birth; c) fetuses who have died of natural causes" (n. 32). "The obtaining of stem cells from a living human embryo...invariably causes the death of the embryo and is consequently gravely illicit... In this case, research...is not truly at the service of humanity. In fact, this research advances through the suppression of human lives that are equal in dignity to the lives of other human individuals and to the lives of the researchers themselves" (n. 32). "The use of embryonic stem cells or differentiated cells derived from them - even when these are provided by other researchers through the destruction of embryos or when such cells are commercially available - presents serious problems from the standpoint of cooperation in evil and scandal" (n. 32).

Numerous studies, however, have shown that adult stem cells give more positive results than embryonic stem cells.

Attempts at hybridization

"Recently animal oocytes have been used for reprogramming the nuclei of human somatic cells... in order to extract embryonic stem cells from the resulting embryos without having to use human oocytes" (n. 33).

"From the ethical standpoint, such procedures represent an offense against the dignity of human beings on account of the admixture of human and animal genetic elements capable of disrupting the specific identity of man" (n. 33).

The use of human "biological material" of illicit origin

For scientific research and for the production of vaccines or other products, cell lines are at times used which are the result of an illicit intervention against the life or physical integrity of a human being.

Experimentation on human embryos "constitutes a crime against their dignity as human beings who have a right to the same respect owed to a child once born, just as to every person. These forms of experimentation always constitute a grave moral disorder" (n. 34). With regard to the use of "biological material" of illicit origin by researchers, which has been produced apart from their research center or which has been obtained commercially, the moral requirement "must be safeguarded that there be no complicity in deliberate abortion and that the risk of scandal be avoided. In this regard, the criterion of independence as it has been formulated by some ethics committees is not sufficient. According to this criterion, the use of `biological material' of illicit origin would be ethically permissible provided there is a clear separation between those who, on the one hand, produce, freeze and cause the death of embryos and, on the other, the researchers involved in scientific experimentation". It needs to be remembered that the "duty to refuse to use such `biological material' springs from the necessity to remove oneself, within the area of one's own research, from a gravely unjust legal situation and to affirm with clarity the value of human life. Therefore, the above-mentioned criterion of independence is necessary, but may be ethically insufficient" (n. 35). "Of course, within this general picture there exist differing degrees of responsibility. Grave reasons may be morally proportionate to justify the use of such `biological material'. Thus, for example, danger to the health of children could permit parents to use a vaccine which was developed using cell lines of illicit origin, while keeping in mind that everyone has the duty to make known their disagreement and to ask that their healthcare system make other types of vaccines available. Moreover, in organizations where cell lines of illicit origin are being utilized, the responsibility of those who make the decision to use them is not the same as that of those who have no voice in such a decision" (n. 35).

 

 

(end—DR)


#6947 From: "Stephen Meyer" <Stephen276@...>
Date: Thu Dec 18, 2008 12:14 am
Subject: Genetics Policy Institute (GPI) invites you to further stem cell sciences
stephen_meye...
Offline Offline
Send Email Send Email
 

GPI Logo

Genetics Policy Institute (GPI) invites you to further stem cell sciences and build worldwide public support for stem cell research by making a year-end donation today.

Once again the holiday season is upon us. It is the time of year to be thankful, and to appreciate all that we have been given.  However, we must not forget those less fortunate, especially adults and children suffering from chronic medical conditions – many of whom define "hope" as the promise of stem cell research.

Throughout 2008, Genetics Policy Institute (GPI) provided the stem cell field with continued support, fearless leadership and passion. GPI's efforts brought 1,000 leading stakeholders to Madison for the World Stem Cell Summit and freely disseminated thousands of copies of the World Stem Cell Report.  GPI addressed society's most challenging policy questions, and supplied accurate educational resources to key policy-makers, media, industry and the public. 

Next year, we will launch two additional initiatives.  We have partnered with the National Association of Biology Teachers to advance stem cell science education in public schools throughout the nation – donor support is essential for this initiative.  We have also begun fundraising to launch Stem Cell Action, a campaign that will enlist 1 million stem cell supporters to ensure the pro stem cell voice is heard loud and clear.

The 2009 World Stem Cell Summit and World Stem Cell Report will achieve greater reach and impact and our bi-monthly newsletter continues to inform 15,000+ subscribers on the latest headlines in science, business and policy.

I invite you to make a year-end gift to the Genetics Policy Institute to advance stem cell sciences, defend the hundreds of millions without cures and build worldwide public support for stem cell research. No donation is too small.

2009 is a critical year.  With a new administration entering the White House, GPI and its partners have a lot to accomplish to ensure stem cell issues are an important priority in the new administration's work plan.

The promise of stem cell research cannot be realized without your help.

Thank you for supporting stem cell research.  And thank you for considering GPI in your holiday thoughts and gift plans.  We wish you a wonderful holiday season and a bright, healthy New Year!

Cordially,

Bernard's Signature
Bernard Siegel, J.D.
Founder and Executive Director
Genetics Policy Institute

Donate Now Button



--

If you do not want to receive any more newsletters this link

To update your preferences visit this link

Forward this message to a Colleague this link


















Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet.
Powered by PHPlist2.10.5, © tincan ltd


#6946 From: "Stephen Meyer" <Stephen276@...>
Date: Sun Dec 14, 2008 7:09 pm
Subject: STEM CELL RESEARCH MAY SOLVE THE ECONOMIC MELTDOWN ....by Don C. Reed
stephen_meye...
Offline Offline
Send Email Send Email
 
 

STEM CELL RESEARCH MAY SOLVE THE ECONOMIC MELTDOWN  

 

by Don C. Reed

 

As President-elect Obama takes office, he will, of course, reverse the Bush prohibitions on stem cell research. That is the right thing to do, in a country built on freedom.

 

But then the real fight will begin—about funding.  President-Elect Obama pledged to double NIH funding, from $28 billion to $56 billion a year. We must, at minimum, hold him to that promise.

 

But, because of the economic crisis, some legislators will argue, America "can't afford" serious funding for stem cell research.

 

This is exactly backward. We must invest—massively—in regenerative medicine, precisely because of the meltdown.

 

Let me prove this.

 

Does anyone disagree that medical costs are a gigantic causative factor in the current economic crisis?

 

It is just common sense.  What is the number one cause of people losing their homes? The inability to pay healthcare costs.

 

Experts may disagree on the number of bankruptcies caused by inability to pay health care costs (American Association of Retired Persons, AARP, estimates

1.85 million families are affected), but by any estimate, the financials are staggering.

 

Here are some  gigantic numbers.

 

1.     $2.3 trillion direct health care costs in 2007. (1)

 

2.     $2 trillion indirect costs (time lost from work,etc.) minimal estimate (2)

 

3.     Total medical cost: $4.3 trillion.

 

4.     Total federal income taxes for last year: $1.8 trillion.(3)

 

Round off those figures, for the sake of argument.

 

Federal income tax-- two trillion.

 

Medical debt—four trillion.

 

Unless you know a way to subtract four trillion from two trillion, the entire federal income tax receipts could not pay our health care costs.

 

Think of that. If we gave the military nothing, shut down every federally-funded institution and program, and gave every federal income tax dollar to health care—we could pay less than half of our nation's medical bills.

 

Why is it so expensive? People are living longer lives, and not getting well from their diseases and disabilities.  Three quarters of all medical costs come from chronic (incurable) diseases and disabilities. (4) Since we cannot cure them, we have no choice but to maintain them in their misery. These are our loved ones; we must do right by them.

 

But-- if we cure just one disease, we lower health care costs by many billions. When the vaccine for polio was found (through very controversial research, strenuously opposed by conservative religion) we saved $30 billion dollars every year, not to mention saving lives, and easing suffering. Not only did we save that money, but we also gained move, because people who did not have polio could be productive additions to our society, giving us the benefit of their labors, and contributing to our tax revenues, instead of taking. Cure made them a financial asset, not an expense—and saved their lives.

 

Doubling the NIH budget is the least we can do, if we are solve our economic crisis.

 

So, get ready for the argument, folks. On its successful outcome depends the lives of our loved ones, and the financial wellbeing of our nation.

 

1.     National Coalition on Health Care document: Poisal, J.A., et al, Health Spending Projections Through 2016: Health Affairs, 21 February 2007, w242-253

 

2.     Estimate extrapolated from: Benefits of Research and the Role of NIH, Executive Summary, U.S. Senate Joint Economic Committee, 2000:  cited indirect health care costs were substantially higher than direct costs in 1999: $1.3 trillion direct, $1.7 trillion indirect.  While I have no reason to suspect this proportion changed since then, I chose a significantly lower figure to err on the side of caution.

 

3.     $1,366, 241, 000,000 personal: $395,536 billion corporation. Source: IRS: Tax Stats at a Glance

 

4.     "Medical care costs of people with chronic diseases account for more than 75% of the nation's $2 trillion medical care costs (2005 figure-DR)"—Dept. Health and Human Services, Center for Chronic Disease Prevention and Health Promotion.

 


#6945 From: "Stephen Meyer" <Stephen276@...>
Date: Tue Dec 9, 2008 10:39 pm
Subject: Stem Cell Action News ....December 9, 2008
stephen_meye...
Offline Offline
Send Email Send Email
 
 

Stem Cell Action News

Powered by Genetics Policy Institute

Forward this newsletter to a Colleague by visiting this link

Stem Cell Action

Stem Cell Report

http://globalstemcell.org/news/uploadimages/webcast_image(1).png

http://globalstemcell.org/news/uploadimages/newsfeed(1).png

December 9, 2008

Welcome to issue number 3 of Stem Cell Action News, dedicated to informing the stem cell community on the latest and most important developments impacting the Pro-Cures Movement.

SPECIAL ANNOUNCMENT

Stem cell stakeholders, mark your calendars. The Genetics Policy Institute announced that the 2009 World Stem Cell Summit will take place in Baltimore, Maryland at the Baltimore Convention Center on September 21-23, 2009. Co-hosted by Johns Hopkins University and the University System of Maryland, the Summit will unite the international stem cell community of researchers, leaders from the biotechnology and pharmaceutical industries, non-profit representatives, advocates, investors, philanthropists, healthcare professionals, law and policy experts, bioethicists, regulators, institutional oversight members and policy-makers.

The diverse summit agenda will feature multiple panels discussing updates on the influence of stem cells upon a broad range of medical conditions. Educational programs will focus on all cell types including human embryonic stem cells, adult stem cells and induced pluripotent stem cells. In addition, the Summit will address funding opportunities (federal, public and private), commercialization, venture capital, market trends, regulatory issues, ethical and societal issues, philanthropic opportunities, medical tourism, cell banking, intellectual property, insurance, international perspectives, clinical use and the 2009-10 advocacy agenda.

New to the 2009 World Stem Cell Summit will be an advanced science track featuring some of the world's most prominent scientists addressing the latest discoveries in basic research, translational and preclinical findings, bioengineering and cellular scaffold initiatives, clinical trials updates, and an in depth look at the pharmaceutical industry's short term and long term vision for stem cells. Visit www.worldstemcellsummit.com to learn more about the industry's flagship event!

HEADLINES & ADVOCACY

Attention patients, physicians and stem cell consumers – the International Society for Stem Cell Research took strong action against unsafe stem cell clinics last week by publishing Guidelines for the Clinical Translation of Stem Cells. GPI encourages all stakeholders to download, read and share these principal guidelines. Visit www.isscr.org to download the document and access the Cell Stem Cell summarizing article. 

Breast cancer research continues to progress. Canadian scientists at the B.C. Cancer Agency took normal human breast stem cells and transplanted them into immunodeficient mice to prevent cellular graft rejection. Subsequently, the human breast stem cells grew into complete, miniature milk producing mammary glands. This critical breakthrough gives scientists a better understanding of how normal human breast stem cells morph into cancer stem cells – a devastating scientific phenomenon taking the lives of too many loved ones (full article link).

Meanwhile, on November 25th, Novocell's CEO Alan Lewis, was named chief executive of the Juvenile Diabetes Research Foundation.   Lewis will lead the 600-person organization in their ambitious fundraising efforts to finance and support the top scientific research projects (full article link).

Traveling abroad? Scientists, think twice before carrying stem cells onboard your next flight. Claudin Castillo's landmark windpipe transplant suffered an alarming hiccup when the airline, EasyJet, refused to transport 1.5liters of stem cells needed for the pioneering operation. Fortunately, Philip Jungebluth, the medical student in charge of the cells called for a private jet from Bristol to Barcelona and saved stem cell history (full article link).

If you ripped your hair out over this news…..relax and sit back. Researchers at the University of Pennsylvania School of Medicine isolated stem cells responsible for hair follicle growth in mice. Four weeks after transplantation, the cells grew new hair follicles and healthy hair. Ultimately, the discovery could add hair to skin grafts for burn patients (full article link).

Also last week, in a scientific trial led by Professor Brinker of the International Neuroscience Institute in Hanover, physicians injected a 49 year-old male with engineered mesenchymal stem cells to produce cell death inhibiting proteins – this technique could limit neurological damage after stroke. In this study, allogeneic encapsulated stem cells avoided the immune system and acted as a protein delivery tool, not as replacement tissue (full article link). Pharmaceutical companies view stem cells as powerful drug discovery and delivery tools, not just therapeutic agents…learn more about this topic at the 2009 World Stem Cell Summit.

For the first time, a heart attack patient had autologous bone marrow derived stem cells injected into his heart via angioplast surgery within 5 hours of the attack. Led by Dr. Anthony Mathur and Professor John Martin, the procedure occurred at the London Chest Hospital and was funded by the UK Stem Cell Foundation (full article link). Also in cardiac stem cell application, University of Wisconsin launched a study sponsored by the Cellular Therapies unit of Baxter Healthcare Corporation. Fifteen to twenty additional research institutes will participate in the study. Lastly, rese! archers at the Children's Hospital of Pittsburg repaired damaged heart muscle in an animal model using a population of stem cells derived from human skeletal muscle tissue (full article link).

POLICY

Following ISSCR's Guidelines for the Clinical Translation of Stem Cells, the MS Society is calling on the Government to regulate medical advertising. Additionally, the society is warning people with MS to avoid a current trial by a company called Integrated BioSciences (IBS website not known) due to lack of evidence to support an MS stem cell treatment. The company is approaching and seeking payment from people with MS in exchange for stem cell injections – the trial has no US or EU approval (full article link).

In Europe, regulators at the European Patent Office upheld a June decision to reject a patent application regarding the use of stem cells filed by the Wisconsin Alumni Research Foundation in 1995. "European patent law prohibits the patenting of human stem cell cultures whose preparation necessarily involves the destruction of human embryos," stated the European Patent Office (full article link)

Additionally, the UK National Stem Cell Network warns that lack of funding threatens the progress of UK stem cell research, especially during times of positive scientific policy change in the states (full article link)

In Japan, Kyoto University research team cultivated two additional "strains" – lines of stem cells – adding to the previous three embryonic stains. Kyoto University will soon seek approval from the Ministry of Education, Culture, Sports, Science and Technology to distribute the cells to research facilities inside and outside of Japan (full article link).

SCIENCE

Cell Stem Cell – Nimet Maherali and Konrad Hochedlinger compare currently reported iPSC protocals, identify the essential common steps, and suggest criteria for defining fully reprogrammed stem cells. Download this must-read review on the state of iPSC technology.

December 1st issue of Blood includes three progressive stem cell articles. Firstly, Advanced Cell Technology published data on large scale production of functional oxygen carrying erythrocytes from human embryonic stem cells (article link). Secondly, Si et al provide evidence that transdifferentiation of c-kit+ cells with a foamy viral vector is sufficient for functional correction of a stem cell phenotype in murine fanconi anemia model. Lastly, University of Oxford reports heme oxegenase (HO-1) plays a key role in HSC maintenance. HO-1 deficient mice showed increased cell proliferation after induced stress by 5-FU treatment. HO-1 is heme isoform produced during heme degredation.

At the Salk Institute for Biological Studies, researchers pioneered a human embryonic stem cell based system for modeling ALS. GPI salutes this ground-breaking work published in the December 4th issue of Cell Stem Cell (full article link)

In Missouri, Linheng Li's Lab at the Stowers Institute identified the precise location of the bone marrow stem cell niche. This noteworthy accomplishment adds laser focus sight on the bone marrow micro-environment – giving physicians greater control during bone marrow transplantation (full article link).

BUSINESS

Stem Cell Sciences share trading was suspended on November 25th. The board is currently reviewing the company's financial position and strategic options (full article link).

Osiris completed patient enrolment in its Phase III trial evaluating Prochymal for the treatment of steroid-refractory acute Graft versus Host Disease (full article link).

Three University of Wisconsin-Madison spin off companies – Cellular Dynamics International, Stem Cell Products, and iPSC Cells Inc. – are merging into one. Furthermore, Cellular Dynamics International successfully raised 18 million to translate UW stem cell research.

Advanced Cell Technologies Inc. entered a joint venture with Korean biotech CHA Biotech Co. Ltd and then formed the new Worchester, MA based company, Allied Cell Technology, to develop human blood cells (full article link)

Neuralstem announced last week its collaboration with China Medical University & Hospital of Taiwan to develop additional ALS stem cell clinical trials (full article link)

Novogen and Yale University researchers revealed their mTOR inhibitor NV-128 has the potential to act against cancer stem cells in addition to rapidly proliferating cells in established tumors (full article link).

Parthenogenetic stem cell company, International Stem Cell Corporation, formed a partnership with Absorption Systems to utilize ISCO's parthenogenetic stem cell derived human corneal tissue to measure drug disposition, drug safety, and drug-drug interactions (full article link).   

ViaGen Inc. partnered with Monash Institute in Melbourne, Australia to access horse embryonic stem cells for the repair of tendon, ligament and cartilage in the performance horse industry (full article link).

Cyntellect entered a collaborative research agreement with the University of Florida Interdisciplinary Center for Biotechnology Research targeting cancer stem cell research. Cyntellect's proprietary LEAP system will purify the cancer stem cells without disturbing the micro-environment (full article link).

Contact GPI
Robert E. Margolin
Associate Director
908-605-4203
rob@...



--

If you do not want to receive any more newsletters click this link

To update your preferences visit this link




Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet.
Powered by PHPlist2.10.5, © tincan ltd


#6944 From: "Stephen Meyer" <Stephen276@...>
Date: Sun Dec 7, 2008 8:30 pm
Subject: CALIFORNIA STEM CELL PROGRAM STUDIED BY EFFICIENCY PROGRAM: First Hearing Report
stephen_meye...
Offline Offline
Send Email Send Email
 

CALIFORNIA STEM CELL PROGRAM STUDIED BY EFFICIENCY PROGRAM: First Hearing Report

 

"Be then as adversaries in law: strive mightily, but eat and drink as friends." –William Shakespeare.

 by Don C. Reed

 

November 20th was the first hearing in the Little Hoover Committee process, beginning an in-depth study of California's stem cell program.

 

How did I feel about it? Probably the way a survivor of the Titanic shipwreck might feel, if he was out on the ocean again, and sees an iceberg, just ahead.

 

First, by way of background, Senate Bill 1565 (Kuehl/ Runner) asked the Little Hoover Commission (LHC, an efficiency organization) to study the California stem cell program: to see (among other things) if the governing board of experts was a conflict of interest. For instance, there were representatives of colleges on the board; although they were not allowed to vote on money which would go to their college, did their presence on the voting board make it automatically corrupt?

 

The California court system had already spoken on that issue, saying:

 

"…by approving Proposition 71, the voters have determined that the advantages of permitting particularly knowledgeable persons to decide which research projects to fund outweighs any concerns that these decisions may be influenced by the personal or professional interests of those members, so long as those members did not participate in any decision to award grants to themselves or to their employers."

 

SB 1565 had been vetoed by Governor Arnold Schwarzenegger, but the Little Hoover Commission was going ahead anyway.

 

They have the power to do that, because, (like the California stem cell program itself), the LHC is both part of the government, and also set up in such a way as to shield it from changing political winds. To do its job, each agency must maintain a high level of independence.

 

Thirteen commissioners now have the power to not only study and criticize, but also to suggest changes in the greatest stem cell program in the world—and offer laws to make those changes mandatory.

 

As I sat in the back of room 4203 of the Capitol building, I thought of all the attacks California's program has had to weather, to get where we are today.

 

Remember the endless assaults on stem cell research: from the Bush Administration, the Republican party, the religious right, and anti-tax forces. One law was actually passed in the GOP-controlled U.S. House of Representatives to put advanced stem cell research scientists in jail for ten years and fine them a million dollars-- a law President Bush  promised to sign if it reached his desk—and which was only blocked after tremendous battles in the United States Senate. That law was proposed four times.

 

California's stem cell program, voted into power four years ago, has only been allowed to operate for about 20 months, delayed by a lawsuit from ideological and anti-tax groups.

 

We were only able to go forward when Governor Arnold Schwarzenegger authorized a state loan, funds to operate with until the lawsuits were decided in our favor. At last, the California Institute for Regenerative Medicine (CIRM) was allowed to begin to fund stem cell research—accompanied by a seemingly endless stream of what I regard as anti-CIRM legislation, so many different laws to limit our program it was hard to keep track of them all, not to mention numerous audits, reviews, and investigations.

 

Despite that ocean of icebergs, California's stem cell ship of state had advanced—and now we faced what might be our greatest threat.

 

The first two speakers were Michael Klausner, Professor of Law, Stanford Law School, and Ken Taymor, Executive Director, Berkeley Center for Law, Business, and the Economy. I knew Ken Taymor; he comes to most of the meetings: great big tall guy, looks like a basketball player.

 

Their testimony was primarily technical, and advisory.

 

Mr. Klausner said a large decision-making board (the ICOC has 29 members) is automatically less efficient because of its size.

 

I wondered how he felt about the United States Senate (100 members) or the U.S. House of Representatives (435 members).

 

Ken Taymor stated that (with exceptions) the California Institute for Regenerative Medicine had done an exemplary job on transparency: keeping the public informed, and allowing involvement.

 

Both men were questioned exhaustively by the committee, given every chance to say exactly what they wanted to say. For instance, after Taymor made the "exemplary" statement, the question came:

 

What do you mean, the ICOC did an exemplary job of informing the public, and then you immediately point out an instance where important scientific deliberations are held in secret—is that not a contradiction?

 

Taymore's answer: That tension describes the situation. On the one hand the public is welcome to the overwhelming majority of meetings; on the other, the scientific advisory board does hold portions of its meetings "in camera" (private).

 

There was a lot like that, complicated questions and difficult answers.

 

Then came the critics: John Simpson, Director, Stem Cell Oversight and Accountability Project, Consumer Watchdog: and Jesse Reynolds, Director, Project on Biotechnology in the Public Interest, Center for Genetics and Society.

 

Both men called for major changes in our program. They asked for a reduction in the leadership board, (the ICOC) that it should be reduced from its present 29 members to 15, and that all representatives of a university or research institute should be removed, or at least not allowed to vote.

 

They asked that our stem cell program be put under the control of another state agency, with hire and fire powers over the board, and the authority to take our funds away.

 

Our hard-won stem cell research money could be spent somewhere else??? 

 

Mr. Reynolds said:

 

 "…the special funds for the CIRM should no longer be allocated in a manner isolated from the budget review process… the large, untouchable set-aside for stem cell research is out of place during these difficult times."

 

John Simpson said he had not yet made up his mind on that issue (allowing our funds to be removed), but felt it should be considered.

 

Both men commented that as President Obama had pledged to remove the Bush restrictions, and to double the NIH budget, there would now be plenty of money. (Hold that thought, please).

 

But then I noticed something: small but important.

 

One member asked Mr. Simpson if one of the reforms he suggested was practiced by the National Institutes of Health. There was a substantive pause, after which Simpson answered honestly.

 

"No".

 

Something clicked in my worrying brain.

 

The Commission was not automatically buying the objectors' case.

 

One of the critics talked about putting the California stem cell program under a separate agency-- but the Chair pointed out that would require a Constitutional amendment. (Which did not mean it was impossible, but more difficult than a simple legislative change.)

 

It felt like they were really trying to understand the situation.

 

I have testified at hearings when the members had their minds made up, and were just going through the motions; this was different.

 

The next two speakers were Susan V. Bryant, Vice Chancellor for Research, University of California, Irvine, and member of the Independent Citizens Oversight Committee (ICOC), and Ralph O'Rear, Vice President, Facilities and Planning, Buck Institute for Age Research;

 

Remember that statement earlier about how there was going to be plenty of money from the Federal Government for research, now that a more understanding President was coming aboard?

 

Ms. Bryant pointed out, even if President-elect Obama doubled the NIH funding, (which must be done—DR) that would only raise the money available to embryonic stem cell research from $40 million to $80 million—no substitute for California's roughly $300 million a year.  

 

 Ralph O'Rear talked about new companies opening up in California, and young scientists were able to find funding in the Golden State. He said that since Prop 71, scientists were no longer afraid of stem cell research because of political worries, but were instead excited about the new possibilities.

 

He contrasted that with the sad situation at the NIH where five years of flat funding has meant more and more caution about giving grants, which favors the older and established scientist--  the average age of a scientist getting a major NIH grant is now about forty-three years old, dashing the hopes of young researchers. This must change, and California is part of the needed improvement.

 

Then it was the turn of Robert Klein, Chairperson, Independent Citizens Oversight Committee and Alan Trounson, President of the California Institute for Regenerative Medicine. 

 

Why was there such a large board?

 

Many specialized viewpoints were needed.

 

What would he (Bob) do differently, if he had to re-write Prop 71 again?

 

Bob asked to confer with the ICOC on that one. It was such an important question, he said. It was his style to lead by consultation.

 

I remembered all the meetings he chaired, and how nothing was decided until everyone—public as well as board member—had ample opportunity to say their say. This was why more decisions passed unanimously, or close to it, because they worked carefully and inclusively.

 

Chairman Daniel Hancock of the LHC asked Bob Klein if he had "benefited personally in any way" from his work as Chair.

 

Bob said no.

 

Then, when Mr. Hancock indicated he wanted more information, the chairman of the ICOC gave a more full answer:

 

If my memory serves, Bob said he had donated $6.5 million to the campaign to pass Proposition 71. He held no stem cell or biomedical/life science stocks, having voluntarily divested himself of anything like that, when he took the job as chair. He worked without a salary for the first four years, but that would have to change, in the economic times at present.

 

But for me the most telling point was that Bob (a real estate man) had written and helped implement the California Housing Finance Authority, which provides loans for low income housing. Klein's own company develops low income housing, which would seem to be an automatic conflict of interest. He could have used his knowledge and position to benefit his company and himself-- but in all the decades of that program's existence, he had never taken a single grant or loan from it.

 

Questions flew, and at last came one I was waiting for:

 

"Did I hear correctly, that the ICOC leveraged $272 million of taxpayer money-- into $1.15 billion in purchasing power?" said Little Hoover Chairman Daniel W. Hancock.

 

Bob said yes:  by requiring matching funds from institutions wanting facilities grants (buildings and equipment) an additional $880 million had been brought to the table.  

 

And then—did my ears deceive me? The chair said something like:

 

"That's A+ work on leveraging. It will be good to study this public/ private partnership. It might be a good test case for how the state might work."

 

He asked Bob to write more about leveraging and how it worked.

 

There was a lot more—Bob said how even a small improvement in the costs of treatment for a few incurable diseases would pay for the whole program. Trounson added that the main payment is cures for our loved ones.

 

What about the international cooperation with Japan that was just announced? President Trounson answered, talking about the growing number of countries—countries!—that are entering into research agreements with California, bringing hundreds of millions of more research dollars to add strength to our efforts.

 

Regulations? The California system has an unprecedented level of oversight, exceeding National Institutes of Health standards in many cases, and our standards are held up as examples to imitate.

 

Was the board "hamstrung" by absences, and an inability to find a quorum, as the critics implied?

 

Bob mentioned that one ICOC member's child has autism, and that it is sometimes very difficult to get to meetings; also, some of our patient advocates for disease have that condition themselves, and health issues get in the way. But a new policy was being worked out where a small number of members could be allowed to telephone in to meetings. (That policy, consideration for which was begun in August, has since been approved.) Even so, there had been a quorum at all 30 of the major ICOC meetings.

 

To me, the real answer is the action accomplished, that decisions were made and funds were awarded, so the researchers could to do the most important work of their lives-- that is a decidedly un-hamstrung ICOC.

 

Both men spoke about the continuing need for cooperation with Assembly and Senate in Sacramento: pointing out that our legislators' input has helped shape California's stem cell research policies, every step of the way.

 

He mentioned the hoped-for human trials on embryonic stem cell therapy for spinal cord injury—I wanted to raise my hand and say, "Originally funded by the Roman Reed Act, named after my son!"—but restrained myself, with some difficulty.

 

Speaking on behalf of the patient advocates were Judy Roberson, Herb Meyer, Susan Rocci and Raymond Barglow—each brought a different perspective to the issue at hand. Each was an effective speaker for our cause.

 

Karen Miner did not come because her wheelchair broke.

 

Bill Remak was ready to come, but in our conversation about travel arrangements, he mentioned that last week he had broken both collarbones in a car crash. I said no, Bill, even for you, there has to be limits.

 

But he sent a letter of public testimony anyway, saying, in part:

 

" …We feel that the intent and language of proposition 71 clearly defined the purpose of the program and created a transparent system where the consumers of successful outcomes from the investments in research would have a voice, thus keeping separate any political influence from having an impact on the decision making of the committee…

 

We do not wish to see this changed in any way.

 

…As a member of consumer and disease organizations that represent a constituency of over 16 million Californians, I respectfully ask the Commission to reject any recommendation that will suggest a change in the mandate and governance that already exists.
 

Sincerely,
 

Bill Remak, B.Sc. MT, B. Public Health, SGNA

Chairman, California Hepatitis C Task Force

Chair, National Association of Hepatitis Task Forces

Executive Committee, California Chronic Care Coalition

Board Member, FAIR Foundation 

 

My overall impression of the meeting? A huge sigh of relief.

 

The Little Hoover Commission's investigation will be lengthy and thorough; I will be involved as much as I can. Naturally, I volunteered to serve on any committees for which I might be eligible. Anything which concerns our stem cell program is of tremendous interest to me, and I want to help, making sure our side is fully considered.

 

There will be several small meetings up and down the state in the next few months. I will let you know when they happen, (or look up Little Hoover Commission on the web, and click on CIRM meetings—you can also sign up to receive email notification) and you can attend, and be part of this important work.

 

But I think the LHC will work to make it fair. Our state has a right to be sure every dollar is carefully and wisely spent.

 

Besides, the California stem cell program should be studied, to be learned from.  If I had my way, every state would have something similar.

 

If they find areas to improve, experience shows what will happen. The ICOC will wrestle with the criticism, agonize and argue over it, and then figure a way to make change where change is needed.

 

And as the LHC takes an in-depth look at the California stem cell program,

I have a pretty good idea what they will find:

 

Something shining: which benefits California, our nation, and the world—and that is worth defending.

 

 

 


#6943 From: "Stephen Meyer" <Stephen276@...>
Date: Tue Nov 25, 2008 2:12 pm
Subject: Stem Cell Action News.........November 24, 2008
stephen_meye...
Offline Offline
Send Email Send Email
 
 

Stem Cell Action News

Powered by Genetics Policy Institute

Maryland Stem Cell Research Symposium

Stem Cell Action

Stem Cell Report

http://globalstemcell.org/news/uploadimages/webcast_image(1).png

http://globalstemcell.org/news/uploadimages/newsfeed(1).png

November 24, 2008

Welcome to issue number 2 of Stem Cell Action News, dedicated to informing the stem cell community on the latest and most important developments impacting the Pro-Cures Movement.

Headlines & Advocacy

Landmark windpipe transplant shocks the world – patient, Claudin Castillo, received a bioengineered trachea after nearly loosing her left lung due to a severe case of tuberculosis.   The bioengineered windpipe was constructed by removing all cells and MHC antigens from a donated trachea - leaving behind a fibrous scaffold.  The scaffold was then populated with autologous mesenchymal stem-cell-derived condrocytes to construct the graft.  The cells were cultured at Professor Martin Birchall's lab at Bristol U! niversity, and the surgery was conducted in Barcelona, Spain.  Additional collaborations were established between colleagues in Padua and Milan, Italy. Listen to NPR's All Things Considered and read The Lancet's Early Online Publication.

Reporter Luke Timmerman interviews Novocell's CSO, Edward Baetge, on the challenges of commercializing embryonic stem cells to treat Diabetes (full article link).

The Vatican once again warns Obama about the ethics of embryonic stem cell research (full article link)

Hadassah is offering an educational program on stem cell research with an invited speaker from the Harvard Stem Cell Institute (full article link)

Dr. Mark Nobel, a leading stem cell researcher from the University of Rochester and a member of the GPI Science Advisory Board, discusses the big picture – a video interview worth watching.

Policy

Maryland Stem Cell Research Commission received 187 letters of intent for stem cell funding compared to last year's 127.  Applications for funding are due on January 15, 2009.  For application and guidelines, please visit www.mscrf.org.  Additionally, on December 3rd Governor O'Malley and the Maryland Stem Cell Research Commission host the first annual Maryland Stem Cell Symposium.  The symposium allows the 2008 awardees to present findings (register by clicking this link!)

Traveling across the Atlantic and south of the equator, Health Ministers from member states of the Economic Commission of West Africa will gather tomorrow to discuss stem cell research and therapy (full article link).

In Washington, Obama transition team selected Jonathan Moreno, professor of bioethics at University of Pennsylvania to manage activities related to bioethics (full article link).  Moreno is a supporter of embryonic stem cell research and serves on the Legal and Human Rights Advisory Board of the Genetics Policy Institute.  Additionally, R. Alta Charo, a UW-Madison professor of law and ethics was appointed to the Obama's transition team.  She was previously a member of former President Bill Clinton's Bioethics Advisory Commission. (read full article).

Science

Researchers at the University of Utah are enrolling 40 patients in a Phase II study that will use autologous, bone-marrow derived stem cells to treat patients with Dilated Cardiomypoathy (DMC, or heart disease).  Of the 40 patients, 20 are to be diagnosed with ischemic DMC and, 20 with nonishemic DMC.  The study is sponsored by Aastrom Biosciences, Inc., a company specializing in autologous cell products (full article link).

Researchers at the University of Pennsylvania School of Medicine discovered a protein marker that helps select for rare adult liver stem cells.  Led by Linda Greeman, MD., the findings allow scientists to now isolate liver stem cells which could be used to regenerate liver tissue.  

Don't space out yet, HepaLife's Patented `PICM-19' Liver Stem Cell Lines are onboard Space Shuttle "Endeavour" for outer space testing (full article link).

Business

G. Steven Burrill, CEO of life sciences VC firm, Burrill and Company, predicts continuing market volatility that will affect both large and small biotech's.  Burrill stated early last week, "Stuff is cascading through the financial system in a toxic way."  He also commented, " The biotech industry has lived with easy access to capital for 30 yeas or more.  That world is now permanently changed." (full article link) 

Meanwhile, pharmaceutical giant, Pfizer, launched a new research unit know as Pfizer Regenerative Medicine.  The unit will be co-located in Cambridge, UK and Cambridge, Massachusetts (full article link)

Also last week, Stem Cell Sciences signed a service agreement for up to five-years with Pfizer Limited.  Stem Cell Sciences will provide research services, cell lines, media, and reagents to support Pfizer's stem cell R&D efforts (full article link). Furthermore, Stem Cell Sciences' patent covering its IRES technology was upheld – the technology can monitor gene activity without knocking out normal gene function (full article link)

Sigma Aldrich announced it will be the exclusive supplier of AlphaGenix-developed antibodies and research tools for regenerative medicine and stem cell biology – expanding Sigma's stem cell product portfolio (full article link).   

Neuralstem, Inc. entered a collaborative agreement with Professor Guido Nikkah Ph.D, of Albert-Ludwigs-University in Freiburg, Germany to further develop Neuralstem's human neural stem cell therapies for Huntington's disease (full article link).

Lastly, Mesoblast Limited's sister company, Angioblast Systems, was awarded the 2008 Frost & Sullivan United States Stem Cell Market Technology Innovation of the Year (full article link).

Contact GPI
Robert E. Margolin
Associate Director
908-605-4203
rob@...



--
If you do not want to receive any more newsletters this link

To update your preferences visit this link

Forward this message to a Colleague this link

Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet.
Powered by PHPlist2.10.5, © tincan ltd


#6942 From: "Stephen Meyer" <Stephen276@...>
Date: Fri Nov 7, 2008 2:31 pm
Subject: THREE GREAT VICTORIES, AND A NEW AGE?
stephen_meye...
Offline Offline
Send Email Send Email
 

THREE GREAT VICTORIES, AND A NEW AGE?

 

by Don C. Reed

 

Three great victories have been won: now we must utilize the opportunity they bring.

 

1. First, the Presidency and the elective offices.

 

In Barrack Obama, we have a man who has the potential to be as great as Lincoln.  He can think, he is not afraid, and he is on our side. Our prayers go with him.

 

Also, the shifting of Congress and the Senate was overwhelmingly in our favor. The defeat of Senators like Elizabeth Dole and John Sununu meant fewer anti-researchers to have to cope with. On the positive side, strong supporters like Kay Hagan, Jeanne Shaheen and Vickie Englund give us much to smile about.

 

2. Second, embryonic stem cell research is no longer controversial:  that has been forever settled by Michigan's Proposal 2, which (in an extraordinarily conservative state) took on the issue: to allow the use of blastocysts left over from In Vitro Fertility procedures.

 

The opposition knew this was a crucial test of strength. The Religious Right  brought in their big guns, and made Michigan a social battleground state. They funded a massive propaganda attack, expensive TV ads in a Falsehood-a-Week ad campaign, with massive financial backing from the Catholic Church and ideological groups.

 

Michiganians took the heat for everyone. Almost alone, that small state fought. We outsiders should have done a lot more. Some did help: Bob Klein came out to fight for the finances to make the campaign possible. The Coalition for the Advancement of Medical Research endorsed the effort. Individuals (especially, one great man, A. Albert Taubman, a champion of research, made the campaign possible with his generosity--) but by and large, the campaign was on its own.

 

After a somewhat muddled and confused beginning, Michiganians came together in a white heat of unity.

 

When the votes were counted, Proposal 2 had prevailed.

 

They won, for all of us. 

 

3. The third victory was the overwhelming defeat of the "personhood" effort, Amendment 48 of Colorado,   the attempt to give a sperm-and-egg microscopic blastocyst citizenship rights. Fortunately, this was recognized as the nonsense it was—dangerous nonsense—and it was crushed, losing nearly three to one.

 

The leaders in that victory were the Women's rights groups: NOW, NARAL, Planned Parenthood :  who saw it (quite rightly) as a threat to a woman's right to choose. For us in the regenerative medicine movement, the "personhood" movement could well have ended embryonic stem cell research.

 

Three victories: the national implications are huge. Regenerative research is no longer controversial; and we have men and women in the White House, Congress and Senate who support our efforts.

 

Now is the time to ask for a lot.

 

When President Bush was in office, the best we could hope for was the very cautious Castle/DeGette bill: the Stem Cell Research Enhancement Act: a little permissions bill.  Even that was vetoed by President Bush.

 

That was then, this is now.

 

Today, our cause has been proven right.

 

We must no longer plead timidly for permission to do the research. That can be accomplished by the stroke of a Presidential pen. On his first day in office, President Obama can reverse the Bush restrictions, which means we do not need Castle/DeGette.

 

If Castle/DeGette goes forward at all, it should be substantively rewritten.

 

We may only have one major "ask"—we must think carefully on what to ask for.

 

What we need now is money to do research, all across the nation.

 

We must think in terms of doubling or tripling the budget of the National Institutes for Health (NIH), because we are up against the most gigantic health problems (literally) in the history of the world. An extra billion or two (not even enough to make up for inflation losses after 5 years of flat funding)—that is nothing compared to the need.

 

Just as we would unify against an invasion of our country—imagine how we would react to a "body count" of one hundred million killed or wounded—even so we must come together to fund regenerative medicine.

 

We must think of the NIH like the Defense Department: one fights with guns against invaders, the other uses test tubes—but both are fighting to save lives.

 

We must no longer be splinter groups, weak and divided, but come together instead as what we are: a nation and a world working together against the common threat of chronic disease and disability.

 

If we can see beyond ourselves, and act on our better convictions, a new Age begins.

 

 

 

 

 

 

 

 

 

 

Don C. Reed
Sponsor, Roman Reed Spinal Cord Injury Research Act
co-chair, Californians for Cures
Vice President, Public Policy, Americans for Cures

#6941 From: "Stephen Meyer" <Stephen276@...>
Date: Mon Nov 3, 2008 1:58 pm
Subject: ELIZABETH DOLE SLANDERS STEM CELL SUPPORTER: Calls Sunday School Teacher “Godle
stephen_meye...
Offline Offline
Send Email Send Email
 

ELIZABETH DOLE SLANDERS STEM CELL SUPPORTER:  Calls Sunday School Teacher "Godless".

Should a craven lie deny America a strong stem cell research-supporting Senator?

A scurrilous attack ad was just run by incumbent Republican Elizabeth Dole against stem cell research supporter and Senatorial candidate Kay Hagan of North Carolina .

In an expensive and widely-distributed television ad, Dole attacked Hagan's religious faith, calling her "Godless".

Believe it or not, the ad shows Kay Hagan's face with her lips moving—and somebody else's voice saying: "There is no God".

Ms. Hagan, by the way, is an elder in her Presbyterian Church for more than ten years. She has worked as a Sunday School teacher for that church, and assists on its missions.

The shame is on Senator Dole, who personally approved the ad, for stooping to such depths to clutch on to her power.

What a tragedy it would be if such slimy trash were allowed to deny North Carolina a stem cell supporting Senator.

Unfortunately, propaganda sometimes works. North Carolina is a deeply Christian state, and if that lie is believed, even for just a few days…

As Ms. Hagan's campaign said: "Elizabeth Dole would love nothing more than to distract from the issues and her record for the last five days of the campaign…."

And speaking of Elizabeth Dole's record, where does she stand on stem cell research?

She takes her cue from George Bush's endless restrictions—no new stem cell lines, ever.

America has repudiated such short-sighted obstacles to progress. Legislation to moderate those restrictions has twice passed the House of Representatives and the United States Senate, only to be vetoed each time by President Bush, with the help of Senator Dole.

With an estimated 100 million citizens suffering from incurable disease and disability, and health care costs skyrocketing beyond our ability to pay, families are united in their determination to have access to the best medical treatment modern science can provide.

How do North Carolinians feel about the research that matters so much to so many?

They support embryonic stem cell research by a huge majority, more than 5-3 in favor*. 

Why does this matter to me?

My son Roman Reed is paralyzed. His neck was broken playing college football. But we have not given up on hope.

Our son inspired California 's first embryonic stem cell research funding, through a law named after him, the Roman Reed Spinal Cord Injury Research Act.

On March 1, 2002, in the Reeve-Irvine Research Center at UC Irvine, I held in my hand a laboratory rat which had been paralyzed, but which now walked again, thanks to embryonic stem cells- and this while my paralyzed son watched from his wheelchair.

That research experiment is now before the Food and Drug Administration (FDA) being considered for human trials. If all goes well, in about three months, newly-paralyzed people may have the chance my son did not—the opportunity to walk out of the hospital, instead of being condemned to a wheelchair for life.

But new stem cell research lines would not be allowed under the Bush-Dole restrictions.

Both Presidential candidates know this, and have pledged to overturn those restrictions: despite their differences, John McCain and Barrack Obama understand the need for new embryonic stem cell research lines.

But not Elizabeth Dole.

She is out of touch with North Carolina 's hopes and dreams for cure, not only for paralysis, but for many diseases and disabilities considered incurable, but which stem cell therapies may alleviate or cure.

Now, behind in the polls, Ms. Dole has even lost track of the North Carolina State Motto, Esse Quam Videri: "to be, rather than to seem."

In North Carolina , honesty matters.

I am myself an outsider to this state, so maybe my opinions do not matter. But I appreciate Ms. Hagan's courageous support for the research which may allow my son to fulfill the great prediction of Christopher Reeve, who said, in a private letter to our family:

"One day, Roman and I will stand up from our wheel chairs, and walk away from them forever."—Christopher Reeve.

Cure did not come in time for our champion, but the flame of his faith still lights our way. The research he supported will go forward—with people like Kay Hagan in office.

I urge every stem cell research supporter in America to do what I just did: go to www.Kayhagan.com, and contribute $25. If you can afford more, do so.

Help her withstand these disgusting attack ads. Do it not just because Kay Hagan is a fighter for stem cell research. But because North Carolina —and America--  need deserve women like her in leadership.

People who will tell the truth.

Thank you.

Don C. Reed is the citizen-sponsor of California 's Roman Reed Spinal Cord Injury Research Act, named after his paralyzed son.

*When asked for their overall opinion on medical research involving stem cells from human embryos…a majority, 53.4%, said they either support or "strongly support" it; 30.8% said they oppose…"—The News Observer, newsobserver.com, October 7, 2008



 

Don C. Reed
Sponsor, Roman Reed Spinal Cord Injury Research Act
Founder and Co-Chair, Californians for Cures
 
Don Reed is also Vice President of Public Policy for Americans for Cures Foundation; opinions voiced here as an individual may or may not reflect those of the Foundation.
 
 
 

#6940 From: "Stephen Meyer" <Stephen276@...>
Date: Mon Nov 3, 2008 2:03 am
Subject: McCain Banking on a Confederacy of Dunces
stephen_meye...
Offline Offline
Send Email Send Email
 

McCain Banking on a Confederacy of Dunces

By David Sirota

[ http://www.inthesetimes.com/article/4007/mccain_banking_on_a_confederacy_of_dunces/ ]

Is John McCain stupid, or does he believe we are? That's the question as he criticizes Barack Obama for allegedly trying to "redistribute the wealth" with a plan to lower taxes on the middle class and raise them on the super-rich.

Of course, the Democrat's proposal would merely slow down (not fully halt) the less-talked-about redistribution whereby Washington sends middle-class money up the income ladder. Either McCain doesn't know about this kleptocracy and is the dumbest presidential candidate in history, or he thinks America is too ignorant to recognize theft. Which is it?

I'm guessing the latter, since the evidence is so overwhelming.

In the last eight years, we the little people have been forced to provide more and more of the taxes fueling America's redistribution machine. As the Congressional Budget Office reports, the $715 billion in tax breaks that President Bush gave to those making more than $342,000 a year began dramatically shifting the overall tax burden from the rich onto the rest of us. Meanwhile, because of lobbyist-crafted loopholes, most corporations pay zero federal income taxes, according to the Government Accountability Office. The result is what Warren Buffett admits: When counting all taxes (income, payroll, property, etc.), billionaires and Big Business often pay lower effective tax rates than their employees.

The output of the redistribution machine is becoming just as regressive. In the age of Halliburton fraud and ExxonMobil subsidies, our government spends $93 billion a year on corporate welfare. (For comparison, that's roughly three times what it spends on a traditional welfare program like food stamps.) That doesn't include the recent bailout giving $700 billion to the same banks currently doling out $70 billion in executive pay and bonuses — a scheme the Financial Times says "amounts to a large transfer of resources from lower to higher income earners."

Thanks to these redistributive policies — policies McCain championed in Congress — the richest 1 percent today owns a larger share of America's wealth than at any time since before the Great Depression.

The Republican standard-bearer likely knows all this, but his fetish is fact-free fairy tales — the kind presenting seven houses, a beer-industry fortune and lockstep conservatism as mavericky Joe-the-Plumber populism. When it comes to economics, McCain is banking on Americans believing similarly inane myths — specifically, those portraying obscene affluence as the commonplace achievement under royalist rule.

During the indigence and socioeconomic immobility of the 19th century's Gilded Age, this meme flourished through Horatio Alger stories. Today, one in five American children live in poverty, and authorities from The Economist magazine to The Wall Street Journal note that our country exhibits the least amount of upward economic mobility in the industrialized world — less than even Europe's supposedly sclerotic socialisms. In light of that, sustaining the "American Dream" narrative requires updated rags-to-riches fantasies like "MTV Cribs," HBO's "Entourage" — and now McCain `08.

The Arizona senator's pulp fiction packs an extra-nationalistic punch, however. We are not only expected to support regressive redistribution, but also to believe that stopping such robbery is subversive. McCain implies Obama is backing Soviet conquest by proposing to finance tax cuts for 95 percent of American workers with tax increases on the richest 5 percent. When Joe Biden said it is "patriotic" for millionaires to pay their fair share of taxes, Republicans waved the bloody shirt of Reaganism and attacked him — as if Al Capone-style tax evasion is how aristocrats display their true love of country.

The GOP campaign, in short, is a brew of redbaiting and free-market zealotry, a concoction with a poisonous purpose: resurrecting the everyone-for-themselves pathologies that perpetuate the status quo. And if we revert to selfish form during this economic crisis, then McCain's cynical calculation is correct: America is a confederacy of dunces.



#6939 From: "Stephen Meyer" <Stephen276@...>
Date: Mon Nov 3, 2008 2:01 am
Subject: Stem Cells May Cure the Economy
stephen_meye...
Offline Offline
Send Email Send Email
 
Stem Cells May Cure the Economy - According to the Centers for Disease Control, the medical care costs of people with chronic diseases account for more than 75% of the nation's $2 trillion medical care costs. See (http://www.cdc.gov/nccdphp/overview.htm) for verification.
That mountain of debt may well be the root cause of the recession.  Consider that health care costs are now more than all federal income taxes combined.  Verify that at (http://www.irs.gov/taxstats/article/0,,id=102886,00.html). 
Our government supported medical research when it came to our own Dr. Jonas Salk.  Where would we be if polio had still been around for a half century?
Consider stem cell research!  Unused embryonic stem cells as well as adult stem cells can make a difference!  Think about your loved ones – think about moving forward with medical science!  Vote in favor of stem cell research and therapy!  It could save your life or that of your loved one!"
Keep up the good work, Don!!!!
Linda Scott
Dallas, TX

#6938 From: "Stephen Meyer" <Stephen276@...>
Date: Fri Oct 31, 2008 12:56 pm
Subject: STEM CELLS MAY CURE THE ECONOMY: One Last E-Blast
stephen_meye...
Offline Offline
Send Email Send Email
 

STEM CELLS MAY CURE THE ECONOMY: One Last E-Blast 

 

by Don C. Reed

 

If I could reach every stem-cell-supportive candidate right now, I would say:

 

Dear Candidate:

 

In these few remaining hours before election, consider a last-minute e-blast about your stem cell research support. Here's why:

 

It is a terrific way to reach independent voters Voters who self-identify as independents are the strongest supporters of stem cell research, stronger even than Democrats.

 

"Support (for embryonic stem cell research) is higher among Democrats (64 percent) than among Republicans (46 percent), and is highest among the politically important independents (67 percent).*--Peter D. Hart Research Associates, Results for America.

 

Reminding voters of your stem cell support cannot hurt you-- and it might help a lot.

 

In virtually every demographic, a majority of voters supports full stem cell research.   Recent polling, for example shows American Catholics support embryonic stem cell research three-to-one.  One national survey sponsored by the National Catholic Reporter shows "77% of American Catholics support stem cell research on excess embryos." Another 2008 poll, by Belden Russonello & Stewart, found: "By a wide margin, they (Catholic voters)  favor stem cell research with early human embryos (69% support)" --http://www.catholicsforchoice.org/documents/executivesummary.pdf.,

 

Who opposes stem cell research? An increasingly isolated minority of die-hard ideological ultra-conservatives—who will never vote for a progressive anyway… 

 

And if I could ask every candidate to send out ONE LAST E-BLAST, it would focus on one tremendous boost to the economy:

 

Dear Fellow Citizen:

 

We all agree: the economic meltdown is the number one concern of every American.

 

But my opponent fails to realize that healthcare costs are at the roots of the current crisis.

 

Listen to the American Association of Retired Persons, "Health care expenses can be one of the biggest, if not the biggest, causes of bankruptcy among older Americans."

 

You know the cost of your healthcare is skyrocketing. But take a look at the total costs…

 

***"The medical care costs of people with chronic diseases account for more than 75% of the nation's $2 trillion medical care costs". –Department of Health and Human Services, http://www.cdc.gov/nccdphp/overview.htm 

 

Two trillion dollars? That mountain of debt may well be the root cause of the recession.

 

Consider: Health care costs are now more than all federal income taxes combined.

(To verify that, visit the Internal Revenue Service website, Tax Stats at a Glance: (http://www.irs.gov/taxstats/article/0,,id=102886,00.html):

 

Individual income tax: $1.3 trillion ($1,366,241,000,000)

Corporation income tax: $400 billion ($395,536,000,000)

Add it up, round it off: $1.7 trillion.

 

All the federal income taxes in America combined, ($1.7 trillion dollars) are not as much as our health care costs ($2 trillion)—and why are our medical costs so high?

 

Because people are getting sick, but not getting well: an estimated 100 million Americans suffer a chronic (incurable) illness or disability: that is one out of three citizens!  We are keeping people alive, maintaining them in their misery, but not curing them.

 

Too many of our loved ones suffer disease and disability for which there is no cure—except, perhaps, through stem cell research.

 

How do we lower these impossible medical costs? The answer is huge, and plain.

 

Cure is the best way to lower health care costs.  Remember an earlier great success America had, when our own Jonas Salk invented a way to prevent the crippling disease of polio. If the Salk vaccine had not been developed, today we would be spending an estimated $28 billion each and every year for that one disease.

 

We do not have that cost today, because we backed medical research: overcoming the objections of the same ultra-conservatives (like my opponent) who are against it today.

 

Stem cells and other biomedical advances are a pillar of the new economy: a great way to help cure the financial crisis.

 

One final example: medical care for a paralyzed person may cost three to five million dollars over a lifetime.  But what is there was a cure? Embryonic stem cell therapies to alleviate paralysis are being considered by the Food and Drug Administration (FDA) right now. Patients with a spinal cord injury may soon have the chance to walk out of the hospital, instead of being condemned to a lifetime in a wheelchair.

 

We must consider our families: shall we develop a new industry bringing good-paying jobs to the community, while working to heal our suffering loved ones? Or not?

 

On November 4th, our country will decide: choosing between leaders who can grasp the shining promise of the future, or those who are inextricably tied to the failures of the past.

 

That decision is in your hands.

 

 


#6937 From: "Stephen Meyer" <Stephen276@...>
Date: Wed Oct 29, 2008 9:35 pm
Subject: 'Personhood' Amendment on Colorado Ballot
stephen_meye...
Offline Offline
Send Email Send Email
 
  •  

'Personhood' Amendment on Colorado Ballot

Listen Now [4 min 3 sec] add to playlist

 
Kristi Burton in La Junta, Colo.
Kristen Wyatt

Kristi Burton, who helped write the personhood amendment, eats lunch with supporters at Trinity Lutheran Church in La Junta, Colo. AP

 
 
 
"If you don't know you're pregnant ... and you drink or do something dangerous -- or you do something problematic very early on, and you're in Colorado or passing through Colorado -- have you committed child abuse and endangerment?"
Jessica Berg
 
 

All Things Considered, October 29, 2008 · Colorado is one of several states facing a controversial ballot measure this fall that could have far-reaching impacts on abortion law. Amendment 48 would define "personhood" as beginning at the moment of conception, giving fertilized human eggs the same constitutional rights as a person.

The first of its kind in the U.S., the amendment is the brainchild of 21-year-old Kristi Burton, who says she wants to establish a concrete definition of when life begins to protect unborn children. On a Sunday in October, Burton drove three hours from her home near Colorado Springs to speak at Life Church, an evangelical congregation in Fort Collins.

"Basically we're then directing our courts and our Legislature to say now that an unborn child is defined as a person; you need to look at that when making your laws," Burton said. She had set up a table displaying pictures of babies, along with bumper stickers and promotional DVDs to support her initiative. "If you'd like to get involved, we have many materials you can pick up, and please do pray for us. I really do believe that in the end, God is the one that fights the battle."

Similar measures have been proposed in Mississippi, Montana and Georgia, but Colorado is the only state to get enough signatures to put the personhood amendment on the ballot. It's the latest tactic by the anti-abortion movement to set the legal groundwork to overturn the controversial Roe v. Wade decision that legalized abortion in 1973.

Burton, who is studying at an online Christian law school, has been working on the concept for the past two years and says an attorney friend of hers wrote the amendment.

"I do believe that Roe v. Wade should be overturned," Burton says. "I mean even a lot of people on the pro-choice side say it was a bad decision made on bad law. And that's why we're trying to define a person and that's why Roe v. Wade should be relooked at. At least present new information."

As it stands, however, the amendment goes far beyond the issue of abortion, raising a host of questions regarding which constitutional rights a fertilized egg can logically be entitled to. Jessica Berg, a professor of law and bioethics at Case Western Reserve University, says the amendment could lead to some bizarre situations — such as counting fertilized eggs in the state census and pregnant drivers using the HOV lanes.

"If you don't know you're pregnant at that point, and you drink or do something dangerous — or you do something problematic very early on, and you're in Colorado or passing through Colorado — have you committed child abuse and endangerment?" Berg wonders.

Berg says that as written, the amendment would classify all the fertilized eggs used in fertility labs — which number in the hundreds of thousands — as persons.

"You could never get rid of them," she says of the fertilized eggs. "It's not clear whether you could freeze them, because we certainly don't have a concept of freezing indefinitely a person. It's not clear how you then adopt them — would you have to go through all the normal adoption proceedings?"

The controversial amendment has divided the anti-abortion community. The Colorado Catholic Conference worries that the courts would strike it down and end up reaffirming current abortion laws, and Colorado's anti-abortion Democratic governor, Bill Ritter, says the state could rack up huge legal bills defending the amendment.

"[The amendment] is outside the bounds of present law, present constitutional law," Ritter says. "It's just an extreme position by a really narrow interest group, narrowly crafted, and it's the wrong response."

The latest polls have the personhood amendment trailing by 15 percentage points, with 16 percent of the electorate undecided. National Conference of State Legislatures analyst Jennie Drage Bowser says even if it does fail, she thinks other states will still copy it.

"When a ballot measure is tried as a new idea in one state, it's not at all uncommon that that model is repeated in other states," she says. "So I do think that people in the anti- abortion community are going to be watching what happens in Colorado, and it could serve as a successful model. At the very least, though, it's important because it is a new strategy."

Should the amendment pass, both sides expect it would spend years being litigated in the courts. Proponents hope it would be challenged all the way to the U.S. Supreme Court to force a review of Roe v. Wade.

Bente Birkeland reports from Rocky Mountain Community Radio.


#6936 From: "Stephen Meyer" <Stephen276@...>
Date: Tue Oct 28, 2008 5:20 pm
Subject: HELP MICHIGAN TODAY—And Skip a Lot of Fighting Later On!
stephen_meye...
Offline Offline
Send Email Send Email
 

HELP MICHIGAN TODAY—And Skip a Lot of Fighting Later On!

 

Folks: Last night I went to a fundraiser for a California Senator, a strong friend of stem cell research. At the end of his remarks, he opened the floor for questions—and naturally I brought up Michigan!

 

What does California have to do with the wolverine state?

 

Because every stem cell supporter in America should be helping in the Michigan fight. The good folks back there are standing up for everyone, taking on the Religious Right, in an all-out battle for freedom for cure research.

 

If the anti-research forces can be defeated in Michigan, in a state held up as a right-to-life model, stem cell research ceases to be a controversy. That is hugely important; we will soon have a President who supports our research, and we want the only question to be—how many billions should be invested—NOT if we should do it or not because of the artificial controversy.

 

The opposition knows this too. They are billing their anti-research struggle as a last stand, and you cannot believe how much money and time they are willing to devote to try and keep the nation's most restrictive anti-science policies in place.

 

I went back there for a week, volunteering to help in the Michigan campaign, and it was a joy. Great folks, friendly and cheerful, despite not getting much sleep in recent history.  They are doing everything right; everybody is working hard, and intelligently.

 

But against them is one of the fiercest political forces on earth. The Catholic Church is the largest single property-owner on Earth, and they know how to use their wealth for political effect.

 

 If you are a Catholic in Michigan right now, you have been hammered relentlessly. Statements have been made from Rome that supporters of the research should be excommunicated, literally damned to Hell for all eternity. Your family would have been inundated with propaganda, not only weekly bulletins and preachments from the altar, but expensive professional slick commercials, multi-media stuff, including at least two major mailings. Two twelve-minute DVDs have been made, packaged and shipped to every Catholic family in Michigan—504,000 households. That's 1,008,000 DVDs alone. Wouldn't it be great if we had the money to send out that level of communication?

 

And on TV? The Michigan Catholic Conference is funding some of the cruelest and most dishonest advertisements ever made.

 

You might think lying would be frowned on, in an ad paid for by a church, but no, the prohibition against fibbing seems to have been set aside.

 

The lies in the ads are too many to fully recount: here are just a few: charges of new taxes (a flat lie, there is not a nickel in government money in Proposal 2), threats of cloning (illegal now, and it will still illegal after the law passes), ludicrous allegations of cow-human monstrosities (one ad features an actor in a cow suit!), and on and on and on.

 

Unfortunately, the ads are working. With the avalanche of lies being hurled at Proposal 2, people apparently are thinking, well, maybe some of this stuff is true—and every week a new ad is built around yet another lie.

 

Our support was high: 50% in favor of loosening some of the cruelest anti-research restrictions, 32% against. But after the media blitz paid for by the Michigan Catholic Conference, our numbers are way down—46 in favor/43 against. That is way too close.

 

The battle must be won.

 

But it cannot be successful if the opposition's lies go unanswered.

 

The campaign needs a few bucks from people like you and I. If you already agree, go to www.CureMichigan.com, and chip in a few more bucks.  (I will do so again, right now—hang on, back in a minute—okay, back, I just contributed another $25. If you know my wife, do not tell her. Like everybody else, we are pinching our pennies right now…)

 

If you are not quite convinced, please read the following update—and then go to www.CureMichigan.com.

 

 

SUMMARY – Michigan voters support eSCR.  Pro- messages are more compelling than anti-, and additional resources will solidify victory by assuring a proper level of closing communication.

 

HISTORIC SUPPORT / PUBLIC OPINION

For years in Michigan public opinion research has showed Michigan voters strongly supporting embryonic stem cell research (ESCR). CureMichigan collected 600,000 petition signatures in only 15 weeks, which proved historic as they collected more signatures in less-time than any other previous effort in Michigan political history.

 

The good news is while every independent statewide poll to-date has showed the effort leading.  Something we all know from experience is that positive cure messages prove more convincing than even the opposition's strongest anti-cure argument against ESCR.

 

WELL-FUNDED OPPOSITION

The Religious-Right has publicly declared Michigan as the "last stand" against ESCR.  They have so far invested over $7,000,000 in a misleading, deceptive television campaign.  The Michigan Catholic Conference has invested over $5 million, alone, with $2.2 million coming in just the past week.  Shamefully, their latest ad invokes racism by blatantly linking stem cell research to the Tuskegee Experiments from the 1940s.  You can watch their ads at www.2goes2far.com.

 

The unfortunate news is that we know this deception confuses voters and instills fear of medical research.

 

WHY MICHIGAN MATTERS

Winning in Michigan this November is critically important.

·         Should Michigan win, the "pro-cure" die is cast, but,

·         Should Michigan lose, the Religious-Right will be empowered.  They will take their despicable tactics and prey on other voters in other states.  They will argue the tide has turned because even Michigan, a political "Blue State", will have said "no" to ESCR.

 

DONOR MATCH

If you act today, your contribution will be matched by a very generous donor as CureMichigan seeks to bolster paid communication over the final days to solidify support amidst a flurry of deception by the Religious Right.

   

More information on the campaign, and the lives it touches, can be found at CureMichigan.com.

 

 

The facts about embryonic stem cell research in Michigan

 

The current law

 

§         Michigan law makes it a felony to use new embryonic stem cells — meaning embryonic stem cells that are leftover from fertility treatment — for research into cures to serious diseases and injuries.

§         Under the current law, a researcher who uses new embryonic stem cells to find cures in Michigan can be fined up to $10 million and imprisoned up to 10 years.

§         Michigan is one of five states with the most severe restrictions on embryonic stem cell research, along with Arkansas, North Dakota, South Dakota and Louisiana.

 

 

Full text of the ballot proposal

 

INITIATIVE PETITION - AMENDMENT TO THE CONSTITUTION

A Proposal to Amend the Constitution of the State of Michigan by adding a new Article I, Section 27 as follows:

Article I, Section 27.(1) Nothing in this section shall alter Michigan's current prohibition on human cloning.

(2) To ensure that Michigan citizens have access to stem cell therapies and cures, and to ensure that physicians and researchers can conduct the most promising forms of medical research in this state, and that all such research is conducted safely and ethically, any research permitted under federal law on human embryos may be conducted in Michigan, subject to the requirements of  federal law and only the following additional limitations and requirements:

(a) No stem cells may be taken from a human embryo more than fourteen days after cell division begins; provided, however, that time during which an embryo is frozen does not count against this fourteen day limit.

(b) The human embryos were created for the purpose of fertility treatment  and, with voluntary and informed consent, documented in writing, the  person seeking fertility treatment chose to donate the embryos for research; and

(i) the embryos were in excess of the clinical need of the  person seeking the fertility treatment and would
otherwise be discarded unless they are used for  research; or

(ii) the embryos were not suitable for implantation and  would otherwise be discarded unless they are used for  research.

(c) No person may, for valuable consideration, purchase or sell human embryos for stem cell research or stem cell therapies and cures.

(d) All stem cell research and all stem cell therapies and cures must be conducted and provided in accordance with state and local laws of general applicability, including but not limited to laws concerning scientific and  medical practices and patient safety and privacy, to the extent that any  such laws do not:

(i) prevent, restrict, obstruct, or discourage any stem cell research or stem cell therapies and cures that are  permitted by the provisions of this section; or

(ii) create disincentives for any person to engage in or otherwise associate with such research or therapies or  cures.

(3) Any provision of this section held unconstitutional shall be severable from the remaining portions of this section.

 

FOLKS, SEND A COUPLE BUCKS RIGHT NOW TO WWW.CUREMICHIGAN.COM

 

Thanks,

 

Don C. Reed

 

P.S. On our last day in Michigan, Gloria and I treated ourselves to a trip to the magnificent Detroit Zoo, one of the most beautiful in the world. Gloria loved  the polar bear swimming underwater, but for me the highlight was three wolverines, powerful, small, agile, fearsome—but nearly extinct in the wild.

 

The wolverine is the symbol of courage and ferocity, but it can well be wiped off the face of the earth if it does not receive a little wisdom and caring from humanity.

 

Like stem cell research in Michigan.

 

www.CureMichigan.com

 
 
 
 

#6935 From: "Stephen Meyer" <Stephen276@...>
Date: Mon Oct 27, 2008 1:19 pm
Subject: MISTAKE IN DON REED’S ARTICLE:
stephen_meye...
Offline Offline
Send Email Send Email
 

MISTAKE IN DON REED'S ARTICLE:

 

The following article, which I posted yesterday, contained an error on the Tuskegee Syphilis Experiment. That cruelty was recently denounced by survivors of the Tuskegee Airmen Experiment, (which was the reason for my confusion) but there were no Airmen in theTuskegee Syphilis Experiment, which was inflicted on uneducated sharecroppers.

 

I apologize for this error. Readers are urged to Google both the Tuskegee Syphilis Experiment and the Tuskegee Airmen Experiment. One is a travesty, the other a triumph.

 

But my original point still stands.

 

Thanks,

 

Don C. Reed

 

SHAME ON MICHIGAN CATHOLIC CONFERENCE: Lies Discredit Church

 

In a series of dishonest TV ads, print media, and DVD mass mailings, the Michigan Catholic Conference is attacking stem cell research, maligning Proposal 2— and undermining the good name of the Catholic Church.

 

My family is Catholic.  But the truth is the truth, and when the Church is wrong, it's wrong.  

 

The Church is run by human beings, who can make mistakes. When the Church ordered Joan of Arc to be burned to death as a witch, that was a mistake. When the Spanish Inquisition tortured and murdered Jews and took their money, that was a crime. When the Vatican maintained silence about the Nazis in World War II, that was a sin of omission, for which Pope John Paul II personally apologized, to his great credit.

 

And when expensive TV ads (paid for by the Michigan Catholic Conference) talk about Proposal 2 wanting to raise taxes, or clone people, or mix cows and human eggs together, these are deliberate and knowing lies.

 

Proposal 2 does not raise Michigan taxes one cent. Proposal 2 does not change Michigan 's strict law against cloning, which still carries a jail sentence. And the only embryonic stem cell research Proposal 2 supports is on blastocysts left over from in vitro fertility procedures—biological material that would otherwise be thrown away.

 

Right now, the Church's leadership is out of touch with its members, the vast majority of whom support embryonic stem cell research.*

 

That is forgivable. Down through history many religions have been slow to support medical breakthroughs. Anesthesia was forbidden by the Church because the Good Book said women were supposed to "bring forth (their) children in pain." The small pox vaccine was opposed because it was thought the disease was God's punishment for sin.

Even X-rays were opposed because it was thought they might be used to see through women's clothing!

 

But the Church is not supposed to lie, ever.  "Thou shalt not bear false witness" is a Biblical Commandment which applies to upper management like everybody else.

 

Anti-Proposal 2 advertisements (paid for by the Michigan Catholic Conference) are filled with manipulation, misinformation, deceit: so many lies, it is difficult to answer them all. 

 

Each ad is built around a different falsehood. 

 

Here are a few:

 

1. Alleged tax increase: false. The ad shows an actor dressed as a custodian shoveling bundles of dollar bills into a wheelbarrow. The camera pulls back, and the money is shaped like the state of Michigan . Michigan can't afford to spend millions of dollars on stem cell research, the ad says. The reality?  Proposal 2 has no taxation. Zero. There is not a single tax dollar in the whole measure. It is what is called a "permissions bill", merely allowing scientists to do their work without fear of imprisonment.

 

2. Another ad shows fictitious cloning companies, with fake names like "Clone Crop", implying that Proposal 2 would allow the cloning of people. This is utterly false. The reality is plain, and verifiable: Michigan has strict laws prohibiting cloning, including a ten year jail sentence; nothing in Proposal 2 changes that.

 

3. In a genuinely ridiculous ad, an actor in a cow costume raises his hoof in objection to a mad scientist wanting to make cow-people. This would be laughable if the purpose was not so damaging. The only kind of embryonic stem cell research Proposal 2 supports is the use of blastocysts that would otherwise be thrown away: leftover biological materials already destined for the trash.

 

4. The most recent ad is perhaps the worst. One of the cruelest acts ever perpetrated by a government was the Tuskegee Airmen Syphilis Experiment. This was a crime against humanity done by the U.S. Public Health Service, a symbol of shame—and now the MCC is  attempting to tie that act of criminality to modern-day stem cell research.

 

Let's take a look at reality.

 

First, what was the Tuskegee Syphilis Experiment? Google it. Find out about it, because it was a crime of Nazi-like evil, which must never be allowed to happen again.

 

Over forty years, 1932 to 1972, the U.S. Public Health Service denied cure to 399 African-American men with syphilis—even after penicillin was invented.

 

Those men could have been cured. But the government denied them the medicine which would have made them well. Many of them died because that medical advance was withheld.

 

Is this not very much like what the Michigan Catholic Conference is trying to do with these ads?   As penicillin was denied to suffering African-Americans, even so research which might ease suffering and save lives for literally millions of Americans today is being held back.

 

Fortunately, survivors and family members of the Tuskegee tragedy have spoken out, objecting to the misleading advertisements.

 

"It's disgraceful that they would use this horrible chapter in American history to score cheap political points and block patients from hope and cures," said Aurelia E. Alexander Smith of Detroit , whose late father, Capt. Halbert L. Alexander was a Tuskegee Airman. "My hope is that people who see this ad aren't fooled by the lies, and instead listen to the facts about stem cell research."

 

Is the Michigan Catholic Conference ( MCC )  responsible for the outrageous lies in this ads? Absolutely, because it paid for them. The MCC is the single largest contributor to the opposition to Proposal 2. That is a matter of public record. 

 

If the Michigan Catholic Conference wants to make a religious objection to the research, that is fine. It has every right to do so, just as some faith communities are opposed to blood transfusions, and forbid their membership to accept that medical treatment.

 

But lying is different.  A church is supposed to be honest. If it deliberately and publicly deceives, not once but systematically, over and over-- how shall it be trusted?

 

Catholics everywhere should speak up. The faith of millions demands a public apology for these disgraceful ads.

 

And if anybody reading this would like to try and help balance the incredibly damaging impact of those TV commercials (which are being run over and over in Michigan ), they need only click on the following:

 

www.CureMichigan.com

 

If you can, do what I just did and make a small donation. I put in another $25—I know, big spender, huh—but the good news is that money will be doubled. A matching grant has been promised, so that every dollar contributed will be matched by one from an anonymous donor.

 

Ads to answer the lies have been made, but it is difficult to find the money to pay for them being aired. The Catholic Church is the largest property owner in the world, and has extremely deep pockets. It would be a shame if their ads were not countered for lack of a few dollars.

 

But whether you can afford to contribute or not, go to www.CureMichigan.com, and take a look at the honest work these citizens of Michigan are doing.

 

They are standing up for everyone. The entire nation will benefit from their efforts to reverse what have been called the most restrictive anti-science laws in the nation.

 

They are fighting for the right of every American family to have access to the best medical care science can provide.

 

We must not let them stand alone.

 

*A recent national survey sponsored by the National Catholic Reporter shows "77% of American Catholics support stem cell research on excess embryos." This is in line with other polls such as that done by Belden Russonello & Stewart, which found that "69% of Catholics support stem cell research with early human embryos"—July, 2008

Don C. Reed
Sponsor, Roman Reed Spinal Cord Injury Research Act
Founder and Co-Chair, Californians for Cures
 
Don Reed is also Vice President of Public Policy for Americans for Cures Foundation; opinions voiced here as an individual may or may not reflect those of the Foundation.
 
 
 

#6934 From: "Stephen Meyer" <Stephen276@...>
Date: Fri Oct 24, 2008 12:51 am
Subject: The 2008 Republican Platform Committee has finally reached the finish line
stephen_meye...
Offline Offline
Send Email Send Email
 

http://corner.nationalreview.com/post/?q=YjM0MGNmZjY2NGIyYzYzMjhmMzI0MGRmODZlZmM5ZDA

 

 

 

Wednesday, August 27, 2008

Going Out With a Bang   [Stephen Spruiell]

The 2008 Republican Platform Committee has finally reached the finish line, but before it crossed it tripped up on the issue of stem-cell research. When the committee reached the stem-cell language, North Carolina delegate Mary Summa offered what appeared on the surface to be a small change. Summa sought to change the sentence:

We call for a ban on human cloning and a ban on the creation of and experimentation on human embryos for research purposes.

to read:

We call for a ban on human cloning and a ban on the creation of or experimentation on human embryos for research purposes.

thus severing experimentation on human embryos from their creation for that purpose. It's just one word, but it has huge implications. It is a call for a total ban on embryonic stem-cell research, including privately funded research using frozen embryos from in-vitro fertilization (IVF) clinics. By contrast, the 2004 platform was in accord with President Bush's policy at the time, which made limited federal funding for embryonic stem-cell research available for the first time.

In introducing her amendment, Summa gave an emotional speech in which she said, "I want my five children to live in a world where the weak are protected from the strong. I want them to live in a world where all life is protected."

The amendment drew opposition from Indiana delegate and pro-life activist James Bopp Jr. "The sentence now in the draft, which ties the creation to the experimentation, is exactly right," Bopp said. He argued that the amendment would declare off-limits certain types of life-saving therapeutic research he supports.

Bopp's objection was itself objected to by several delegates who supported the amendment. Then Summa asked Bopp point-blank, "Under the current language in this document, does this mean that you can experiment on human embryos that are frozen in IVF clinics?"

Bopp answered, "The way I read this sentence is that it does have limited application. It does not call for a ban on everything that I might support. The amendment that has been put forward would ban not only the type of research that I oppose, but also the types of therapeutic research I have described."

He added, "We should not be in the business of prohibiting therapeutic research."

At this point, Kansas delegate Kris Kobach offered an amendment to Summa's amendment that would have replaced the words "experimentation on" with "destruction of." Committee co-chairman Sen. Richard Burr asked Summa if she would accept the change. She replied, "I certainly would accept the amendment, but the former prosecutor in me would like Mr. Bopp to answer my question."

Bopp quipped, "The defense attorney in me would say I have answered her question."

Bopp then offered his own amendment to Summa's amendment. At this point Burr broke it up. He instructed Summa, Bopp and Kobach to confer until they had come up with a single amendment on stem-cells. The committee then moved on to other matters.

When the three of them returned, Summa's eyes were red and swollen. She re-submitted her original amendment, without modification. Burr called for a vote, and the motion passed.

The 2008 Republican Platform calls for a ban on all embryonic stem-cell research, public or private.

 


#6933 From: "Stephen Meyer" <Stephen276@...>
Date: Fri Oct 24, 2008 12:37 am
Subject: The National Republic Online-Change of One Word Effects Stem Cell Research
stephen_meye...
Offline Offline
Send Email Send Email
 

http://corner.nationalreview.com/post/?q=YjM0MGNmZjY2NGIyYzYzMjhmMzI0MGRmODZlZmM5ZDA

 

 

 

Wednesday, August 27, 2008

Going Out With a Bang   [Stephen Spruiell]

The 2008 Republican Platform Committee has finally reached the finish line, but before it crossed it tripped up on the issue of stem-cell research. When the committee reached the stem-cell language, North Carolina delegate Mary Summa offered what appeared on the surface to be a small change. Summa sought to change the sentence:

We call for a ban on human cloning and a ban on the creation of and experimentation on human embryos for research purposes.

to read:

We call for a ban on human cloning and a ban on the creation of or experimentation on human embryos for research purposes.

thus severing experimentation on human embryos from their creation for that purpose. It's just one word, but it has huge implications. It is a call for a total ban on embryonic stem-cell research, including privately funded research using frozen embryos from in-vitro fertilization (IVF) clinics. By contrast, the 2004 platform was in accord with President Bush's policy at the time, which made limited federal funding for embryonic stem-cell research available for the first time.

In introducing her amendment, Summa gave an emotional speech in which she said, "I want my five children to live in a world where the weak are protected from the strong. I want them to live in a world where all life is protected."

The amendment drew opposition from Indiana delegate and pro-life activist James Bopp Jr. "The sentence now in the draft, which ties the creation to the experimentation, is exactly right," Bopp said. He argued that the amendment would declare off-limits certain types of life-saving therapeutic research he supports.

Bopp's objection was itself objected to by several delegates who supported the amendment. Then Summa asked Bopp point-blank, "Under the current language in this document, does this mean that you can experiment on human embryos that are frozen in IVF clinics?"

Bopp answered, "The way I read this sentence is that it does have limited application. It does not call for a ban on everything that I might support. The amendment that has been put forward would ban not only the type of research that I oppose, but also the types of therapeutic research I have described."

He added, "We should not be in the business of prohibiting therapeutic research."

At this point, Kansas delegate Kris Kobach offered an amendment to Summa's amendment that would have replaced the words "experimentation on" with "destruction of." Committee co-chairman Sen. Richard Burr asked Summa if she would accept the change. She replied, "I certainly would accept the amendment, but the former prosecutor in me would like Mr. Bopp to answer my question."

Bopp quipped, "The defense attorney in me would say I have answered her question."

Bopp then offered his own amendment to Summa's amendment. At this point Burr broke it up. He instructed Summa, Bopp and Kobach to confer until they had come up with a single amendment on stem-cells. The committee then moved on to other matters.

When the three of them returned, Summa's eyes were red and swollen. She re-submitted her original amendment, without modification. Burr called for a vote, and the motion passed.

The 2008 Republican Platform calls for a ban on all embryonic stem-cell research, public or private.

 


Messages 6933 - 6962 of 6993   Newest  |  < Newer  |  Older >  |  Oldest
Advanced
Add to My Yahoo!      XML What's This?

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help